57799 final prog timetable
29/3/05
11:40 am
Page 2
BEST PRACTICE Scottish Exhibition & Conference Centre Glasgow
Association of Surgeons of Great Britain and Ireland President: Mr Robert Lane
PROGRAMME
ANNUAL SCIENTIFIC MEETING 2005
Key to colour coding used within the Scientific Programme
57799 final prog timetable
29/3/05
11:40 am
Page 3
General
Breast
Colorectal
Endocrine
Laparoscopic
Paediatric
Upper Gastrointestinal
Transplantation
Vascular
Society of Academic and Research Surgery (SARS)
57799 final prog timetable
29/3/05
11:40 am
Page 1
Association of Surgeons of Great Britain and Ireland
ANNUAL SCIENTIFIC MEETING BEST PRACTICE: GLASGOW 2005
CONTENTS Welcome from the President, Mr R H S Lane
2
ROYAL COLLEGES, SPECIALTY ASSOCIATIONS AND SOCIETIES
4
GENERAL INFORMATION On-site Registration Fees
6
Conference Registration Desk
6
Continuing Professional Development
6
Messages
6
Car Parking
6
Cloakroom
6
Trade Exhibition
6
Lunches and Refreshments
6
Organising Committee
7
Corporate Patrons
7
PRIZES AND AWARDS Moynihan Prize
7
Six of the Best Short Paper Prizes
7
Poster Prizes
7
John Wiley & Sons Audio Visual Prize
7
John Farndon Prize
8
TAUGHT COURSES
8
BREAKFAST MEETINGS
9
AUDIO VISUAL SERVICE CENTRE
9
PROGRAMME
INTRODUCTION
SOCIAL PROGRAMME Evening Programme
10
Accompanying Persons’ Programme
10
GUEST SPEAKERS AND INTERNATIONAL VISITORS
12
SCIENTIFIC PROGRAMME
18
LIST OF POSTER PRESENTATIONS
40
PLAN OF THE TRADE EXHIBITION HALL
46
LIST OF EXHIBITORS
47
EXHIBITORS’ DETAILS
48
PLAN OF THE SECC
61
1
57799 final prog timetable
29/3/05
11:40 am
Page 2
WELCOME FROM THE PRESIDENT
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
Mr Robert Lane
2
I have great pleasure in welcoming you to Glasgow for the 2005 Annual Scientific Meeting of the Association of Surgeons of Great Britain and Ireland. The Scottish Exhibition and Conference Centre is ideal for our purposes as it has an excellent sized auditorium, good breakout theatres and a large space for our Trade Exhibition. Specialisation within general surgery has become the order of the day and sometimes one forgets the skills and expertise that are required to undertake emergency surgery. It is for this reason that we have introduced four didactic sessions which will provide an update on the management of Upper GI, Colorectal and Urological emergencies and also on the difficult problem of serious head injuries. This is an innovation which I anticipate will be popular. It is so easy to become focused on one’s own specialty and forget what is going on elsewhere. The Moynihan Prize papers will be read at the outset of the Meeting on Wednesday and I have to say the standard this year has been exceptional. This will be immediately followed by the Helen Rollason Memorial Lecture and we are delighted that this year it will be given by Professor Umberto Veronesi entitled “Changing Paradigms in the Management of Breast Cancer”. Professor Veronesi is an accomplished speaker and his lecture will be well worth listening to whatever our own speciality interest might be. The Association of Surgeons in Training and the National Association of Assistants in Surgical Practice will again be having their sessions whilst the ASGBI Annual General Meeting is taking place. Forty five minutes are set aside after the AGM for discussion of a Hot Topic; the title of which is always left to the last moment! The four Royal Colleges of Surgeons encompassed by the Association will each present their eponymous lectures on the theme of “Best Practice”. Modernising Medical Careers continues apace and we shall have a timely update by Professor Alan Crockard and Dr Peter Simpson (PMETB), amongst others, on Thursday morning. Much discussion has been undertaken in recent months and I do believe that a sense of direction has now taken place and hopefully the process will roll out in a seamless way as envisaged. That is not to say there will be no problems, but the profession, as a whole, will have to be sensitive to the situation especially in the transition period. Education, training and research are all integral to MMC and we welcome Professor Hilary Sanfey from Charlottesville who will give the American perspective followed by Sir Ara Darzi and Denis Wilkins who will present the UK perspective. Modern aspects of training and the commitment by trainers will be addressed. Training necessitates assessment and examinations and this aspect will be discussed in detail and should be of great interest to our future trainees who will have a far more structured and competency based programme of training than in the past. That is provided we can sort out the European Working Time Directive! Professor Brian Rowlands, the 2005 BJS Travelling Fellow, will address this in his lecture entitled “Eurocrats, Europhiles and the Island Race: Making Sense of the EWTD”. In the subsequent session there will be ample time to consider the effect this is having upon training and life in general together with discussing a number of solutions. Service delivery, including manpower and resources, will also be addressed on Thursday. Tom Dehn will report on the evolution and likely success of Independent Treatment Centres and Professor Allyson Pollock will present an overview of the National Health Service and its future. I have heard what she has to say and her conclusions are very important for the National Health Service as a whole and surgery in particular.
57799 final prog timetable
29/3/05
11:40 am
Page 3
Melanoma and sarcoma are rare presentations to general surgeons but, nonetheless, when they do occur they need careful assessment and timely referral for specialist treatment. This issue will be addressed on Friday morning followed by a session on multidisciplinary cancer management. Team working is so important and we welcome Professor Hartley Stern from Ottawa who will give the Canadian perspective. This year the Independent Practice Session will include an important presentation by Mr Ronald Bowie, Chairman of the Pensions Board of the Institute of Actuaries, who will discuss the proposed changes to our pension agreements.
This meeting, which is again held in association with the Specialty Associations and Societies within General Surgery, welcomes Dr Rudolf Steffen from Bern (British Obesity Surgery Society), Mr Michael Li from Hong Kong, Professor Raffaele Pugiliese from Milan and Dr Benoit Navez from Belgium (Association of Laparoscopic Surgeons), Professor Emile Rutgers from Amsterdam (Association of Breast Surgeons at BASO) and Professor Olle Ljungqvist from Stockholm (Society of Academic and Research Surgery). Each Specialty Association or Society has a Breakfast Session (pre-booking essential), at least one symposium, a “Six of the Best” short paper session and a number of other short paper and oral poster sessions. Taught courses and workshops were introduced last year and were extremely popular. This year we again offer “Critical Care Update for Surgeons” and “Sentinel Node Biopsy for Trainees”. An innovation this year is “Endocrine and Breast Surgical Sonography” followed by “Emergency Ultrasound for the General Surgeon”. Pre-booking is essential for these courses. The Association of Surgeons of Great Britain and Ireland is extremely grateful to its Corporate Patrons; B Braun, Ethicon, Stryker, Tyco and GlaxoSmithKline, for their continuing support. Our commercial partners contribute significantly to the success of the Meeting and I do urge you to support the excellent Trade Exhibition which will be held in Halls 1 and 2 adjacent to the Lomond Auditorium. There is a very varied and active social programme which includes a city tour and a visit to the Burrell Collection, a tour of Stirling Castle culminating with a trip on Loch Lomond and finally, for those who still yearn for great art, a visit to Bellahouston Park which, apart from being a gallery, is home for the Glasgow Art School. The Association’s Annual Dinner will be held at the Hilton Hotel and I promise that this will be an occasion to remember.
PROGRAMME
The Overseas Session has been extended and we welcome Imre Loefler from Nairobi who has been an influential voice of surgery in Africa for many years. For the first time the Association is holding a Military Surgery Symposium and this has all the hallmarks of being a very interesting and stimulating session. Military surgical trainees have always had a better deal than those in civilian practice, especially in terms of obtaining breadth of experience and knowledge. I suspect that civilian trainees will find this session very worthwhile.
I hope you are going to enjoy the Meeting. The Scientific Committee have done their utmost to accommodate all specialties as well as including sessions on other important topics relevant to the practice of surgery today. I welcome you all.
Mr R H S Lane, MS, FRCS President 3
57799 final prog timetable
29/3/05
11:40 am
Page 4
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
ROYAL COLLEGES, SPECIALTY ASSOCIATIONS AND SOCIETIES
4
We are delighted that this Annual Scientific Meeting is being held in collaboration with the general surgical specialty associations and societies and that the four Surgical Royal Colleges and many other societies are contributing to the Meeting. We are, therefore, pleased to welcome the following Presidents and representatives to Glasgow: Association of Breast Surgery at BASO Chairman: Mr Hugh Bishop
Vascular Society President: Professor Michael Horrocks
Association of Coloproctology of Great Britain and Ireland President: Mr John Hyland
Society of Academic and Research Surgery President: Professor Irving Taylor
Association of Laparoscopic Surgeons of Great Britain and Ireland President: Professor Michael Bailey
Royal College of Physicians and Surgeons of Glasgow President: Professor Graham Teasdale
Association of Upper Gastrointestinal Surgeons President: Professor Michael Griffin
Royal College of Surgeons of Edinburgh President: Mr John Smith
British Association of Endocrine Surgeons President: Mr Anthony Young
Royal College of Surgeons of England President: Mr Hugh Phillips
British Transplantation Society President: Mr John Forsythe
Royal College of Surgeons in Ireland President: Professor Niall O’Higgins
29/3/05
11:40 am
Page 5
Association of Surgeons in Training President: Mr Leith Williams
Specialist Advisory Committee in General Surgery Chairman: Mr John Black
British Association of Paediatric Surgeons President: Mr Victor Boston
British Journal of Surgery Society Chairman: Professor Neil Mortensen
BASO~The Association for Cancer Surgery President: Professor Robert Mansel
Helen Rollason Cancer Care Centre Appeal Chairman: Professor Neville Davidson
British Obesity Surgery Society President: Professor Alan Johnson
Society of British Neurological Surgeons President: Mr James Steers
National Association of Assistants in Surgical Practice Chairman: Miss Jill Biggins
British Association of Urological Surgeons President: Mr Paddy O’Reilly
PROGRAMME
57799 final prog timetable
The Association would also like to thank the following for their generous support of this Meeting B Braun Medical Ethicon Endo-Surgery Ltd GlaxoSmithKline Stryker UK Tyco Healthcare
5
57799 final prog timetable
29/3/05
11:41 am
Page 6
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
GENERAL INFORMATION FEES FOR REGISTRATIONS “ON-SITE” AT THE SECC Fellows & Medical Delegates of Consultant Status:
£235 per day (Wednesday / Thursday / Friday) OR: £580 all three days
Trainees, Affiliates, Associates, Seniors, Honorary Fellows and Overseas Delegates:
£140 per day (Wednesday / Thursday / Friday) OR: £260 for all three days
Nurses and Paramedics:
£65 per day (Wednesday / Thursday / Friday) OR: £125 for all three days
CONFERENCE REGISTRATION DESK The Conference Registration Desk will be situated in the entrance to Hall 1 of the SECC where delegate bags, badges and individual tickets must be collected on arrival. Please note that name badges must be worn for the duration of the meeting. The Registration Desk will be open at the following times: Wednesday 13th April 2005: Thursday 14th April 2005: Friday 15th April 2005:
8.00am to 6.15pm 8.00am to 5.45pm 8.00am to 2.00pm
CONTINUING PROFESSIONAL DEVELOPMENT A CPD register will be available for signature at the Conference Registration Desk and must be signed by delegates for each day on which they wish to be accredited. The register will be kept at the Association’s offices and may be used by your College after the meeting to check against the record in your CPD diary. CPD points (where relevant) have been awarded as follows: Wednesday 13th April 2005: Thursday 14th April 2005: Friday 15th April 2005:
7 CPD points 8 CPD points 6 CPD points
MESSAGES URGENT MESSAGES for delegates may be left and retrieved from the Conference Registration Desk. Delegates are asked to ensure that mobile telephones do not disturb sessions. The emergency telephone number for delegates is: 020 7304 4787
CAR PARKING For those delegates unable to park at their hotel, there are a total of 3000 car parking spaces at the SECC. The charge to park a car for the day is £3.50.
CLOAKROOM A cloakroom is situated just off the main concourse at the SECC. The charge to deposit an item is £1.00 per day. The cloakroom can also be used for left luggage. Items deposited in the cloakroom will be left at your own risk.
TRADE EXHIBITION A major Trade Exhibition will be held in Halls 1 & 2 throughout the Meeting. This will open from 8.00am on Wednesday 13th April 2005 and close at 2.00pm on Friday 15th April 2005. The Exhibition will feature many interesting and diverse commercial stands and exhibits.
LUNCHES AND REFRESHMENTS Lunch, coffee and tea are included in the Registration Fee and will be served in the Exhibition Hall. Coffee and tea will also be available throughout each day, on a self-service basis, in the Exhibition Hall.
6
57799 final prog timetable
29/3/05
11:41 am
Page 7
ORGANISING COMMITTEE The Association is most grateful to the Scientific Committee and members of staff who have contributed to the organisation of this Meeting. Professor H Paul Redmond Professor Michael L Nicholson Mr Rowan W Parks Professor Matt M Thompson Professor John N Primrose Mr Robert H S Lane Professor Brian Rowlands
Mr Denis C Wilkins Mr Graham T Layer Mr John L Duncan Mr John MacFie Dr Nicholas P Gair Miss Angela Kirby Dr Connor Shields
CORPORATE PATRONS The Association is grateful to its five Corporate Patrons (B.Braun, Ethicon, GlaxoSmithKline, Stryker, Tyco) for their continued support and for their significant contribution towards the organisation of this Meeting.
MOYNIHAN PRIZE This is the Association’s most prestigious scientific award. The prize consists of £1,000 together with a medal, and is presented to the author of the best research work delivered at the Annual Scientific Meeting. The person reading the paper must be the principal research worker and have been qualified for less than fifteen years. The papers short-listed for the 2005 Moynihan Prize will be presented in conference session W1L from 9.00am to 10.30am on Wednesday 13th April 2005 in the Lomond Auditorium. The Moynihan session will be chaired by the President and adjudication will be carried out by members of the Association’s Scientific Committee. The winning paper will be announced by the President at the beginning of session W3L, immediately after the coffee break.
SIX OF THE BEST SHORT PAPER PRIZES There will be eight “Six of the Best” short paper sessions as follows: W2A W2M3 W3C T1B T2B T3B T5D F4A
Six of the Best Vascular Papers Six of the Best SARS Papers Six of the Best Endocrine and Transplant Papers Six of the Best Upper GI Papers Six of the Best General Papers Six of the Best Colorectal Papers Six of the Best Breast Papers Six of the Best Laparoscopic Papers
The winner in each session will receive a cheque for £150. Adjudication will be undertaken by the joint Chairmen and the Specialty Adjudicator, and the winners will be announced, by the Chairmen, at the end of each session.
POSTER PRIZES One hundred and twenty scientific posters will be presented in the Exhibition Hall throughout the Meeting. Poster adjudication will take place at lunchtime on Thursday 14th April 2005 when presenters will be expected to stand by their poster for the “poster run”.
PROGRAMME
PRIZES AND AWARDS
Each poster will also be presented orally. There will be six oral poster presentation sessions in the Moat House Hotel on Wednesday 13th April 2005, when each presentation will be allocated a maximum of 5 minutes (3 minutes presentation, plus 2 minutes discussion) with no more than four PowerPoint slides. There will be six Poster Prizes and the winner in each category will receive a cheque for £100. Adjudication will be carried out by members of the Scientific Committee and representatives of the Specialty Associations and Societies in General Surgery, who will also chair the mini-oral poster presentation sessions. The six winning entries (one from each session) will be displayed prominently in the entrance foyer to the conference for the remainder of the Meeting.
JOHN WILEY & SONS LTD AUDIO VISUAL PRIZE Short-listed videos/DVDs submitted for the John Wiley & Sons Ltd Audio Visual Prize will be screened during conference session W2D from 11.30am to 12.30pm on Wednesday 13th April 2005 in the Dochart Lecture Theatre. There will be two categories of award: Entries produced “in-house” by a consultant surgeon in association with his/her department of medical illustration, and entries produced more “commercially” by a consultant surgeon with external technical or financial assistance. The winner in each category will receive a plaque and a cheque for £300. The prize winning entries will be announced by the Chairmen at the end of the session. All entries presented in the Video/DVD session will be screened regularly throughout the remainder of the Meeting in a ‘mini cinema’ located in the Etive Room adjacent to the Lomond Auditorium.
7
57799 final prog timetable
29/3/05
11:41 am
Page 8
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
JOHN FARNDON PRIZE The British Journal of Surgery has endowed a prize of £500 for the best paper published in the Journal after the work has been accepted in abstract form for this Annual Scientific Meeting. Other papers may be published, but their inclusion in the Journal is subject to the usual system of editorial review. Manuscripts can either be handed-in to the Conference Registration Desk at the Meeting, or sent direct to: John Farndon Prize (ASGBI) British Journal of Surgery John Wiley & Sons Ltd The Atrium Southern Gate Chichester West Sussex PO19 8SQ To be eligible for consideration for the prize, papers must be published in, or before, the January 2006 edition of the British Journal of Surgery. The winner of the John Farndon Prize will be announced at the Association’s Annual Dinner.
TAUGHT COURSES Four Taught Courses, as detailed below, will be offered in parallel with the Scientific Meeting. A Course Fee will be charged for attendance on these Courses, in addition to the Conference Registration Fee applicable. Numbers are strictly limited and attendance will only be permitted to those holding valid, pre-registered, tickets. However, it may be that some of the Taught Courses do not reach their maximum number of delegates in advance of the Annual Scientific Meeting and that it will, therefore, be possible to register “on-site” at the SECC. Please apply to the Conference Registration Desk. Unreserved places will be allocated on a ‘first come, first served’ basis.
Wednesday 13th April 2005 Critical Care Update for Surgeons 9.00am to 3.00pm on Wednesday 13th April 2005 Maximum 40 delegates Course Fee: £75 per person, in addition to the applicable Conference Registration Fee. This one-day workshop will use lectures, small group teaching, case-based scenarios and panel discussions. The course will provide an update on the contemporary management of critically ill surgical patients. Topics to be covered include the modern management of shock, sepsis and trauma; current practice in nutrition, perioperative optomisation and pre-operative assessment; renal failure and renal replacement therapy.
Thursday 14th April 2005 Endocrine and Breast Surgical Sonography 9.00am to 12.00 noon on Thursday 14th April 2005 Maximum 40 delegates Course Fee: £50 per person, in addition to the applicable Conference Registration Fee. This half-day workshop aims to introduce surgeons to the basic principals of ultrasound. It will demonstrate the role of surgical sonography in breast and endocrine disease and provide hands-on practical tuition in the use of surgical sonography for breast and endocrine imaging. Sponsored by SONOSITE Emergency Ultrasound for the General Surgeon 1.00pm to 4.00pm on Thursday 14th April 2005 Maximum 40 delegates Course Fee: £50 per person, in addition to the applicable Conference Registration Fee. This half-day workshop will introduce surgeons to the basic principals of ultrasound. It will demonstrate the role of emergency ultrasound incorporating focused abdominal sonography in trauma (FAST) and provide hands-on practical tuition in the use of emergency ultrasound for the general surgeon. Sponsored by SONOSITE
Friday 15th April 2005 Sentinel Node Biopsy for Trainees 9.00am to 3.30pm on Friday 15th April 2005 Maximum 40 delegates Course Fee: £75 per person, in addition to the applicable Conference Registration Fee. This Breast SLN course is aimed at senior general/breast trainees (HST 5/6). The course will provide the historical context and background to this emerging surgical technique, as well as the current evidence base. A combination of lectures, debates and mini-workshops will introduce delegates to the practicalities of SLN service delivery. A faculty of UK experts have been assembled for what promises to be an exciting and stimulating day.
8
57799 final prog timetable
29/3/05
11:41 am
Page 9
BREAKFAST MEETINGS There will be a number of Breakfast Meetings throughout the Annual Scientific Meeting, as detailed below. Numbers are strictly limited and attendance will only be permitted to those holding valid, pre-registered, tickets. However, it may be that some of the Breakfast sessions do not reach their maximum number of delegates in advance of the Annual Scientific Meeting and that it will, therefore, be possible to register “on-site” at the SECC; please apply to the Conference Registration Desk. Unreserved places will be allocated on a ‘first come, first served’ basis and, unless stated otherwise, an Attendance Fee of £15 per person will be charged for each meeting (in addition to the applicable Conference Registration Fee), which includes a continental breakfast.
Wednesday 13th April 2005, 8.00am to 9.00am • British Association of Paediatric Surgeons Problems with the care of inflammatory bowel disease in adolescence Dr Mark Dalzell, Mr Roy Maxwell and Mr Bill McCallion Fyne Room (SECC). Maximum 15 persons
• Staff and Associate Specialist Surgeons / NCCG’s Diversity Leadership – Opportunities and Challenges Ms Laraine Kaminsky Carron Suite (SECC). Maximum 100 persons • American College of Surgeons The American dream for Surgical education and the ASA Blue Ribbon Report Professor Brian Rowlands, Mr Graham Layer and Professor Hilary Sanfey Dochart Suite (SECC). Maximum 100 persons FREE OF CHARGE • British Association of Endocrine Surgeons Bring your problems Professor Zyg Krukowski, Mr David Scott-Coombes and Mr Richard Bliss Rockall Room (Moat House Hotel). Maximum 12 persons • Christian Medical Fellowship Reverend Alan Donald Boardroom (Moat House Hotel). Maximum 22 persons FREE OF CHARGE
Thursday 14th April 2005, 8.00am to 9.00am • Stryker UK Ltd Options for laparoscopic obesity surgery Professor Michael McMahon Stand 65, Exhibition Hall (SECC). Maximum 25 persons FREE OF CHARGE
Friday 15th April 2005, 7.45am to 8.45am
PROGRAMME
Thursday 14th April 2005, 7.45am to 8.45am
• Association of Coloproctology of Great Britain and Ireland Getting started with laparoscopic colorectal surgery Mr Hugh Gallagher Malin Room (Moat House Hotel). Maximum 12 persons • Association of Breast Surgery An Oncoplastic MDT - Case Discussions Rockall Room (Moat House Hotel). Maximum 12 persons • Association of Upper Gastrointestinal Surgeons Mr David Kerrigan and Mr Alberic Fiennes Orkney Room (Moat House Hotel). Maximum 20 persons • Association of Laparoscopic Surgeons Mr Ian Beckingham and Mr Jeremy Tate Boardroom (Moat House Hotel). Maximum 22 persons
AUDIO VISUAL SERVICE CENTRE There will be an Audio Visual Service Centre and viewing room for speakers and presenters in the Ness Room of the Seminar Suite, where technicians and networked PCs will be available throughout the Meeting. The Audio Visual Service Centre will be open from 8.00am on Wednesday 13th April 2005.
9
57799 final prog timetable
29/3/05
11:41 am
Page 10
SOCIAL PROGRAMME
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
EVENING PROGRAMME WEDNESDAY 13th APRIL 2005 Civic Reception, Glasgow City Chambers You and your partner are invited to join the Lord Provost of Glasgow, Liz Cameron, for a Civic Reception at the City Chambers. Coaches will depart from the SECC at 6.00pm and the Reception commences at 6.15pm and will conclude at 7.30pm. Return coaches will not be provided. Free of charge, LOUNGE SUIT. Association of Laparoscopic Surgeons – Annual Dinner The ALS Annual Dinner will be held at “78 St Vincent”. Cost: £50.00 per person, LOUNGE SUIT.
THURSDAY 14th APRIL 2005 ASGBI Annual Dinner The Association’s Annual Dinner will be held at the Hilton Hotel, 1 William Street, Glasgow, G3 8HT. A drinks reception hosted by the Association’s Corporate Patrons (B.Braun, Ethicon, GlaxoSmithKline, Stryker and Tyco) from 7.15pm will be followed by dinner at 8.00pm. Glasgow’s premier five star hotel, the Hilton has one of the largest ballrooms in Scotland and first-class cuisine. The evening will also feature entertainment provided by a jazz band, magicians and a traditional piper. Cost: £65.00 per person, BLACK TIE.
ACCOMPANYING PERSONS’ PROGRAMME Glasgow is one of Europe’s most exciting and beautiful destinations, combining the energy and sophistication of a great international city with some of Scotland’s most spectacular scenery. Glasgow is an architectural dream: Victorian red and honey sandstone, Italianate steeples and medieval spires sit harmoniously with neo-gothic towers, the sensuous Art Nouveau of Charles Rennie Mackintosh and the titanium, glass and steel of the contemporary city. Glasgow has an amazing portfolio of museums and galleries from the unique Burrell Collection, the stunning Mackintosh House to the cool and contemporary Gallery of Modern Art. An exciting and varied Accompanying Persons’ Programme will be available throughout the Annual Scientific Meeting. There are three organised tours, details of which are given below, for which you can book now. Wednesday 13th April 2005 (2.00pm to 5.00pm) GLASGOW CITY TOUR AND POLLOK COUNTRY PARK This introduction to Glasgow will cover a panoramic tour of the City Centre, including the River Clyde, the historic Cathedral and Merchant City, the Georgian grandeur of Blythswood Square, Kelvington Art Gallery and the University Campus. The tour will then take you through the Clyde Tunnel to visit the Burrell Collection, which houses a world-famous collection gifted to Glasgow by Sir William Burrell. This award winning building displays a fine collection of furniture, textiles, ceramics, medieval European sculptures, drawings and a stunning collection of stained glass. Cost per person (including afternoon tea and entrance to the Burrell Collection): £28.00 Thursday 14th April 2005 (9.30am to 4.30pm) STIRLING CASTLE AND LOCH LOMOND On this tour you will travel northwards to the historic town of Stirling, once the home of the Scottish Kings and Queens. You will then be given a guided tour of the Castle set high above the town, with views over to the Wallace Monument. The tour will continue in the shadow of the Fintry Hills to the “bonnie, bonnie banks of Loch Lomond”, where you will have a two course lunch. You will then be treated to views of the loch from the best vantage point – the loch itself - during a boat trip, before returning to Glasgow. Cost per person (including a two course lunch, guided tour of Stirling Castle and boat trip on Loch Lomond): £65.00 Friday 15th April 2005 (9.30am to 12.30pm) HOUSE FOR AN ART LOVER On this visit you will be taken to the House for an Art Lover set in the grounds of Bellahouston Park. The building was an original design by Glasgow’s most famous architect – Charles Rennie Mackintosh – which was a competition entry. It was never built in his lifetime, but has now been built, and as well as being a gallery open to the public is also an annex of the Glasgow Art School. Cost per person (including entrance to House for an Art Lover, morning coffee and shortbread): £40.00
10
29/3/05
11:41 am
Page 11
Glaxo advert
PROGRAMME
57799 final prog timetable
GlaxoSmithKline is the UK’s largest investor in science. In 2003 GSK invested £2.7 billion in the research and development of new medicines and vaccines. 40% of this investment was in the UK.
For more information on the medicines that GlaxoSmitKline provide to help support surgeons and patients please contact us: RET/FPA/05/18030/1 - Mar 11 05
57799 final prog timetable
29/3/05
11:41 am
Page 12
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
GUEST SPEAKERS AND INTERNATIONAL VISITORS
12
interest in widening participation of disadvantaged groups of students in medicine. His research interests are in peritoneal adhesions and cyclosporin nephrotoxicity in renal transplantation.
Professor Allyson Pollock Allyson Pollock is Head of the Public Health Policy Unit at UCL (University College London) and Director of Research & Development at UCL Hospitals NHS Foundation Trust. She trained in medicine and became a consultant in public health. Her research interests include the financing of health care, the funding and structures of primary, intermediate, and long term care, and health and globalisation. She is a leading authority on the private finance initiative and the implications of market mechanisms and privatisation for public services including health care and long term care. She has given evidence to the Health, Transport, and Treasury Select Committees of the House of Commons, and to the Finance Committee of the Scottish Parliament. She has researched on the impact of the WTO and GATS on health and other public services and has been invited to speak on all these issues in countries as diverse as Spain, France, Hungary, Sweden, Canada, the US, Cuba, Taiwan, Indonesia, South Africa, and Australia. She is chair of the NHS Consultants’ Association, and was chair of the Society for Social Medicine in 2003. Allyson’s book NHS plc: the privatisation of our health care has recently been published by Verso, and she is currently working on a textbook to be published this year by Routledge, The New NHS explained.
Mr Andrew Raftery Andrew Raftery is a Consultant General Surgeon with a special interest in Renal Transplantation at the Sheffield Kidney Institute at the Northern General Hospital, Sheffield. He is a Member of the Council of the Royal College of Surgeons and an examiner in anatomy at the Royal College of Surgeons of England. He is a member of the panel for the Intercollegiate Speciality Board in General Surgery and Sub-Dean for Admissions at the University of Sheffield Medical School, where he has a special
Professor Sir Ara Darzi, KBE Ara Darzi holds the Chair of Surgery at Imperial College London and is an Honorary Consultant Surgeon at St. Mary's Hospital NHS trust. He previously held the office of the Tutor in Minimal Access Surgery at the Royal College of Surgeons of England where he set the national guidelines in education and training in Minimal Access Surgery. Professor Darzi's main clinical and academic interest is in minimal invasive therapy, including imaging and biological research together with investigating methods to measure core competencies of surgery objectively. He has published widely in the field of minimally invasive therapy. Recently Professor Darzi was elected to the National Modernisation Board and he currently advises the Government on Modernising the NHS. Professor Darzi actively pursues the need for improved inter-disciplinary research with a closer integration of information technology, biotechnology and physical sciences and is engaged in a number of fundamental research issues related to the future development of minimally invasive surgery as well as covering a wide spectrum of engineering and basic sciences research topics encompassing Medical Image Computing, Biomedical Engineering, Clinical Safety, Robotics, Man-Machine Interfacing, Virtual/Augmented Reality and Bio-Medical Simulation. Professor Darzi and his team were awarded the Queen’s Anniversary Prize in 2001 for Excellence in Higher and Further Education in recognition of their achievements in pioneering new technologies to address training requirements for trainee surgeons, surgeons in post and other professionals.
57799 final prog timetable
29/3/05
11:41 am
Page 13
Dr Hartley Stern Hartley Stern is currently the Vice President of Cancer Services at The Ottawa Hospital Regional Cancer Centre. He is a professor in the Department of Surgery at the University of Ottawa and served as Chairman of the Department of Surgery from 1994 to 2004. Dr Stern completed his undergraduate medical education and surgical training at the University of Toronto, followed by a Research Training Fellowship at the London Hospital Medical College, London, England. Dr Stern specializes in treating patients with colorectal cancer and continues to conduct research with the hope of improving prevention strategies for the disease. In addition, Dr Stern has had the opportunity to preside over the Canadian Oncology Society (now Past President), and to chair the Integration Group of the Canadian Strategy for Cancer Control as it developed into a national Council. Dr Stern is the Provincial Coordinator of Surgical Oncology with Cancer Care Ontario. In this role he leads an initiative aimed at improving the quality of cancer care.
Dr Hilary Sanfey Hilary Sanfey was elected President-Elect of the Association of Women Surgeons at the Annual Clinical Congress of the American College of Surgeons in New Orleans in October 2004. Born and raised in Ireland, graduating from TCD, Dr Sanfey has worked in Baltimore, Barcelona, Edinburgh and the University of Virginia in Charlottesville where she now practices as a transplant surgeon. Currently, Dr Sanfey is an associate professor in the Department of Surgery at the University of Virginia and she has earned a national reputation both as a surgical educator and as an advocate for women in surgery. She is a recipient of the Association for Surgical Education (ASE) Outstanding Teacher Award (2003) and serves on the Executive Committee of the ASE and chairs their Committee on Faculty Development. She was appointed to the University of Virginia Academy of Distinguished Educators in 2003. In addition to her clinical role as
Dr Imre Loefler Imre Loefler was born in Budapest and served in the Second World War, being held as a prisoner of war in Regensburg, Germany, from 1945. After the war, Imre escaped from Hungary in 1948 and studied Medicine, History, Sociology and Philosophy in West Germany, achieving an MMed from Erlangen in 1956 and a Surgical Specialist Diploma in 1962. Imre undertook postgraduate studies in the United States before being appointed as a Surgeon at Virika Hospital, Port Fortal, Uganda in 1964. Imre was Senior Lecturer in Surgery at Makerere University, Kampala and Foundation Professor of Surgery at the University of Zambia, Lusaka. He has been a Surgeon at Nairobi Hospital, Kenya since 1975. A Fellow of the Royal College of Surgeons of Edinburgh, Imre has been a member of the Zambia Medical Council, the Zambia National Scientific Research Council, the Association of Surgeons of East Africa (previous Chairman), the Medical Advisory Committee of Nairobi Hospital (previous Chairman), the Aero Club of East Africa (previous Chairman) and the Ngong Forest Sanctuary Trust (Chairman 1993-2004). He is currently the Chairman of the East African Wildlife Society. Imre has published several hundred scientific papers, articles, essays, book reviews and letters on subjects ranging from surgery, medicine, hospital organization, education, ethics, philosophy, history, to safari journals, ecology, forest conservation, ornithology and aviation. Imre has, for many years, served as a part-time Flying Surgeon, and has operated in some 120 hospitals in the Eastern African Region. Imre’s main interest is the adaptation of surgical technology to austere environments. He considers himself to be an “Old Style” General Surgeon and his two most commonly performed procedures are hysterectomy and prostatectomy.
PROGRAMME
a transplant surgeon Dr Sanfey is the Associate Program Director for general surgery and has served as co-chair of the ASE National Task Force on Surgical Attrition. She is a founding member of the American College of Surgeons Junior Faculty Mentorship Program. Dr Sanfey serves on the Editorial Boards of both the British Journal of Surgery and the Association for Surgical Education and has published on a number of topics including gender issues in transplantation, and surgical education.
13
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
14
29/3/05
11:41 am
Page 14
Laraine Kaminsky Laraine Kaminsky is a recognised leader in the fields of Diversity, Cross-Cultural Awareness, Employment Equity, Language, and Mentoring training and consulting. She has lived on three continents and worked in over twenty countries. As a new immigrant in Canada, Laraine worked many years as an adult ESL educator and launched Malkam Cross-Cultural Training in 1989 as a venue for adult immigrants to develop the linguistic and cultural competencies required in the North American workplace. Laraine focuses on global issues and how they impact on organisational effectiveness and inclusion. She works with senior management teams to help them and their organisations adapt to the realities of diversity in the ever changing world of work. Laraine’s commitment to global competence and understanding has been proven through her recognition as a finalist for the Women’s Business Achievement Award.
Dr Peter Simpson Peter Simpson was appointed Senior Lecturer in Anaesthetics at the University of Bristol in 1978 and Consultant Anaesthetist to Frenchay Hospital, Bristol in 1982. His clinical interests include anaesthesia for neurosurgery and invasive neuroradiology. His research interests have included anaesthetic-related immunology and hypersensitivity, the fibrinolytic effects of anaesthesia, perioperative fluid balance and anti-diuretic hormone, and hypotensive anaesthesia, in particular the metabolism and toxicity of sodium nitroprusside. Dr Simpson was Medical Director of Frenchay before and during the merger with Southmead in 1999, to form the North Bristol NHS Trust. He was elected to Council of the Royal College of Anaesthetists in 1997, subsequently elected Vice-President in 2001 and President in 2003. He has a major interest in training, examinations, assessment and accreditation of anaesthetists and is a Board Member (and Acting Chairman) of the PMETB. Peter Simpson is also Chairman and a Trustee of NCEPOD, a PastChairman of the Royal Colleges International Forum and President of the Tri-Service Anaesthetic Society. He was a Physiology Examiner for Primary and then Part II FRCA from 1984 to1996 and also helped create the European Diploma of Anaesthesiology and Intensive Care in 1984. Dr Simpson is currently Chairman of the Examination Committee and a member of the Executive Committee and Senate of the European Academy of Anaesthesiology.
Mr Michael Kelly Michael Kelly is a MRCP and FRCS and is currently a Consultant Colorectal Surgeon in Leicester. He is also the National Lead Clinician for Colorectal Cancer, Vice-President of the Coloproctology Section of the Royal Society of Medicine, a member of Council of the Association of Coloproctology of Great Britain and Ireland, a member of the Court of Examiners of the Royal College of Surgeons (Chairman of colorectal MCQ’s) and Leicestershire Chairman of HCSA. Professor Umberto Veronesi Umberto Veronesi is a surgeon who has devoted the greater part of his professional life to exploring the paths of research with the aim of improving the treatment and the quality of life for cancer patients. It was he who, on the basis of controlled clinical trials, first contributed at the National Cancer Institute in Milan to the development of the conservative treatment of breast cancer. He first demonstrated that in the case of small cancer of the breast it is safe to perform a wide resection followed
29/3/05
11:41 am
Page 15
by radiotherapy and, thereby, preserve the breast, thus obviating the mutilating procedure of mastectomy. More recently he has developed new researches with sentinel node biopsy procedure to avoid axillary dissection when the lymphnodes are not involved. In the last twenty years he has devoted his interests to the prevention of breast cancer conducting two major randomised studies aiming at the reduction of the risk of breast cancer in normal women with retinoids and tamoxifen. Very recently he has reconsidered the procedures of postoperative radiotherapy after breast conserving surgery, introducing the technique of intraoperative radiotherapy. By founding the International Melanoma Group he attracted the attention of pathologists and clinician to the need for international co-operation in melanoma research and he devised and conducted trials which showed that prophylactic dissection of regional nodes in stage I disease could safely be avoided. Furthermore, he advocated a conservative approach to melanoma which has been adopted by the World Health Organisation Melanoma Group of which he was chief investigator for 20 years. Professor Veronesi has also dedicated his energies to initiating and promoting educational enterprises for the training of oncologists. In 1982, he founded the European School of Oncology, which has since become a point of reference throughout Europe and, in particular, an advisory body for the European Community. The European Society of Surgical Oncology, also founded by Umberto Veronesi, has, likewise, undertaken an educational line which follows well in the wake of the guidelines traced by the School. He has been President of the International Union Against Cancer (UICC), of the European Organisation for Research and Treatment of Cancer, and of the Federation of European Cancer Societies (FECS). He was founder and first President of the European Cancer Societies of Mastology. In 1994 he was appointed President of the Committee of Cancer Experts of the Commission of European Communities. Professor Veronesi is the author of more than 640 scientific publications and 12 Oncological Treatises and has been the Scientific Director of the European Institute of Oncology in Milan since 1994.
University of Belfast, Northern Ireland, between 1986 and 1997 and Associate Professor of Surgery, University of Texas Health Science Center at Houston, Texas, USA between 1978 and 1986. His research interests include Obstructive Jaundice, Surgical immunology, Surgical nutrition, Fluid and electrolyte balance, Sepsis, SIRS, MODS. His clinical interests are Hepato-pancreatico-biliary surgery, Intensive Care Medicine, Nutritional support and Emergency surgery. A Past-President of SARS, Brian is currently Vice President-Elect of ASGBI and is the 2005 British Journal of Surgery Travelling Fellow.
Ms Linda de Cossart Linda de Cossart graduated in medicine from the University of Liverpool in 1972, and began training for a surgical career in Merseyside. She became a Fellow of the Royal College of Surgeons of England in 1978 and after a period of full time research gained by thesis, a ChM from Liverpool on the subject of venous disease. She was appointed as Consultant General Surgeon with an interest in vascular surgery at the Countess of Chester Hospital in 1988. Currently, she has a busy clinical commitment, which involves teaching undergraduates and postgraduates in surgery. Her particular research in the clinical field has been in the areas of Risk Assessment, claudication and venous disease in pregnancy on which she regularly presents and publishes. As Associate Postgraduate Dean in the Mersey Deanery since 1993, she has been closely involved with the changes in both Specialist Registrar and SHO levels in surgery and their educational implications. After election to the council of the Royal College of Surgeons of England in 1999 she has continued this interest in surgical education and has led the college's development of curriculum design for SHOs in surgery.
PROGRAMME
57799 final prog timetable
Professor Brian Rowlands Brian Rowlands has been Professor of Surgery and Head of the Section of Surgery at University of Nottingham since September 1997. He is also Consultant Surgeon and Clinical Director for Surgery at the Queen's Medical Centre. His previous appointments include Head of the Academic Department of Surgery, Queen's
15
57799 final prog timetable
29/3/05
11:41 am
Page 16
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
Joint Replacements Trauma Spine
Results matter
Micro Implants Orthobiologics Instruments Interventional Pain
At Stryker results speak louder than words.
We succeed when our customers succeed; your results help millions of people around the world lead more active and satisfying lives. At Stryker, we don’t just make promises, we deliver results.
Navigation Endoscopy
Stryker Advert
To know more about our capabilities, please contact Stryker on; Tel: +44 (0)1635 262400 or visit our website at www.stryker.co.uk
16
TM
Communications
Patient Handling Equipment EMS Equipment
57799 final prog timetable
29/3/05
11:41 am
Page 17
Association of Surgeons of Great Britain and Ireland
Logbook Help Desk Lizzie Cecil, the Association’s Data Manager, will be running a Logbook Help Desk on Stand 55 in the Trade Exhibition Hall from 12.30pm on Wednesday 13th April 2005 until 12.00 noon on Friday 15th April 2005. Help and advice will be available on:
• • • •
The web-based, PDA and Access Version 3 of the Logbook. Downloading the Logbook from the ASGBI and ASiT websites. Data collection. Conversion of data from all previous versions of the Logbook to Version 3.
PROGRAMME
LOGBOOK NEWS
Please feel free to come and discuss any other queries you may have.
www.surgeonslog.com
17
57799 final prog timetable
29/3/05
11:41 am
Page 18
WEDNESDAY 13th APRIL 2005 – Morning Session (pre-coffee) Time
08.00 09.00 09.00
Lomond
Alsh
Boisdale
Carron
625 seats
220 seats
220 seats
200 seats
R E G I S T R A T I O N Moynihan Prize Papers (x 6) Upper GI Papers (x 9) 10mins + 5 mins 8 mins + 2 mins
Breast Papers (x 9) 8 mins + 2 mins
Chairs:
Chairs:
Chairs:
Mr Robert Lane (President, ASGBI)
Professor James Garden (Edinburgh) Mr Colin McKay (Glasgow)
Mr Timothy Lees (Newcastle) Mr John Harvey (Llandough)
Mr Tom Bates (Ashford, Kent) Mr Peter Crane (Welwyn)
9.00 7044: HAS THE INTRODUCTION OF ENDOVASCULAR TREATMENT MADE ELECTIVE REPAIR OF INFRA-RENAL ABDOMINAL AORTIC ANEURYSM SAFER? Y C Chan*, T A Bucher, A I Anjum, C L Wood and P R Taylor (London)
9.00 7335: HAS THE SURVIVAL OF BREAST CANCER CHANGED SINCE THE INTRODUCTION OF MULTIDISCIPLINARY MEETINGS? A Haji*, C Chianakwalam, A Imkampe, S Bendall and T Bates (Ashford)
ASGBI Scientific Committee 9.00
7122: ELECTROMAGNETIC STIMULATION IMPROVES ANASTOMOTIC HEALING IN ISCHAEMIC BOWEL J B Conneely*, D C Winter and D J Bouchier-Hayes (Dublin)
9.00 6787: PRELIMINARY RESULTS OF THE EUROPEAN COLORECTAL LIVER METASTASIS (CLM) RESECTION REGISTRY (ECR): IMPACT OF PRIMARY TUMOUR CHARACTERISTICS G Poston*, J Figueras, G Mentha, S Trapatonni and R Adam (Aintree, Barcelona, Geneva, Turin and Paris) 9.10 7423: OUTCOME OF REPEAT OGD TO ENSURE COMPLETE GASTRIC ULCER HEALING A N Hopper*, M R Stephens, M C Allison and W G Lewis (Newport)
9.15 6535: THE CONDYLOMATA CONUNDRUM P Mullerat* and M C Winslet (London) 9.30 7252: A RANDOMISED CONTROLLED TRIAL OF MINOR SURGERY IN GENERAL PRACTICE AND IN HOSPITAL P Pockney*, S George, J Primrose, H Smith, P Little, H Kinley, V Lattimer, A Lowy and R Kneebone (Southampton, Brighton, Switzerland and Trowbridge) 9.45 6501: PHYSIOLOGICAL CHANGES IN LYMPHATIC FUNCTION IN THE UPPER LIMB OF PATIENTS UNDERGOING SURGERY FOR BREAST CANCER T M Bennett Britton*, S O'Mahony, R W Barber, P S Mortimer, A D Purushotham and A M Peters (Cambridge and London) 10.00 7237: ENTERIC BACTERIA DO TRANSLOCATE: PROOF AT LAST B S Reddy*, M Gatt, A M Snelling, K Bitzopoulou, L R Macfarlane-Smith and J MacFie (Scarborough and Bradford) 10.15 7551: EFFECT OF PERIOPERATIVE BLOOD TRANSFUSION ON LONG-TERM OUTCOME OF LIVER RESECTION FOR COLORECTAL METASTASIS Y Kato*, C Coldham, S R Bramhall, A D Mayer, S Olliff, J A C Buckels and D Mirza (Birmingham)
10.30 10.30
Vascular Papers (x 9) 8 mins + 2 mins
Chair:
Adjudicators:
09.30 09.30
C O F F E E
W1L
9.20 7319: EFFECT OF NEOADJUVANT CHEMORADIOTHERAPY ON CELL GROWTH AND APOPTOSIS IN OESOPHAGEAL ADENOCARCINOMA A A Raouf*, D A Evoy, M M Griffin and J V Reynolds (Dublin) 9.30 6995: PREOPERATIVE PREDICTION OF LYMPH NODE METASTASES IN OESOPHAGEAL AND GASTRIC SURGERY: A PROSPECTIVE MULTICENTRE STUDY P P Tekkis, S Purkayastha*, G N Hanna, A W Darzi and P McCulloch (London and Oxford) 9.40 6324: ROLE OF ANGIOGENESIS AND GENETIC POLYMORPHISM IN THE DEVELOPMENT OF SECOND PRIMARY SQUAMOUS CANCER OF THE OESOPHAGUS AND THE HEAD AND NECK A Immanuel*, D Meikle, N R McLean, M Bennett, S Preston, D Karat, N Hayes and S M Griffin (Newcastle upon Tyne) 9.50 7446: ENDOSCOPIC INVESTIGATION OF UNEXPLAINED IRON DEFICIENCY ANAEMIATHE NUMBERS NEEDED TO ENDOSCOPE (NNE) S White*, M R Stephens,A N Hopper, S Jugool, R Stratford, M C Allison and W G Lewis (Newport) 10.00 6558: OPERATIVE APPROACH HAS NO SIGNIFICANT EFFECT ON TUMOUR CLEARANCE IN OESOPHAGEAL CANCER: RESULTS FROM 462 CONSECUTIVE RESECTIONS S A Suttie*, S Nanthakumaran, A G K Li and K G M Park (Aberdeen) 10.10 6822: PREDICTING SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA J W C Kung*, S J Wigmore, K K Madhavan, O J Garden and R W Parks (Edinburgh) 10.20 7442: PROSPECTIVE COMPARISON OF DEFINITIVE CHEMORADIATION, SURGERY ALONE AND MULTIMODAL THERAPY FOR OESOPHAGEAL CARCINOMA P Stevens*, A N Hopper, M Stephens, S A Roberts, A Brewster, T Crosby, T J Havard and W G Lewis (Newport, Cardiff and Llantrisant)
W1A
9.10 6233: RATIONING OF REFERRALS FOR VARICOSE VEINS: ITS EFFECT ON SURGICAL WORKLOAD M E Harris*, R J Davies, S Brown, S M Jones, P S Eyers and J F Chester (Taunton) 9.20 6318: ENDOLUMINAL THERAPY IS THE TREATMENT OF CHOICE FOR RECURRENT LONG SAPHENOUS VARICOSE VEINS R Hinchliffe*, J Ubhi, A Beech, J Ellison and B Braithwaite (Nottingham) 9.30 7061: USE OF BLOOD PRODUCTS IN RUPTURED AORTIC ANEURYSM REPAIR A L McCullough*, P Bachoo, J Brittenden, G G Cooper and E MacAuley (Aberdeen) 9.40 7358: INFLUENCE OF ANEURYSM MORPHOLOGY ON PROCEDURE COST AND HOSPITAL STAY K Krishna*, N Sinclair, J Hancock, S J Travis and K R Woodburn (Truro) 9.50 7480: A TRIAL OF THE CLINICAL AND COST EFFECTIVENESS OF A SUPERVISED EXERCISE PROGRAMME FOR CLAUDICATION H L D Lee*, T Mehta, B Ray, M S T Heng, P T McCollum and I C Chetter (Hull) 10.00 6417: CHANGING INDICATIONS AND OUTCOME OF AORTO-ILIAC RECONSTRUCTION T A Beckitt *, J Day, P Murphy, F C T Smith, R N Baird and P M Lamont (Bristol) 10.10 6743: SURGERY INCREASES PLATELET AGGREGATION IN PATIENTS WITH SEVERE LIMB ISCHAEMIA P Collins*, I Ford, E MacAulay, M Greaves, J Brittenden (Aberdeen) 10.20 6981: PLAQUE ECHOLUCENCY AND PLASMA INFLAMMATORY MARKERS PREDICT EMBOLISATION DURING CAROTID ANGIOPLASTY R Jindal*, C Bicknell, D Peck, A Rice, S Dhanjil, J Wolfe, M Jenkins, A Darzi, N Cheshire (London)
9.10 7304: BIOLOGICAL MARKERS ASSOCIATED WITH RESPONSE TO GEFITINIB (‘IRESSA’) IN PATIENTS WITH BREAST CANCER E Gutteridge*, J M W Gee, R I Nicholson and J F R Robertson (Nottingham and Cardiff) 9.20 6744: LOW MOLECULAR WEIGHT HEPARINS AS INHIBITORS OF CARCINOMA METASTASIS J Harvey*, P Mellor, S Ali, J Kirby and T Lennard (Newcastle-upon-Tyne) 9.30 7134: DO CHANGES IN HORMONE SENSITIVITY OF BREAST CANCER EXPLAIN IMPROVED SURVIVAL? N Henley, D Hole, R Leake and T Cooke (Glasgow) 9.40 6915: PRE-OPERATIVE STAGING FOR PRIMARY BREAST CANCER (GUIDELINES AND PRACTICE) A Kasem*, S Daniels, A Desai and P Sinha (Farnborough) 9.50 6988: ASSESSING THE SAFETY OF SKIN SPARING MASTECTOMY C L E Osborne*, D J Thomson, P S Tibbitts, E Wu and E H Drabble (Plymouth) 10.00 7243: CAN 3 WEEKS OF NEOADJUVANT TAMOXIFEN THERAPY IMPROVE SURVIVAL IN BREAST CANCER? M R Kalbassi *, C Hodgson, E A Griffiths, A C Davison, F Mohamed, M J Higgs, J D Hemming, W J Cunliffe, B K Shenton and D A Browell (Gateshead and Newcastle upon Tyne) 10.10 7402: ULTRASOUND GUIDED MAMMOTOME BIOPSY BY THE SURGEON AS A TREATMENT FOR SINGLE DUCT NIPPLE DISCHARGE S Govindarajulu*, S R Narreddy, M H Shere, N Ibrahim, A K Sahu and S J Cawthorn (Bristol) 10.20 7625: REDESIGNING BREAST SERVICE TO REDUCE WAITING TIMES, IMPROVE PATIENT SATISFACTION AND ENHANCE THE QUALITY OF CARE: A SUCCESSFUL INNOVATIVE APPROACH A Jibawi, T Jackson, J Scally, J Baker, L Gurnani, L Arnett, A Jefferies, D Cade and S Selvachandran (Modernisation Agency)
W1B
W1C
Helen Rollason Memorial Lecture CHANGING PARADIGMS IN THE MANAGEMENT OF BREAST CANCER Professor Umberto Veronesi (European Institute of Oncology, Milan)
Chair:
11.00 11.00 11.30 18
Mr Bernard Ribeiro (Basildon)
W2L
C O F F E E
B R E A K
A N D
N D
57799 final prog timetable
29/3/05
11:41 am
Page 19
Dochart
Moat House 1
Moat House 2
Moat House 3
200 seats
100 seats
100 seats
100 seats
A N D
T R A D E
General Papers (x 9) 8 mins + 2 mins Chairs: Ms Jane Linsell (Lewisham) Mr Ian Ramus (Taunton) 9.00 7019: PERFORATED APPENDICEAL TUMOURS PRESENTING AS PSEUDOMYXOMA PERITONEI SYNDROME: SURGICAL FINDINGS, PATHOLOGICAL FEATURES AND OUTCOMES IN 123 CASES E Murphy*, B Meade, R Sexton, T Cecil and B Moran (Basingstoke) 9.10 6497: A PROSPECTIVE DOUBLE BLINDED RANDOMISED CONTROLLED TRIAL COMPARING PORCINE DERMAL COLLAGEN WITH POLYPROPYLENE MESH FOR INGUINAL HERNIA REPAIR D M Ridgway*, F Mahmoud, L Moore, S Stojkovic, A Al-Muhktar and P J Moore (Scunthorpe) 9.20 6833: OPERATION OR OBSERVATION FOR PATIENTS WITH AN ASYMPTOMATIC INGUINAL HERNIA. A RANDOMISED CLINICAL TRIAL A Alani*, J Norrie, P Duffy, P Horgan and P J O'Dwyer (Aberdeen) 9.30 7125: ASSESSMENT OF SURGICAL SKILLS FOR OPEN INGUINAL HERNIA REPAIR R Jacklin*, R Aggarwal, J Hance, S Munshi and A Darzi (London) 9.40 6828: ASSESSMENT OF TECHNICAL SKILLS IN OPEN & LAPAROSCOPIC SURGERY S K Sarker*, A Chang, C Vincent and A W Darzi (London) 9.50 7618: ASSESSING THE IMPACT OF THE TWOWEEK-WAIT ON PROCESS DELAYS FOR COLORECTAL CANCER PATIENTS IN A LARGE DISTRICT GENERAL HOSPITAL T B Huynh*, A Bhargava, C Wood and D Johnston (Romford) 10.00 7365: VIDEO ASSESSMENT OF BASIC SURGICAL TRAINEES’ (BSTS) OPERATIVE SKILLS P J Driscoll*, A M Paisley and S Paterson-Brown (Edinburgh) 10.10 7452: ADVERSE EVENTS CONTRIBUTE SIGNIFICANTLY TO THE EARLY POSTOPERATIVE DEATH OF PATIENTS IN SCOTLAND A Alijani*, W Ritchie, R Murdoch, P A Stonebridge and A M Thompson (Glasgow) 10.20 6641: ISOLATED LIMB PERFUSION WITH MELPHALAN IN THE TREATMENT OF MALIGNANT MELANOMA OF THE EXTREMITIES A Goyal*, W D Evans and R E Mansel (Cardiff)
W1D
General Oral Poster Presentations (x 18) 3 mins + 2 mins
Laparoscopic Oral Poster Presentations (x 18) 3 mins + 2 mins
Chairs:
Chairs:
Mr Andrew Guy (Crewe) Mr Simon Raimes (Carlisle)
Mr Barry Clements (Belfast) Mr David Kerrigan (Liverpool)
Adjudicator:
Adjudicator:
Mr Robert Stuart (Glasgow)
Mr Mark Vipond (Gloucester)
9.00 6118: STAT SIGNALLING DIRECTS RESOLUTION OF INFLAMMATION THROUGH NF-KAPPA-B INHIBITION
9.00 6603: ON TABLE CHOLANGIOGRAPHY FOR LAPAROSCOPIC CHOLECYSTECTOMY: “NEVER SAY DIE TO THE DYE.”
9.05 6217: RECOGNITION AND TREATMENT OF ABDOMINAL COMPARTMENT SYNDROME (ACS): A QUESTIONNAIRE STUDY OF INTENSIVE CARE UNITS IN THE UNITED KINGDOM
9.05 6261: THE LEARNING CURVE OF LAPAROSCOPIC NISSEN FUNDOPLICATION
Laparoscopic Papers (x 6) 8 mins + 2 mins
9.10 6615: APPLICATION OF LAPAROSCOPY IN REVERSAL OF HARTMANN'S PROCEDURE
Chairs:
9.10 6617: THE EFFECTIVENESS, RELIABILITY AND ACCEPTABILITY OF PEER MARKING IN FIRST YEAR MEDICAL STUDENTS
9.15 6632: A RETROSPECTIVE STUDY OF OPEN AND LAPAROSCOPIC INCISIONAL HERNIA REPAIRS
9.15 6616: SURGERY BY NUMBERS
9.20 6665: PAEDIATRIC LAPAROSCOPIC NEPHRECTOMY: THE LEARNING CURVE
9.20 6645: GASTROINTESTINAL STROMAL TUMOURS (GIST): CLINICO-PATHOLOGICAL STUDY OF 185 CASES
9.25 7139: LAPAROSCOPIC LARGE VOLUME MICROWAVE TISSUE ABLATION OF LIVER TUMOURS USING A NOVEL APPLICATOR
9.25 5851: A COMPARISON OF DIFFERENT METHODS OF RISK STRATIFICATION IN URGENT AND EMERGENCY SURGERY
9.30 6900: AN AUDIT OF LAPAROSCOPIC COLORECTAL RESECTIONS PERFORMED IN ONE YEAR BY TWO NEWLY APPOINTED CONSULTANTS
9.30 6491: A PROSPECTIVE STUDY OF TELEPHONE FOLLOW-UP AFTER TREATMENT FOR MINOR ANORECTAL CONDITIONS 9.35 6756: PROSPECTIVE STUDY OF CLINICAL DATA COLLECTION USING PALM PILOT AND TRADITIONAL PAPER FORM 9.40 6773: EARLY ULTRASOUND CAN REDUCE THE LENGTH OF HOSPITAL STAY 9.45 6774: POSSUM AND P-POSSUM SCORING SYSTEMS OVERESTIMATE MORTALITY IN PATIENTS WITH SEVERE PERITONITIS TREATED WITH LAPAROSTOMY PLUS IMMEDIATE VACUUM ASSISTED ABDOMINAL CLOSURE (VAC) 9.50 6782: DEGREES IN TRAINING. HOW ADVANTAGEOUS ARE THEY WHEN APPLYING FOR JUNIOR SURGICAL POSITIONS? 9.55 6854: PRE VS POSTPYLORIC FEEDING: A RANDOMISED CLINICAL TRIAL 10.00 6947: EPIDEMIOLOGY AND TRENDS IN MAJOR TRAUMA IN NORTHERN IRELAND 10.05 7000: IS THE HEPATOCYTE GROWTH FACTOR REGULATORY SYSTEM THE REASON FOR WOUNDS BECOMING CHRONIC? 10.10 7212: HOW ACCURATELY CAN DIRECT AND INDIRECT INGUINAL HERNIAS BE DISTINGUISHED? 10.15 7406: SURGICAL EMERGENCY REVIEW CLINIC: A NEW CONCEPT 10.20 7565: ADVERSE EVENTS AND ADVERSE PROCESSES: HOW CAN QUALITY OF CARE BE BEST IMPROVED? 10.25 7616: HOUSE OFFICERS IN SURGICAL TRAINING
W1M1
9.35 7069: ASSESSMENT OF TECHNICAL SURGICAL ERRORS COMMITTED DURING TRAINING COURSES BY OBSERVATIONAL CLINICAL HUMAN RELIABILITY ASSESSMENT 9.40 7199: DOES HEPATIC MICROWAVE TISSUE ABLATION INDUCE A SYSTEMIC INFLAMMATORY RESPONSE? AN INVESTIGATION WITH A NOVEL MICROWAVE SYSTEM 9.45 7197: CLINICAL COMPARISON OF DEFECTS WITH THAT FOUND DURING LAPAROSCOPIC REPAIR OF VENTRAL HERNIAS; A CASE FOR HIGH RECURRENCE RATE IN OPEN REPAIR OF VENTRAL HERNIA 9.50 7269: DEXTERITY ANALYSIS FOR THE ASSESSMENT OF LAPAROSCOPIC PROCEDURES IN THE OPERATING THEATRE 9.55 7614: ROLE OF STAGING LAPAROSCOPY IN UPPER GI MALIGNANCY 10.00 7454: ROUTINE LAPAROSCOPIC REPAIR OF PRIMARY UNILATERAL INGUINAL HERNIAS – A VIABLE ALTERNATIVE IN THE DAY SURGERY UNIT? 10.05 7466: LAPAROSCOPIC RESECTION OF GASTRIC LEIOMYOMA: A SHORT SERIES 10.10 7507: MINIMALLY INVASIVE SURGERY: A CHOICE FOR "ALL COMERS" WITH BILIARY AND GASTRIC OUTLET OBSTRUCTION 10.15 7537: THE IMPACT OF PATIENT CONTROLLED ANALGESIA ON DAY CASE LAPAROSCOPIC CHOLECYSTECTOMY IN AN INPATIENT MODEL 10.20 7542: THE RELATIVE SAFETY OF VERES NEEDLE COMPARED TO THE OPEN TECHNIQUE WHEN USED TO ESTABLISH A PNEUMOPERIONEUM 10.25 WITHDRAWN
W1M2
For full details of W1M1 and W1M2 please see page 40
T R A D E
08.00 09.00 09.00
E X H I B I T I O N
E X H I B I T I O N
09.30 09.30
Professor Michael Bailey (President, ALS) Professor Michael McMahon (Leeds) 9.30 6610: LAPAROSCOPIC ADRENALECTOMY FEASIBILITY STUDY J Farrow*, P Chong, L Chisholm and P O'Dwyer (Glasgow) 9.40 7281: TRAINING IN LAPAROSCOPIC COLORECTAL SURGERY: A SPECIALIST CENTRE'S EXPERIENCE A H Engledow*, A Acharya, L Dickinson, T Arulapmalam and R W Motson (Colchester) 9.50 6482: LAPAROSCOPIC CHOLECYSTECTOMY: EVOLUTION OF A GOLD STANDARD A Tompkins*, S Nixon and T Crofts (Edinburgh) 10.00 7418: LAPAROSCOPIC NISSEN-ROSSETTI FUNDOPLICATION FOR GERD: LONG TERM RESULTS AND IMPROVEMENT OF QUALITY OF LIFE I Fiume*, G Del Genio, D Izzo, F Russo, C Di Stazio and A Del Genio (Naples) 10.10 6957: LAPAROSCOPIC COLORECTAL RESECTION IN THE U.K: A COST EFFECTIVE ALTERNATIVE IN SELECTED PATIENTS S E Noblett* and A F Horgan (Newcastle Upon Tyne) 10.20 6792: LAPAROSCOPIC HARYNGOLARYNGOESOPHAGECTOMY C G S Hüscher*, C Ponzano, M Di Paola, A Recher, G Sgarzini and T Arulampalam (Rome and Colchester)
W1M3
10.30 10.30
11.00 11.00 11.30 19
57799 final prog timetable
29/3/05
11:41 am
Page 20
WEDNESDAY 13th APRIL 2005 – Morning Session, continued (post-coffee/pre-lunch) Time
11.00 11.30 11.30
Lomond
Alsh
Boisdale
Carron
625 seats
220 seats
220 seats
200 seats
C O F F E E Best Practice: I
Six of the Best Vascular Papers 10 mins + 5 mins
UPDATE ON THE MANAGEMENT OF UPPER GI EMERGENCIES
Chairs: Professor Michael Horrocks (President, VS) Mr Peter Lamont (Bristol)
Chairs:
B R E A K BAES Symposium
A N D
BAPS Paediatric Symposium
BEST PRACTICE IN ENDOCRINE SURGERY (Including illustrative case and debate)
THE PROVISION OF GENERAL PAEDIATRIC SURGERY IN DISTRICT GENERAL HOSPITALS
Chair:
Mr Robert Lane (President, ASGBI)
Mr Nicholas Wilson (Winchester)
Professor Michael Griffin (President, AUGIS)
11.30 1: UPPER GASTROINTESTINAL PERFORATION Mr Simon Raimes (Carlisle) 11.48 2: UPPER GASTROINTESTINAL BLEEDING Mr Colin McKay (Glasgow) 12.06 3: OBSTRUCTIVE JAUNDICE Mr Tom Diamond (Belfast) 12.24 4: EMERGENCIES IN THE ACUTE PANCREATITIC PATIENT Mr C Ross Carter (Glasgow) 12.42 5: LIVER AND SPLENIC TRAUMA Mr Rowan Parks (Edinburgh)
12.30 12.30
Chair:
Mr Tony Young (President, BAES)
Adjudicator:
11.30 7303: FAILURE OF ADAPTATION IN VENOUS FLOW DYNAMICS MAY ACCOUNT FOR CHANGES IN LOWER LIMB VOLUME FOLLOWING REPERFUSION PROCEDURES A J Grant and R Holdsworth (Stirling) 11.45 7441: INTERMITTENT CLAUDICATION: SHOULD MORE PATIENTS RECEIVE INVASIVE TREATMENT? E M Mulkern*, J A Michaels and P Chan (Sheffield) 12.00 7185: IS IT SAFE TO FOLLOW A POLICY OF NON-SURGICAL INTERVENTION FOR CERVICAL RIBS IN PATIENTS WITH REVERSIBLE CHRONIC UPPER LIMB ISCHEMIA? R P S Gambhir* (Pune, India)
Mr Victor Boston (President, BAPS)
1: PARATHYROID: WHEN AND HOW TO BE MINIMALLY INVASIVE Mr Gordon Wishart (Cambridgeshire) 2: ADRENAL: HOW TO AVOID INAPPROPRIATE SURGERY Mr Greg Sadler (Oxfordshire) 3: THYROID: WILL THE NICE GUIDELINES STOP YOU OPERATING ON THE THYROID? Mr Mark Lansdown (Leeds) Mr Johnathan Hubbard (London)
1: TRAINING ISSUES FOR GENERAL SURGEONS AND THEIR ROLE IN PROVIDING GENERAL PAEDIATRIC SURGERY SERVICE IN THE DISTRICT GENERAL HOSPITAL Mr John Black (Chairman, SAC in General Surgery) 2: THE ROLE OF TRAINING OF GENERAL SURGEONS IN TERTIARY CENTRES AND THE LIKELY PROFILE OF THE PROVISION OF GENERAL PAEDIATRIC SURGERY AS PROVIDED IN TERTIARY CENTRES Mr John Orr (Chairman, SAC in Paediatric Surgery) 3: THE PROVISION OF THE GENERALITY OF PAEDIATRIC SURGERY IN THE HIGHLAND REGION OF SCOTLAND Professor George Youngson (Aberdeen)
12.15 7101: ENDOVENOUS LASER TREATMENT OF INCOMPETENT LONG SAPHENOUS VEIN M A Sharif, L L Lau, G Mallon, R Corvan, B Lee, C V Soong and R J Hannon (Belfast)
SPONSORED BY 12.30 7195: WHAT IS THE EARLY OUTCOME FOLLOWING VARICOSE VEIN SURGERY? S Subramonia* and T A Lees (Newcastle-upon-Tyne) 12.45 7387: NATIONAL SERVICE FRAMEWORK FOR RENAL SERVICES: THE CURRENT STATE OF DELIVERING VASCULAR ACCESS SURGERY A R Weale*, S Gillett and D C Mitchell (Bristol)
1.00
W3L
W2A
W2B
W2C
1.30 2.00 20
L U N C H
B R E A K
A N D
57799 final prog timetable
N D
29/3/05
11:41 am
Page 21
Dochart
Moat House 1
Moat House 2
Moat House 3
200 seats
100 seats
100 seats
100 seats
T R A D E Video/DVD Session JOHN WILEY & SONS Ltd AUDIO VISUAL PRIZE Chairs: Mr John Duncan (Inverness) Professor Paul Redmond (Cork)
Adjudicator: Professor Alasdair Munro (Inverness) 11.30 SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER R E Mansel, A Goyal, C Stone and M Bankhead (Cardiff) 11.40 LAPAROSCOPIC LIVER RESECTION FOR CANCER I S Tait, F M Polignano and G D Adamson (Dundee) 11.50 LAPAROSCOPIC ABDOMINOPERINEAL EXCISION FOR T4 RECTAL CANCER J Leroy, A Rikkers, J Marescaux and A A Haddou (Strasbourg, France) 12.00 “THE FORGOTTEN SPHINCTER” INCLUSION OF THE ILEO-CAECAL VALVE IN THE END ILEOSTOMY A Macdonald, M Downey and R Milligan (Airdrie) 12.10 TOTAL LAPAROSCOPIC FEEDING JEJUNOSTOMY D Francis, R Lown, M Moor and S Warren (Enfield) 12.20 PANCREAS PRESERVING DUODENECTOMY FOR DUODENAL FAMILIAL ADENOMATOUS POLYPOSIS A M Smith and R M Walsh (Cleveland, USA)
W2D
E X H I B I T I O N Upper GI Oral Poster Presentations (x 18) 3 mins + 2 mins
Breast Oral Poster Presentations (x 18) 3 mins + 2 mins
Chairs:
Chairs:
Mr Geoffrey Clark (Cardiff) Mr Nicholas Hayes (Newcastle)
Mr Anand Purushatham (Cambridge)
Adjudicator:
Adjudicator: Mr Ian Monypenny (Cardiff)
11.30 7131: THE INFLUENCE OF A POSITIVE CIRCUMFERENTIAL RESECTION MARGIN ON THE PROGNOSIS IN RESECTED OESOPHAGEAL CANCER: UNIVARIATE AND MULTIVARIATE SURVIVAL ANALYSIS 11.35 6687: THE IMPACT OF SOCIOECONOMIC DEPRIVATION ON THE TREATMENT OF OESOPHAGEAL AND STOMACH CANCER IN EAST ANGLIA 1993-2001 11.40 7045: A DAMPENED C-REACTIVE PROTEIN RESPONSE FOLLOWING LIVER RESECTION AS AN INDICATOR OF POOR HEPATIC RESERVE 11.45 5836: VALIDATING PROPHYLACTIC TOTAL GASTRECTOMY FOR CDH1 GERMLINE GENE MUTATION 11.50 6527: DOES SURGERY HAVE A ROLE IN LOCALLY ADVANCED OESOPHAGEAL CANCER?
UPDATE ON THE MANAGEMENT OF UROLOGICAL EMERGENCIES
12.05 6810: OUTCOME FOLLOWING RERESECTION FOR COLORECTAL LIVER METASTASES – ANALYSIS OF PROGNOSTIC FACTORS AND INFLUENCE OF THE TYPE OF FIRST HEPATECTOMY 12.10 6960: NF-KAPPAB ACTIVITY AND CYTOKINES PATTERN PRE AND POST CHEMORADIOTHERPY IN OESOPHAGEAL CANCER PATIENTS 12.15 7059: THE EXTENT OF GASTRECTOMY FOR OGJ TUMOURS AND TYPE OF RECONSTRUCTION AFFECT THE DUODENOOESOPHAGEAL REFLUX 12.20 7057: VALUE OF HISTOLOGY IN A HIGHVOLUME CHOLECYSTECTOMY UNIT 12.25 7102: HEPATIC RESECTION: TOWARDS MINIMAL BLOOD LOSS AND MORTALITY
12.50 7438: MODIFIED D2 GASTRECTOMY FOR CANCER: THE LEARNING CURVE UNMASKED
2: TORSION OF THE TESTICLE
12.55 7463: OUTCOME OF MODIFIED D2 GASTRECTOMY FOR JUNCTIONAL CANCER OF THE PROXIMAL STOMACH
3: HAEMATURIA INCLUDING TRAUMA
W2M1
4: THE DIFFICULT CATHETERISATION Mr Michael Hehir (Falkirk)
D
11.50 6578: BREAST CANCER PATIENTS OVER THE AGE OF 80 - SURGERY VERSUS PRIMARY ENDOCRINE TREATMENT
12.00 7021: COMPLICATION RATES OF SKINSPARING MASTECTOMY WITH IMMEDIATE TRAM FLAP RECONSTRUCTION
12.45 7241: GASTRO-OESOPHAGEAL REFLUX DISEASE AFFECTS VOICE QUALITY
1: COLIC
11.45 6508: THE VALUE OF POST OPERATIVE HAEMOGLOBIN ASSESSMENT FOLLOWING ROUTINE THERAPEUTIC BREAST CANCER SURGERY
12.00 6688: THE RELATIONSHIP BETWEEN SOCIOECONOMIC DEPRIVATION AND OESOPHAGEAL AND STOMACH CANCER INCIDENCE AND SURVIVAL
12.40 7154: RAPID LARGE VOLUME MICROWAVE TISSUE ABLATION OF UNRESECTABLE LIVER TUMOURS USING A NOVEL APPLICATOR: RESULTS OF A PILOT CLINICAL TRIAL
Mr Paddy O’Reilly (President: BAUS) Mr Denis Wilkins (Vice President, ASGBI)
11.40 6485: METASTATIC PATHWAYS IN EARLY BREAST CANCER
11.55 6968: CORRELATION OF MRNA FOR OESTROGEN RECEPTOR BETA VARIANTS WITH OUTCOME IN TAMOXIFEN TREATED BREAST CANCER
12.35 7119: ACUTE PANCREATITIS: AN UNDERESTIMATED RISK OF PERCUTANEOUS TRANSHEPATIC DISTAL BILIARY INTERVENTION
Chairs:
11.35 5878: CLEAR SURGICAL EXCISION MARGINS ARE A KEY FACTOR IN REDUCING DCIS RECURRENCE RISK FOLLOWING BREAST CONSERVING SURGERY
11.55 6682: HYPOXIA AND ANGIOGENESIS IN COLORECTAL LIVER METASTASES
12.30 7106: MESENTERIC LYMPH DUCT LIGATION REDUCES RED BLOOD CELL DAMAGE CAUSED BY ACUTE PANCREATITIS
Best Practice: II
11.30 5874: SKIN SPARING MASTECTOMY AND IMMEDIATE BREAST RECONSTRUCTION: DOES IT INCREASE RISK OF LOCAL RECURRENCE OF BREAST CANCER?
12.05 7141: PREDICTORS OF POSITIVE MARGINS IN LOBULAR CARCINOMA TREATED WITH BREAST CONSERVATION 12.10 7143: WOUND INFECTION PROPHYLAXIS IN BREAST SURGERY: A RANDOMISED CONTROLLED TRIAL COMPARING THE EFFICACY OF ANTIBIOTICS AND PERIOPERATIVE WOUND WARMING 12.15 7147: A PATHOLOGICAL ASSESSMENT OF ADEQUATE MARGIN STATUS AND PREDICTORS OF RESIDUAL DISEASE IN BREAST CONSERVATION SURGERY 12.20 7155: THE EFFICACY OF ULTRASOUND, STEREOTACTIC AND CLINICAL CORE BIOPSIES IN THE DIAGNOSIS OF BREAST CANCER, WITH AN ANALYSIS OF FALSE NEGATIVE CASES 12.25 7178: SIMPLE TECHNIQUE TO PREVENT DOGEAR AFTER MASTECTOMY 12.30 7193: PROSPECTIVE EVALUATION OF ARM SWELLING FOLLOWING LEVEL III AXILLARY CLEARANCE: 5 YEAR RESULTS 12.35 7380: THE PROGNOSTIC SIGNIFICANCE OF MUC1 EXPRESSION IN PRIMARY BREAST CANCER AND THE EFFECT OF NEOADJUVANT TAMOXIFEN TREATMENT ON ITS EXPRESSION 12.40 7385: BREAST IMPLANT SALVAGE AND LAVAGE FOR THE TREATMENT OF INFECTED BREAST IMPLANTS FOLLOWING IMMEDIATE BREAST RECONSTRUCTION 12.45 7411: RAMAN SPECTROSCOPY IS A SENSITIVE, SPECIFIC AND RAPID TECHNIQUE FOR THE ASSESSMENT OF LYMPH NODE METASTASES IN BREAST CARCINOMA 12.50 7449: SYSTEMATIC CAVITY SHAVES REDUCES POSITIVE MARGINS AND RE-EXCISION RATES IN BREAST CONSERVING SURGERY 12.55 7626: TRAINEES’ EVALUATION OF A SIMULATOR FOR SENTINEL NODE BIOPSY IN BREAST CANCER: A NEW STANDARD
W2M2
Six of the Best SARS Papers 10mins + 5mins
11.00 11.30 11.30
Chairs: Professor Irving Taylor (President SARS) Professor John Primrose (Southampton) 11.30 A PREDICTIVE ROLE FOR ETS-2 AND SRC-1 IN ENDOCRINE RESISTANT BREAST CANCER E, Myers, A D K Hill, E W McDermott, N J O’Higgins and L S Young (Dublin) 11.45 CYCLOOXYGENASE-2 INHIBITION DECREASES TUMOUR GROWTH BY INCREASING APOPTOSIS AND INHBITING LYMPHANGIOGENESIS IN A XENOGRAFT MODEL OF BREAST CANCER N L P Barnes*, F Warnberg, G Farnie, W Jiang, E Anderson and N J Bundred (Manchester and Cardiff) 12.00 A DNA FUSION GENE VACCINE INDUCES EPITOPE-SPECIFIC CYTOTOXIC T CELLS ABLE TO KILL HUMAN CELLS EXPRESSING PP65 OF CYTOMEGALOVIRUS A T King*, S M Thirdborough, J Rice, N Khan, F K Stevenson and C H Ottensmeier (Southampton and Birmingham) 12.15 ADMINISTRATION OF A NOVEL PERIOPERATIVE MULTIPLE HEAT SHOCK PROTEIN (HSP) LOADED DENDRITIC CELL (DC) VACCINE SIGNIFICANTLY ATTENUATES RECURRENT BREAST CANCER GROWTH IN VIVO M J Smith*, D A Shilling, S Killeen, M A Kelly, R Tyther, K England, J H Wang, T G Cotter, L O’Mahony and H P Redmond (Cork)
12.30 12.30
12.30 C5 COMPLEMENT INHIBITOR ATTENUATES SHOCK AND ACUTE LUNG INJURY IN A MODEL OF RUPTURED ABDOMINAL AORTIC ANEURYSM C Marron*, B B Rubin, T F Lindsay and D W Harkin (Belfast and Toronto, Canada) 12.45 MEASURING EARLY ADAPTIVE RESPONSE TO 5-FU THERAPY USING FLT-PET F Pakzad*, M Loizidou, D Davies, P J Ell and I Taylor (London)
W2M3
1.00
For full details of W2M1 and W2M2 please see page 41
W3D
T R A D E
1.30 E X H I B I T I O N
2.00 21
57799 final prog timetable
29/3/05
11:41 am
Page 22
WEDNESDAY 13th APRIL 2005 – Afternoon Session (post-lunch/pre-tea) Time
Lomond
Alsh
Boisdale
Carron
625 seats
220 seats
220 seats
200 seats
1.00 1.30 1.30
2.00 2.00
L U N C H
Best Practice: III
Breast Papers (x 9) 8 mins + 2 mins
UPDATE ON THE MANAGEMENT OF COLORECTAL EMERGENCIES
Chairs:
SARS Educational Symposium
Mr Arnold Hill (Dublin) Mr Martin Lee (Birmingham) 2.00 7231: BLUE DYE ASSISTED FOUR LYMPH NODE SAMPLING: A FEASIBLE ALTERNATIVE IN ACCURATE AXILLARY STAGING S R Narreddy*, S Govindarajulu, N Ibrahim, S J Cawthorn and A K Sahu (Bristol)
Chairs: Mr John Hyland (President, ACPGBI) Mr Robert Lane (President, ASGBI)
2.10 5870: TWO VIEW MAMMOGRAPHY-WELSH EXPERIENCE AND OVERVIEW G D Osborn*, G Stevens, H Beer, J Evans, D Brook, E Vaughan-Williams and K Gower-Thomas (Cardiff)
2.00 1: PERITONITIS Mr Ian Botterill (Leeds)
2.20 7315: ESTROGEN RECEPTOR EXPRESSION IN HUMAN BREAST CANCER DURING LONGTERM FULVESTRANT TREATMENT J F R Robertson, E Gutteridge, K L Cheung, S Pinder and A Wakeling (Nottingham and Macclesfield)
2.18 2: LARGE BOWEL OBSTRUCTION Ms Deborah McNamara (Dublin)
2.30 7240: ACCURACY OF SUBAREOLAR MAMMOTOME BIOPSY IN PREOPERATIVE ACCURACY OF PRE-OPERATIVE SUBAREOLAR MAMMOTOME BIOPSY IN SUBCUTANEOUS MASTECTOMY WITH OR WITHOUT NIPPLE PRESERVATION S R Narreddy*, S Govindarajulu, M Shere, N Ibrahim and S J Cawthorn (Bristol)
2.36 3: FULMINATING COLITIS Mr Michael O’Riordain (Cork) 2.54 4: PERINEAL SEPSIS INCLUDING STRANGULATED HAEMORRHOIDS Mr Graham Williams (Wolverhampton) 3.12 5: MASSIVE BLEEDING PER RECTUM Mr John Hartley (Hull)
B R E A K
2.40 7273: RE-ASSESSMENT OF BREAST CANCER RISK IN WOMEN ALREADY ATTENDING FOR FAMILY HISTORY SURVEILLANCE J Saldanha*, R Garret, M Longmuir, C Watt, D George, C Wilson, J Doughty, D Smith, S Stallard and R Davidson (Glasgow)
Six of the Best Endocrine and Transplant Papers 10 mins + 5 mins
SURGICAL RESEARCH IS INTEGRAL TO MODERN SURGICAL TRAINING Professor Matt Thompson (London) Professor John Primrose (Southampton)
1: WHY AND HOW? Professor Irving Taylor (London) 2: SURGICAL RESEARCH IN A DISTRICT GENERAL HOSPITAL: LUXURY OR NECESSITY? Mr John MacFie (Scarborough) 3: NHS / MRC FUNDING Mr Gordon Carlson (Salford) 4: WHAT ABOUT THE CURRICULUM? Mr Denis Wilkins (Plymouth)
22
T E A
Professor Thomas Lennard (Newcastle upon Tyne) 2.00 7184: CAN FOCUSSED PARATHROIDECTOMY BASED ON DUAL IMAGING ALLOW IT TO BE DONE AS A DAY CASE E Carr*, K Contractor, D Remedios, K Kaur and M Burke (London) 2.15 6596: TOTAL PARATHYROIDECTOMY WITHOUT AUTOTRANSPLANTATION FOR SECONDARY HYPERPARATHYROIDISM H Charfare*, N Chhaya, I McFarlane and G C Wishart (Cambridge)
3.00 6704: A PILOT STUDY TO ASSESS THE USE OF DIGITAL PHOTOGRAPHY IN RENAL TRANSPLANTATION A G Edwards*, A R Weale, J D Morgan and C Rudge (Bristol)
3.10 6823: IDENTIFICATION OF OESTROGENREGULATED GENES IN BREAST CANCER USING DNA MICROARRAYS P K Wright*, F E B May, B R Westley and T W J Lennard (Newcastle upon Tyne)
W3A
Adjudicator:
2.45 6599: THE EFFECT OF AMP-ACTIVATED PROTEIN KINASE (AMPK) ON SUCCESS RATE AND GLYCAEMIC CONTROL OF MURINE ISLET ISOGRAFTS S K Richards*, I LeClerc, P W Mathieson, J D T Morgan, G A Rutter and R M Smith (Bristol)
2.50 6594: BREAST REDUCTION SURGERY IN THE UK AND IRELAND: CURRENT TRENDS O C Iwuagwu, A J Platt and P J Drew (East Riding)
W4L
Mr Tony Young (President, BAES) Mr Robert Johnson (Manchester)
2.30 7174: IS COMPLETION THYROIDECTOMY FOLLOWING LOBECTOMY FOR LOW RISK THYROID CANCER MANDATORY? T K Mc Adam* and Z H Krukowski (Aberdeen)
3.15 6859: LEUCOCYTE DEPLETION SIGNIFICANTLY IMPROVES RENAL FUNCTION DURING REPERFUSION USING AN ISOLATED HAEMOPERFUSED PORCINE KIDNEY MODEL S J F Harper*, S A Hosgood, M D Kay and M L Nicholson (Leicester)
3.20 7103: OPEN APPOINTMENTS AS A STRATEGY FOR REDUCED OUTPUT WORKLOAD IN BENIGN BREAST PATIENTS *S K C S Nareddy (Bristol)
3.30 3.30 4.00
Chairs:
Chairs:
3.00 7274: SURVIVIN IS RELATED TO COX-2 EXPRESSION AND RECURRENCE IN DCIS N L P Barnes*, P B Haywood, P J Flint, W F Knox and N J Bundred (Manchester)
SPONSORED BY
A N D
W3B
B R E A K
W3C
A N D
57799 final prog timetable
D
29/3/05
11:41 am
Page 23
Dochart
Moat House 1
Moat House 2
Moat House 3
200 seats
100 seats
100 seats
100 seats
T R A D E
Transplant and Vascular Oral Poster Presentations (x 24)
3 mins + 2 mins
Colorectal Oral Poster Presentations (x 24) 3 mins + 2 mins
Chairs:
Chairs:
Mr Timothy Lees (Newcastle) Mr John Harvey (Llandough)
Mr Alan Hearn (Preston) Mr Michael Jamison (Bangor)
Adjudicator:
Adjudicator:
Mr John Buckels (Birmingham) 1.30 5848: CREATION OF TOLEROGENIC ANTIGEN PRESENTING CELLS VIA INTRACELLULAR CTLA4: A NOVEL STRATEGY WITH POTENTIAL CLINICAL UTILITY IN TRANSPLANTATION
BOSS Symposium BYPASS AND MALABSORPTIVE SURGERY
1.40 7041: THE ADDITION OF MYCOPHENOLATE AND/OR BASILIXIMAB TO CALCINEURININHIBITOR IMMUNOSUPPRESSION REDUCES THE HIGH RISK OF ACUTE REJECTION IN LIVE DONOR TRANSPLANTS
1.40 7087: ATTENUATION OF COLONIC SECRETION BY THE CALCIUM SENSING RECEPTOR IS MEDIATED BY BASOLATERAL NKCC. A POTENTIAL TARGET IN DIARRHOEAL ILLNESSES
1.45 WITHDRAWN
1.45 6509: COLORECTAL CANCER TRENDS IN VARIOUS SOCIOECONOMIC CLASSES: ARE WE TARGETING THE RIGHT POPULATION?
2.00 6642: IMPROVING OPERATIVE CODING ACCURACY: THE ROLE OF THE SURGEON
2.00 1: WHAT ARE THE INDICATIONS FOR THIS TYPE OF SURGERY AND THE DIFFERENCES IN OUTCOMES? Mr Stephen Pollard (Leeds)
2.05 6194: SCREENING FOR ABDOMINAL AORTIC ANEURYSMS IN PATIENTS WITH CARDIOVASCULAR SYMPTOMS
2.15 2: WHAT IS THE BEST GASTRIC BYPASS? Mr Simon Dexter (Leeds)
2.20 6786: DOES ENDOVENOUS LASER TREATMENT (EVLT) IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH VARICOSE VEINS?
2.30 3: STANDARD BPD: WHAT IS ITS PLACE? Professor John Baxter (Swansea) 2.45 4: BPD PLUS DUODENAL SWITCH: IS IT THE MOST EFFECTIVE PROCEDURE? Mr David Kerrigan (Aintree) 3.00 5: EFFICACY, SAFETY AND UNDESIRED SIDE-EFFECTS OF BILIOPANCREATIC DIVERSION Guest Speaker: Dr Rudolf Steffen (Bern)
2.10 7396: INFLUENCE OF ANEURYSM MORPHOLOGY ON PROCEDURE COST AND HOSPITAL STAY 2.15 5975: MOST PATIENTS WITH VARICOSE VEINS HAVE FEARS OR CONCERNS ABOUT THE FUTURE, IN ADDITION TO THEIR PRESENTING SYMPTOMS
2.25 6903: MRSA SCREENING IN VASCULAR SURGERY: THE WAY FORWARD? 2.30 WITHDRAWN 2.35 6949: RELATIONSHIP OF ISCHAEMIA MODIFIED ALBUMIN (IMA) AND CARDIAC TROPONIN I (CTNI) DURING ABDOMINAL AORTIC ANEURYSM REPAIR 2.40 7068: INTERMITTENT CHRONIC ELECTRICAL STIMULATION PROVIDES SUSTAINABLE FUNCTIONAL AND HAEMODYNAMIC IMPROVEMENTS IN STABLE CLAUDICANTS: A COST EFFECTIVE ALTERNATIVE?
2.00 6702: INTESTINAL STOMAS: AN ANALYSIS OF 216 CASES 2.05 6814: ANAL CANAL SENSATION IS AN IMPORTANT FACTOR IN THE OUTCOME OF TREATMENT WITH INTRA ANAL COLLAGEN INJECTIONS FOR PATIENTS WITH PASSIVE FAECAL LEAKAGE 2.10 7137: IDENTIFICATION OF UP-REGULATED GENES BY ARRAY ANALYSIS IN THE PATHOGENESIS OF ULCERATIVE COLITIS 2.15 6899: THE OUTCOME OF PATIENTS WITH LOCALLY ADVANCED PRIMARY AND RECURRENT COLON CANCER 2.20 6930: DAY CASE STAPLED HAEMORRHOIDOPEXY 2.25 7003: AN ASSESSMENT OF CELLULAR RESPONSE TO 5FU WITH FLT PET 2.30 7054: IMPLICATION OF SUBSPECIALISATION ON THE PROVISION OF GENERAL SURGICAL SERVICE 2.35 WITHDRAWN 2.40 7202: NURSE-LED COLORECTAL CLINICS: AN INNOVATIVE APPROACH!
2.50 7130: ABDOMINAL COMPARTMENT SYNDROME AFTER REPAIR OF RUPTURED AORTIC ANEURYSM – DOES MESH CLOSURE ALTER MORTALITY?
2.50 7298: DELAY IN THE DIAGNOSIS OF PROXIMAL COLON CANCER 2.55 7366: DO SPONTANEOUS APOPTOSIS AND COX 2 EXPRESSION PREDICT RESPONSE OF RECTAL CANCER TO NEOADJUVANT RADIOCHEMOTHERAPY?
3.00 7176: SINGLE CENTER EXPERIENCE OF 400 VASCULAR ACCESS PROCEDURES USING AN ‘INTENT TO TREAT’ RULE FOR REPORTING RESULTS
3.00 7450: MAST CELL DEGRANULATION ENHANCES INTESTINAL HEALING UNDER ISCHAEMIC CONDITIONS
3.05 7287: GROWTH FACTOR AND GROWTH FACTOR RECEPTOR EXPRESSION IN HEALING ISCHAEMIC ULCERS
3.10 7503: OUTCOMES OF PATIENTS UNDERGOING EMERGENCY COLORECTAL SURGERY BY HIGHER SURGICAL TRAINEES ARE COMPARABLE TO THOSE OPERATED BY CONSULTANTS
3.15 7371: SHORT-TERM RESULTS OF A PROSPECTIVE STUDY OF CAROTID ARTERY STENTING (CAST) UNDER NEURO-PROTECTION AND CAROTID ENDARTERECTOMY (CEA) IN HIGH RISK PATIENTS 3.20 7401: CAN PRE-OPERATIVE DUPLEX MARKING OF THE SAPHENO-POPLITEAL JUNCTION (SPJ) BE AVOIDED? 3.25 7622: PEAK WALL STRESS; VALUE AND LOCATION IN RUPTURED AND NON-RUPTURED ABDOMINAL AORTIC ANEURYSMS
T R A D E
1.55 6685: A PROSPECTIVE STUDY TO ASSESS PERFORMANCE OF THE SPECIALIST COLORECTAL UNIT
2.45 7260: DELORME’S PROCEDURE FOR RECTAL PROLAPSE: LOW RISK, LOW RECURRENCE – LOW UTILISATION?
2.55 7160: VARICOSE VEIN SURGERY: PATIENT’S MISCONCEPTIONS PROVE DIFFICULT TO DISLODGE.
2.00 2.00
1.50 6668: DO WE PRODUCE SALICYLATES IN VIVO?
2.45 7121: DILEMMA IN THE MANAGEMENT OF YOUNG ISCHEMIC PATIENTS WITH THROMBOANGITIS OBLITERANS (TAO)
3.10 7369: INCREASED HIF-1ALPHA EXPRESSION AND ANGIOGENESIS IN CRITICAL LIMB ISCHAEMIA (CLI) IN HUMAN
W4D
1.30 6309: EFFECT OF PYRROLIDINE DITHIOCARBAMATE ON INTESTINAL BLOOD FLOW IN ISCHAEMIA REPERFUSION INJURY OF THE INTESTINE 1.35 6606: COLONOSCOPY FOR SCREENING OF PATIENTS WITH A FAMILY HISTORY OF COLORECTAL CANCER
1.55 7586: LIVER RESECTION FOR NONCOLORECTAL NON-NEUROENDOCRINE HEPATIC METASTASES
Mr Roger Ackroyd (Sheffield)
Six of the Best SARS Papers
Mr Ron Keenan (Aberdeen)
1.35 6328: WARM HYPOXIA-REOXYGENATION TRIGGERS APOPTOSIS OF HUMAN SINUSOIDAL ENDOTHELIAL CELLS
1.50 WITHDRAWN
Chair:
1.00 1.30 1.30
E X H I B I T I O N
3.05 WITHDRAWN
3.15 7536: ROLE OF VECTOR VOLUME MANOMETRY IN THE MANAGEMENT OF FAECAL INCONTINENCE 3.20 7610: THE ROLE OF PREOPERATIVE COUNSELLING IN DETERMING QOL IN PATIENTS WITH PERMANENT STOMA 3.25 7611: IS DIET THE CAUSE OF VITAMIN B12 DEFICIENCY AFTER RESTORATIVE POCTOCOLECTOMY?
W3M1
W3M2
E X H I B I T I O N For full details of W3M1 and W3M2 please see pages 42 and 43
W2M3
3.30 3.30 4.00 23
57799 final prog timetable
29/3/05
11:41 am
Page 24
WEDNESDAY 13th APRIL 2005 – Afternoon Session, continued (post-tea/pre-Civic Reception) Time
Lomond
Alsh
Boisdale
Carron
625 seats
220 seats
220 seats
200 seats
4.00
Breast Papers
ASiT Symposium
Association of Surgeons of Great Britain and Ireland
REVALIDATION AND APPRAISAL
National Association of Assistants in Surgical Practice Symposium Chairs: Ms Jenny Ellams (General Surgery Chair, NAASP)
Chairs: Mr Dominic Slade (Secretary, ASiT)
Mrs Fiona Slim (Vascular Subspecialty Chair, NAASP)
Mr Mo Baguneid (Treasurer, ASiT) 1: REVALIDATION FOR SURGICAL SpRs - WHY? Professor David Leaper (SAC in General Surgery) 2: REVALIDATION AND LICENSING: A GMC UPDATE Dr Brian Keighley (GMC)
ANNUAL GENERAL MEETING 2005
4.00 THE CURRICULUM FRAMEWORK: ONE STANDARD IN SURGICAL PRACTICE Mrs Linda de Cossart (Council Member, RCSEng) 4.15 NAASP’S EDUCATIONAL DEVELOPMENTS TO SUPPORT CURRICULUM FRAMEWORK Mrs Janet Thatcher (Education Director, NAASP) 4.30 EXPERT PANEL DISCUSSION
President Mr Robert Lane
Ms Jill Biggins (National Chairman, NAASP)
Vice President Mr Denis Wilkins
Mr Robert Pearson (Honorary President, NAASP)
Vice President-Elect Professor Brian Rowlands
Mrs Linda de Cossart (Council Member, RCSEng) Mr Keith Poskitt (Advisor, NAASP)
Honorary Secretary Mr Graham Layer
Mrs Janet Thatcher (Education Director, NAASP)
Honorary Treasurer Mr John Duncan
Mr Doug McWinnie (Surgical Advisor, NAASP)
Chief Executive Dr Nicholas Gair
W4B
W5L
W4C
HOT TOPIC SESSION To be announced at the meeting
WA TC SP H T AC H E IS
5.15 5.15
6.00
W6L
W3A
C I V I C 24
R E C E P T I O N
G
57799 final prog timetable
29/3/05
11:41 am
Page 25
Dochart
Moat House 1
Moat House 2
Moat House 3
200 seats
100 seats
100 seats
100 seats
4.00
BOSS Short Paper Session Chairs: Mr Alberic Fiennes (London) Mr Shaw Somers (Portsmouth) 6950: 5 YEARS EXPERIENCE WITH ISOLATED LAPAROSCOPIC SLEEVE GASTRECTOMY FOR MORBID OBESITY: DO WE NEED A SECOND STAGE? M Adamo, S P L Dexter, G Salter, S Shantikumar and M J McMahon (Leeds)
Oral Poster Presentations
Oral Poster Presentations
Six of the Best SARS Papers
7090: PROSPECTIVE STUDY OF LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING IN THE WEST OF SCOTLAND J T Jenkins, P Modak* and D J Galloway (Glasgow) 6281: CAN VERTICAL BANDED GASTROPLASTY BE UNDERTAKEN IN A DISTRICT GENERAL HOSPITAL? T K McAdam*, R K MacKenzie, D M Bruce and J D B Miller (Elgin) 6701: GHRELIN AND GASTRIC BYPASS: DO WE UNDERSTAND BARIATRIC SURGERY? M Adamo*, S P L Dexter, J Holmfield, G Salter, D Johnston and M J McMahon (Leeds) 7356: PROSPECTIVE CHANGES IN GUT HORMONES AFTER ROUXEN-Y GASTRIC BYPASS FOR MORBID OBESITY C M Borg, C W le Roux, M A Ghatei, S R Bloom, A G Patel and S J B Aylwin (London) 7584: EARLY BAND EROSION: COMPUTED TOMOGRAPHY, CONTRAST STUDIES OR ENDOSCOPY, A COMPARATIVE STUDY A El atar*, E Chung, L Bidlake, S McCluskey, J F Morgan, S Nussey and A G T W Fiennes (London)
5.15 5.15
7563: LAPAROSCOPIC ADJUSTABLE SWEDISH GASTRIC BANDING (LASGB) AFTER THE 5TH YEAR: LONG TERM OUTCOMES IN A LARGE UK SERIES A El atar, E Chung, L Bidlake, S McCluskey, J F Morgan, S Nussey and A G T W Fiennes (London)
W5D
G L A S G O W
W3M1
C I T Y
W3M2
W2M3
6.00
C H A M B E R S 25
57799 final prog timetable
29/3/05
11:41 am
Page 26
THURSDAY 14th APRIL 2005 – Morning Session (pre-coffee) Time
09.00
Lomond
Alsh
625 seats
220 seats
Best Practice: IV
General Papers (x 9) 8 mins + 2 mins
MODERNISING MEDICAL CAREERS
Chairs: Mr George Humphreys (Ballymena) Mr John MacFie (Scarborough)
Chairs: Mr Robert Lane (President, ASGBI) Mr Denis Wilkins (Vice President, ASGBI)
9.00 7570: NEOPLASMS ESCAPE PROLONGED COX-2 INHIBITION OF TUMOUR GROWTH M Barry*, J Harmey, G Roche-Nagle and D Bouchier-Hayes (Dublin)
1: STRUCTURE OF THE CURRICULUM Professor Alan Crockard (National Director for MMC) 2: ROLE OF PMETB Dr Peter Simpson (Acting Chairman, PMETB)
9.10 7508: STAGING LAPAROSCOPY AND INTRAOPERATIVE ULTRASOUND FOR POTENTIALLY RESECTABLE COLORECTAL LIVER METASTASES C D Mann*, C J Pattenden, M S Metcalfe, C P Neal, D P Berry and A R Dennison (Leicester)
3: THE ENGLISH COLLEGE PERSPECTIVE OF ENTRY INTO HIGHER SURGICAL TRAINING Mr Bernard Ribeiro (Vice President, RCSEng)
9.20 7485: ELECTRONIC PATIENT DATA CONFIDENTIALITY PRACTICES AMONGST SURGICAL TRAINEES D J. Mole*, C Fox and G Neapolitano (Belfast)
4: THE FUTURE OF THE SAC IN GENERAL SURGERY Mr John Black (Chairman, SAC in General Surgery)
9.30 7488: IMPACT OF SHIFT PATTERN AND EWTD ON PATIENT CARE E Sideso *, T Richards and R Galland (Reading) 9.40 7468: SOFT TISSUE TUMOURS OF THE ABDOMEN: TO BIOPSY OR NOT? C Chew* and P J O'Dwyer (Glasgow) 9.50 7599: HIGH MOTILITY GROUP BOX PROTEIN 1 (HMGB1) IS A LATE MEDIATOR OF THE LOCAL AND SYSTEMIC EFFECTS OF ACUTE PANCREATITIS A O’Callaghan*, J H Wang and H P Redmond (Cork) 10.00 7211: WE STILL NEED TO OPERATE AT NIGHT! O D Faiz *, S Banerjee , P P Tekkis, J A Rennie and A J Leather (London) 10.10 6714: EMERGENCY ABDOMINAL SURGERY: STILL A HAZARDOUS UNDERTAKING? J O Jansen*, P M King and Z H Krukowski (Aberdeen) 10.20 6134: RAISED FAECAL CALPROTECTIN LEVELS IN THE PRESENCE OF RIGHT ILIAC FOSSA PAIN WARRANT MANDATORY LAPAROSCOPY: A NONINVASIVE PREDICTOR OF ACUTE APPENDICITIS C Power*, H Al-Suwaidi, K Muhammad, M Floyd*, C Barry-Kinsella, P Keeling and T N Walsh (Dublin)
10.30 10.30 11.00 26
T1L
COFFEE
T1A
BREAK
57799 final prog timetable
29/3/05
11:42 am
Page 27
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
Six of the Best Upper GI Papers 10 mins + 5 mins
BTS Symposium
General Papers (x 9) 8 mins + 2 mins
TECHNIQUES OF LIVE KIDNEY DONATION
Chairs: Professor Michael Griffin (President, AUGIS) Mr Rowan Parks (Edinburgh)
Chairs: Mr Andrew Guy (Cheshire) Mr Dominic Slade (Manchester)
Chair: Professor Michael Nicholson (Leicester)
Mr Simon Raimes (Carlisle)
1: OPEN DONOR NEPHRECTOMY Mr Paul Lear (Bristol)
9.00 6983: DELAY IN CHOLECYSTECTOMY FOR SYMPTOMATIC GALLSTONE DISEASE RESULTS IN INCREASED MORBIDITY AND COST A S Shekkeris*, S Sarkar, M Klein and R M Anwar (Enfield)
2: HAND-ASSISTED LAPAROSCOPIC LIVE DONOR NEPHRECTOMY Mr Nizam Mamode (London)
Adjudicator:
9.15 6952: CURRENT NICE URGENT REFERRAL GUIDELINES FAIL TO IDENTIFY MANY PATIENTS WITH UPPER GI CANCER P C Munipalle, B R Gopinath, P Vassallo, J Vasani, J Stephen, P Davis and Y K S Viswanath (Cleveland)
9.00 7510: ADVERSE EVENTS IN SURGICAL PRACTICE I S Currie*, A M Hair, B Raju and K C Ballantyne (Dunfermline) 9.10 7398: CT SCANS TO ASSESS PATIENTS WITH HEAD INJURY: THAT WOULD BE NICE T E Irvine*, K Yeung and J Giles (Hastings)
3: TRANSPERITONEAL LAPAROSCOPIC DONOR NEPHRECTOMY Professor Michael Nicholson (Leicester)
9.20 7302: LOCALISED INFRARED IRRADIATION: A NOVEL PRECONDITIONING TECHNIQUE F C Chan*, J G McGuinness and D Bouchier-Hayes (Dublin) 9.30 7171: NOTSS: A NON-TECHNICAL SKILLS TAXONOMY FOR SURGEONS S Yule*, R Flin, S Paterson-Brown and N Maran (Aberdeen and Edinburgh)
9.30 6757: THE DIAGNOSIS OF DUCT DISRUPTION AND PANCREATIC LEAK WITH DYNAMIC SECRETIN STIMULATED MRCP T R Kurzawinski*, A Gillams and W Lees (London)
9.40 7070: HOW USEFUL IS HERNIOGRAPHY? J P Garner*, S Patel and K Ravi (Chesterfield)
9.45 6521: PLASMA TUMOUR-M2-PYRUVATE KINASE (TUM2-PK) AND SERUM CARBOHYDRATE ANTIGEN (CA 19-9) FOR THE PRE-OPERATIVE DIAGNOSIS OF PANCREATIC CANCER H P P Siriwardana, N K K King, M W France and A K Siriwardena* (Manchester)
9.50 6973: PRE INCISION INFILTRATION OF LOCAL ANAESTHETIC REDUCES POSTOPERATIVE PAIN WITH NO EFFECTS ON BRUISING AND WOUND COSMETICS IN THYROID SURGERY A Bagul*, M S Metcalfe, N R Brook, R Taha and M L Nicholson (Leicester)
10.00 6991: MINIMAL ACCESS PANCREATIC NECROSECTOMY CONFERS A SURVIVAL BENEFIT OVER OPEN SURGERY M G T Raraty*, S Connor, J Evans, M Murphy, P Rowlands, P Ghaneh, R Sutton, and J P Neoptolemos (Liverpool)
10.00 6889: THE ROLE OF WHITE CELL COUNT & CRP IN THE DIAGNOSIS OF ACUTE APPENDICITIS M Khan*, E Davie and A Naqvi (Basingstoke)
10.15 6948: QUALITY OF LIFE FOLLOWING LAPAROSCOPIC 90 DEGREE ANTERIOR OR NISSEN FUNDOPLICATION. RESULTS FROM A MULTICENTRE DOUBLE-BLIND RANDOMISED CONTROL TRIAL S A Woodcock*, D I Watson, G G Jamieson, C Lally, S Archer, J R Bessell, M Booth, R Cade, G Cullingford, P G Devitt, D R Fletcher, J Hurley, G Kiroff, C J Martin, I J G Martin, L K Nathanson and J A Windsor (Australia and New Zealand)
10.10 7589: SURGICAL PERFORMANCE ASSESSMENT: A COMPARISON OF VIEWS FROM GENERAL SURGICAL AND CARDIOTHORACIC CONSULTANTS N Kessaris*, P P Tekkis and A Perry-Kessaris (Maidstone and London) 10.20 7582: ARE GENERALISTS STILL REQUIRED IN SPECIALISED TEACHING HOSPITALS? K S Stevenson, P N Rogers, D S Byrne and D B Kingsmore (Glasgow)
T1B
AND
T1C
TRADE
T1D
EXHIBITION 27
57799 final prog timetable
29/3/05
11:42 am
Page 28
THURSDAY 14th APRIL 2005 – Morning Session, continued (post-coffee/pre-lunch) Time
11.00
Lomond
Alsh
625 seats
220 seats
Best Practice: V
Colorectal Papers (x 9) 8 mins + 2 mins
EDUCATION, TRAINING AND RESEARCH
Chairs: Dr Ruth McKee (Glasgow) Mr Michael Jamison (Bangor)
Chairs: Professor Irving Taylor (London) Professor Oscar Traynor (Dublin)
1: SURGICAL EDUCATION AND TRAINING IN THE UNITED STATES Professor Hilary Sanfey (Virginia, USA) 2: CHALLENGES AND INNOVATIONS IN EDUCATION AND TRAINING Professor Sir Ara Darzi (London) 3: LEARNING THROUGH INCIDENT REPORTING Mr Denis Wilkins (Vice President, ASGBI)
SPONSORED BY
11.00 6834: BASCOM'S CLEFT CLOSURE: RESULTS AND VIDEO OF A SIMPLE AND EFFECTIVE METHOD OF CLEFT CLOSURE IN PILONIDAL DISEASE M Drage*, S Gupta, R Guy and A Wells (Peterborough) 11.10 6579: FLEXIBLE SIGMOIDOSCOPY IN THE COMMUNITY: A PILOT PROJECT K Maruthachalam*, E Stoker, G Nicholson and A F Horgan (Newcastle upon Tyne) 11.20 6545: THE RELATIONSHIP BETWEEN THE SYSTEMIC INFLAMMATORY RESPONSE, TNM STAGE, ADJUVANT CHEMOTHERAPY AND SURVIVAL IN PATIENTS UNDERGOING POTENTIALLY CURATIVE SURGERY FOR COLORECTAL CANCER J E M Crozier*, D C McMillan, C S McArdle, W J Angerson, J H Anderson, P G Horgan and R F McKee (Glasgow) 11.30 6232: COLOVESICAL FISTULA: AN EVIDENCE-BASED APPROACH TO INVESTIGATION AND TREATMENT M J Forshaw*, M Solkar, D Sankararajah, M Stewart and M C Parker (Dartford)
12.00 12.00
T2L Royal College of Surgeons in Ireland Robert Smith Lecture INGUINAL HERNIA: WHEN SHOULD WE OPERATE AND WHAT OPERATION? Professor Patrick O’Dwyer (Glasgow)
Chair:
11.40 7142: DOES SITE OF TUMOUR AFFECT QUALITY OF LIFE IN COLORECTAL CANCER? T R Wilson* and D J Alexander (York) 11.50 6604: A PROSPECTIVE RANDOMISED CONTROLLED TRIAL (RCT) OF MULTIMODAL PERI-OPERATIVE MANAGEMENT PROTOCOL OF PATIENTS UNDERGOING ELECTIVE COLORECTAL RESECTION FOR CANCER C K Khoo*, C Vickery, P Ewings and I Eyre-Brook (Taunton) 12.00 7553: ELECTROLYTES NEED TO BE MONITORED IN THE PERI-OPERATIVE PERIOD FOLLOWING BOWEL PREPARATION K Marimuthu, H Jayasinghe*, A K Sharma, C Chigeru, N Evgenikos and T Daniel (Dunfermline)
Professor Niall O’Higgins (President, RCSI)
12.10 7292: LIMITED LATERAL ANAL SPHINCTEROTOMY (L-LAS) IS ADEQUATE TO ACHIEVE HEALING OF CHRONIC FISSURE IN ANO B Miri* and W M Thomas (Leicester)
12.30 12.30 1.30 28
T3L
LUNCH
12.20 6799: SURGICAL MANIPULATION OF THE LARGE INTESTINE INCREASES BACTERIAL TRANSLOCATION IN PATIENTS UNDERGOING ELECTIVE COLORECTAL SURGERY B S Reddy*, M Gatt, R Sowdi and J MacFie (Scarborough) T2A
BREAK
57799 final prog timetable
29/3/05
11:42 am
Page 29
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
Six of the Best General Papers 10 mins + 5 mins
Vascular Symposium
Modernisation Agency Symposium
Chairs:
VASCULAR TRAUMA AND THE GENERAL TAKE
ACTION ON GENERAL SURGERY: THE FINAL PRODUCT
Chair:
11.00 1: INTRODUCTION Mr Charles Collins (Clinical Lead, Action On General Surgery)
Professor Paul Redmond (Cork) Mr Jonathan Pye (Wrexham)
Professor Michael Horrocks (President, VS)
Adjudicator: Mr Alan Hearn (Preston) 11.00 6934: THE VALIDITY OF THE OPERATIVE COMPETENCE ASSESSMENT FOR SURGICAL TRAINEES C G Burt*, C Ricketts, J R Grant and D C Wilkins (Plymouth) 11.15 7515: THE POSITION OF THE APPENDIX: SHOULD ANATOMY BOOKS BE AMENDED? I Ahmed*, K S Asgeirsson, I J Beckingham and D N Lobo (Nottingham) 11.30 7025: OVERALL AND DISEASE FREE SURVIVAL FOLLOWING COMPLETE CYTOREDUCTION AND INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL SURFACE MALIGNANCY, PREDOMINANTLY OF APPENDICEAL ORIGIN, IN 95 PATIENTS E Murphy*, B Meade, R Sexton, T Cecil and B Moran (Basingtsoke) 11.45 7494: REDUCED SURVIVAL TIME WITH PROLONGED HYPOTENSIVE VS NORMOTENSIVE RESUSCITATION C Parry*, J Garner, J Bird, S Watts and E Kirkman (Salisbury) 12.00 7455: UNIVERSAL SHO AND SpR SHIFT ROTAS ADVERSELY INFLUENCE SHO OPERATIVE EXPERIENCE C Beaton*, M R Stephens, A N Hopper and W G Lewis (Newport) 12.15 7064: THE EUROPEAN WORKING TIME DIRECTIVE ‘TRIPLE WHAMMY’: HITTING SURGICAL TRAINEES WHERE IT HURTS R M Heath*, T Gate, C Halloran, M Callaghan, M Paraoan and S D Blair (Wirral)
1: SEVERE VASCULAR TRAUMA: THE MILITARY PERSPECTIVE Professor Philip Barker (Birmingham) 2: ENDOVASCULAR TECHNIQUES IN VASCULAR TRAUMA Dr Tony Nicholson (Leeds)
11.25 3: EMERGENCIES VERSUS ELECTIVES: CONFLICT OR UNION? Mr Paul Skinner (Sheffield)
3: THE INFECTED GROIN: MANAGEMENT OF VASCULAR COMPLICATIONS Mr David Berridge (Leeds)
11.45 4: THE PRESTON RECTAL BLEEDING PROJECT: NEW ROLES AND IMPROVED ACCESS Mr Douglas Stewart (Preston)
4: BLUNT POPLITEAL TRAUMA: THE ORTHOPAEDIC PERSPECTIVE Mr David McDonald (Leeds)
12.05 5: THINKING THE UNTHINKABLE: TRAINING NURSES TO DO HERNIA SURGERY Professor Andrew Kingsnorth (Plymouth)
THE VASCULAR PERSPECTIVE Mr William Butcher (Bournemouth)
12.25 6: WHAT NEXT? Mr Charles Collins (Clinical Lead, Action On General Surgery)
5: BLUNT SHOULDER TRAUMA: THE ORTHOPAEDIC PERSPECTIVE Mr Alistair Ross (Bath) THE VASCULAR PERSPECTIVE Mr Raj Nair (Sheffield) 6: HEAD AND NECK VASCULAR TRAUMA Mr Paul Blair (Belfast)
T2B
AND
11.05 2: STREAMLINING THE ELECTIVE PATIENT PATHWAY Mr Keith Rigg (Nottingham)
T2C
TRADE
T2D
EXHIBITION 29
57799 final prog timetable
29/3/05
11:42 am
Page 30
THURSDAY 14th APRIL 2005 – Afternoon Session (post-lunch/pre-tea) Time
1.30
Lomond
Alsh
625 seats
220 seats
Royal College of Surgeons of England Moynihan Lecture A QUESTION OF PROFESSIONALISM: MOVING FORWARD THE SURGICAL TEAM
Chair: Mr Bernard Ribeiro (Vice President, RCSEng)
T4L
Mr Simon Paterson-Brown (Edinburgh) Mr Ian Beckingham (Nottingham)
1.40 6505: SYSTEMIC INFLAMMATION IS MORE ACCURATE THAN STAGE IN DETERMINING EARLY PROGNOSIS IN GASTRO-OESOPHAGEAL CANCER C Deans *, S Wigmore, J Ross, A de Beaux, S Paterson-Brown and K Fearon (Edinburgh) 1.50 6649: THE ADDITION OF AN ANTI REFLUX PROCEDURE TO LAPAROSCOPIC HELLER’S SEROMYOTOMY: THE DEBATE CONTINUES C D Sutton*, C Neal, G Garcea, J de Caestecker, P S Veitch, A Hall, D M Lloyd, S S Ubhi and G S Robertson (Leicester)
Best Practice: VI SERVICE DELIVERY
2.00 6893: LAPAROSCOPIC ANTI-REFLUX SURGERY IS EFFECTIVE IN OBESE PATIENTS WITH GASTRO-OESOPHAGEAL REFLUX DISEASE V V Ng*, M I Booth and T C B Dehn (Reading)
Chairs: Mr Robert Lane (President, ASGBI) Mr John Black (Chairman, SAC in General Surgery)
2.10 6785: TISSUE INJURY AND ORAL TAURINE THERAPY AUGMENT EPITHELIAL PROGENITOR CELL RECRUITMENT IN PATIENTS WITH BARRETT'S OESOPHAGUS W B Robb*, P Naughton, J J Kelly, C Condron, T N Walsh and D Bouchier-Hayes (Dublin)
1: DAY TREATMENT CENTRES Mr Tom Dehn (Reading)
2.30 2.30
Chairs:
1.30 7191: PREDICTION OF SURVIVAL FROM CARCINOMA OF OESOPHAGUS AND OESOPHAGO-GASTRIC JUNCTION (OGJ) FOLLOWING SURGERY WITH CURATIVE INTENT USING AN ARTIFICIAL NEURAL NETWORK (ANN) R Mofidi*, C Deans, M D Duff, A C de Beaux and S Paterson-Brown (Edinburgh)
Ms Linda de Cossart (Chester)
2.00 2.00
Upper GI Papers (x 12) 8 mins + 2 mins
2.20 6692: INDEPENDENT PROGNOSTIC FACTORS FOR SURVIVAL IN GASTRIC CANCER SURGERY: RESULTS OF 475 CONSECUTIVE CASES S Nanthakumaran*, S A Suttie, E Fernandes, A G K Li, A M Thompson, F J Gilbert and K G M Park (Aberdeen)
2: MAKING THE BEST OF THE SURGICAL WORKFORCE Mr Anthony Giddings (London)
2.30 6250: OUTCOME OF ONTABLE REPAIR OF IATROGENIC BILE DUCT INJURY; THE EXPERIENCE OF A TERTIARY REFERRAL UNIT IN THE WEST MIDLANDS M A Silva *, V Muralidhran, C Coldham, J A C Buckels, S R Bramhall, D F Mirza (Birmingham)
3: FUTURE OF THE NHS Professor Allyson Pollock (Chair of Health Policy and Services, UCL)
2.40 7288: A PROSPECTIVE RANDOMISED CONTROLLED TRIAL COMPARING ANTI-REFLUX STENTS WITH STANDARD STENTS IN THE PALLIATION OF LOWER THIRD OESOPHAGEAL CANCER C Power*, G Lim, N Ravi, P Byrne, J Moore, N Keeling and J V Reynolds (Dublin)
SPONSORED BY
2.50 7213: ARE PREOPERATIVE OESOPHAGEAL PH AND MANOMETRY STUDIES NECESSARY PRIOR TO LAPAROSCOPIC NISSEN FUNDOPLICATION? P Sanjay* and A Woodward (Llantrisant)
3.00
3.00 7181: IDENTIFICATION OF SEVERE ACUTE PANCREATITIS USING AN ARTITIFCIAL NEURAL NETWORK R Mofidi*, M D Duff, K K Madhavan, S J Wigmore, O J Garden and R W Parks (Edinburgh) 3.10 6693: MALNUTRITION IN OBSTRUCTIVE JAUNDICE: POORLY RECOGNISED AND UNDER-TREATED A Clugston, K Yuill, H M Paterson * and R W Parks (Edinburgh) 3.20 7331: THE NARDI TEST FOR SPHINCTER OF ODDI DYSFUNCTION: WORTH THE PAIN? A Thaper*, A S Takhar, B J Rowlands and D N Lobo (Nottingham)
3.30 3.30 4.00 30
T5L
TEA
T3A
BREAK
57799 final prog timetable
29/3/05
11:42 am
Page 31
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
Six of the Best Colorectal Papers 10 mins + 5 mins
Vascular Papers (x 12) 8 mins + 2 mins
Endocrine Papers (x 6) 8 mins + 2 mins
Chairs:
Chairs:
Chairs:
Mr John Hyland (President, ACPGBI)
Professor Kevin Burnand (London) Mr John Murie (Edinburgh)
Mr Paul Maddox (Bath) Miss Julie Doughty (Glasgow)
1.30 7049: COMPARISON OF MICROVASCULAR DYSFUNCTION BETWEEN PATIENTS WITH DIABETES AND INTERMITTENT CLAUDICATION S C J Goh*, J Parmar, M Aslam and N J Standfield (London)
1.30 7148: SUCCESSFUL LAPAROSCOPIC MICROWAVE TISSUE ABLATION OF LARGE HEPATIC METASTASIS FROM PARATHYROID CARCINOMA F Ahmad*, A D Strickland, G M Wright, M Elabassy, P Kiruparan, P R F Bell and D M Lloyd (Leicester and Blackpool)
Mr Ian Finley (Glasgow)
Adjudicator: Ms Jane Linsell (Lewisham) 1.30 7530: IMPACT OF TECHNICAL FACTORS ON OUTCOME OF RESTORATIVE PROCTOCOLECTOMY FOR FAMILIAL ADENOMATOUS POYLPOSIS (FAP) P P Tekkis*, A G Heriot, A Von-Roon, S Truvolon, S Cornaglia, R J Nicholls and R K S Phillips (London) 1.45 7440: GLYCERYL TRINITRATE OINTMENT IN THE TREATMENT OF EARLY SYMPTOMATIC HAEMORRHOIDS- A PROSPECTIVE, RANDOMISED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL M Aslam*, K T Natarajan, M Hanif and C J Ryan (London) 2.00 6608: A COMPARATIVE AUDIT OF LAPAROSCOPIC VERSUS TREPHINE STOMA FORMATION S Jugool*, E Mckain, K Swarnkar, K D Vellacot and B Stephenson (Newport) 2.15 7375: DEALING WITH LONG COLONOSCOPY WAITING LISTS: A SOLUTION! A Kumar* and W Ashraf (Essex)
1.40 6747: EXISTING DELAYS FOLLOWING THE PRESENTATION OF RUPTURED ABDOMINAL AORTIC ANEURYSM ALLOW SUFFICIENT TIME TO ASSESS PATIENTS FOR ENDOVASCULAR REPAIR P J Gibbs*, A Kruger, S Raptis, G E M Morris, C P Shearman, M J Phillips and J R Boyle (Southampton and Adelaide, Australia) 1.50 6669: ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR IS SAFE AND EFFECTIVE, BUT AT WHAT COST? D Oswal*, A Atwal, J Patel, A Mavor, S Homer, A Nicholson, M Gough and S McPherson (Leeds) 2.00 6655: THE EFFECT OF NEUROPATHY AND PLANTAR PRESSURE UPON PLANTAR CUTANAEOUS PERFUSION IN THE DIABETIC FOOT FOLLOWING A STANDARD WALKING TEST D R Miller*, P E Price, E F J Ring and K G Harding (Cardiff) 2.10 6591: QUALITY OF LIFE (QOL) FOLLOWING LYMPHOEDEMA SURGERY S O Ogunbiyi*, B Modarai and K G Burnand (London)
2.30 6752: PALLIATION OF COLONIC OBSTRUCTION USING SELFEXPANDING METALLIC STENTS B Elsberger, K Rourke *, M H S Collie, J Brush and R G Wilson (Edinburgh)
2.20 7627: MANAGEMENT OF ACUTE TYPE B AORTIC DISSECTION REMAINS CONSERVATIVE DESPITE ADVANCES IN ENDOVASCULAR TECHNIQUES M J Brooks *, H Ashrafian, N J Cheshire and M P Jenkins (London)
2.45 7483: CHANGING TRENDS IN THE MANAGEMENT OF CHRONIC ANAL FISSURE S Narayanan*, H Mukthar, A Oshowo and C Ingham-Clark (London)
2.30 7451: PATENT IS NOT POTENT! HIGH FLOW RATES WITHIN AN ARTERIOVENOUS FISTULA DO NOT MEAN ADEQUATE DIALYSIS S Narayanan*, M Kakollu, A Robinson and A daSilva (Wrexham) 2.40 7316: THE EFFECT OF INTRA-NEURAL LOCAL ANAESTHETIC INFUSION ON POST-OPERATIVE ANALGESIA REQUIREMENTS IN MAJOR LOWER LIMB AMPUTATIONS A Grant*and C Wood (Cleveland)
T3B
1.50 7591: SINGLE CENTRE EXPERIENCE OF FIFTY CONSECUTIVE ADRENALECTOMIES A Chakravorty*, N Inston and A R Ready (Birmingham) 2.00 6788: AQUAPORIN-5 IN NORMAL AND HYPERHIDROTIC HUMAN ECCRINE GLANDS S L Lindsay, D Wilson, A D Corbett, D L Bovell* and R J Holdsworth (Glasgow and Stirling) 2.10 7458: INCIDENCE OF INADVERTENT PARATHYROID GLAND EXCISION DURING THYROID SURGERY T Rix, M French and P Sinha (Orpington) 2.20 7205: INTRA-OPERATIVE PARATHYROID HORMONE (PTH) MEASUREMENT PREDICTS CURE FOLLOWING TOTAL PARATHYROIDECTOMY FOR RENAL HYPERPARATHYROIDISM I McFarlane, N Chhaya*, H Charfare and G C Wishart (Cambridge)
T3D
Transplant Papers (x 6) 8 mins + 2 mins Chairs: Professor Michael Nicholson (Leicester) Mr John Buckels (Birmingham)
2.50 7311: WE ARE MISSING THE OPPORTUNITY TO IMPROVE SURVIVAL IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSMS G M Lloyd*, J D Newton, M G A Norwood, S C Franks, M J Bown and R D Sayers (Leicester)
2.30 7379: LAPAROSCOPIC NEPHRECTOMY SHOULD NOW BE THE GOLD STANDARD IN LIVE KIDNEY DONATION: RESULTS OF A RANDOMISED CONTROLLED TRIAL N R Brook*, R Elwell, G R R Lewis, J R Waller and M L Nicholson (Leicester)
3.00 7128: IS MEDICAL TREATMENT OF PERIPHERAL ARTERIAL DISEASE AND CORONARY ARTERY DISEASE EQUIVALENT? S Janes*, J Walsh and B Hopkinson (Wolverhampton and Nottingham)
2.40 7357: CONTROLLED NON HEART BEATING DONOR IN LIVER TRANSPLANTATION: NORTH OF ENGLAND EXPER A Al-Mukhtar*, E Hidalgo, S Balapuri*, A Aldouri, S White, N Banga, G J Toogood, S G Pollard, D Manas, D Talbot*, J P A Lodge and R Prasad (Leeds)
3.10 7109: ENDOVASCULAR ABDOMINAL AORTIC ANEURYSM REPAIR: A UK DISTRICT GENERAL HOSPITAL’S PERSPECTIVE P M Trivedi*, M J Ramdass, T Chance, M Downes, S Biswas and N V Wilson (Canterbury) 3.20 7093: USING A PROSPECTIVE REGIONAL DATABASE TO IDENTIFY RISK FACTORS FOR AN ADVERSE OUTCOME FOLLOWING CAROTID ENDARTERECTOMY F Serracino-Inglott*, S Awad, J Morris and A Nasim (Manchester)
T3C
AND
1.40 6614: EXTRA-ADRENAL ABDOMINAL PARAGANGLIOMA: A CURRENT SURGICAL MANAGEMENT A T Abdel-Rahman1*, D Westbroek, S Clark, H Hitch-Smith, C Baker, J P Monson, M Ashby and R Carpenter (London)
TRADE
2.50 6865: PROLONGED WARM ISCHAEMIC TIME LEADS TO SIGNIFICANT IMPAIRMENT OF EARLY GRAFT FUNCTION DURING PERFUSION ON AN ISOLATED HAEMOPERFUSED PORCINE KIDNEY MODEL S J F Harper*, S A Hosgood, M D Kay and M L Nicholson (Leicester) 3.00 6536: VALIDATION OF A RISK-PREDICTION SCORE TO ESTIMATE SURVIVAL ON DIALYSIS AND TRANSPLANTATION AND ASSIST THE CLINICAL DECISION TO LIST PATIENTS FOR A KIDNEY TRANSPLANT G C Oniscu*, H Brown and J L R Forsythe (Edinburgh) 3.10 5849: MODULATION OF HUMAN DENDRITIC CELL FUNCTION FOLLOWING VIRAL VECTORS: IMPLICATIONS FOR GENE THERAPY IN VACCINATION P H Tan*, S A Xue1, Y H Wang, S C Beutelspacher, J C McAlister, D F P Larkin, M O McClure, H J Stauss, M A Ritter, G Lombardi and A J T George (London and Heidelberg, Germany) 3.20 5847: INHIBITION OF NFKB AND OXIDATIVE PATHWAYS IN HUMAN DENDRITIC CELLS BY ANTI-OXIDATIVE VITAMINS GENERATES REGULATORY T CELLS P H Tan*, P Sagoo1, C Chan1, J B Yates, J Campbell, S C Beutelspacher, B M J Foxwell, G Lombardi and A J T George (London and Heidelberg, Germany)
T4D
EXHIBITION 31
57799 final prog timetable
29/3/05
11:42 am
Page 32
THURSDAY 14th APRIL 2005 – Afternoon Session, continued (post-tea/pre-Annual Dinner) Time
4.00
Lomond
Alsh
625 seats
220 seats
BJS TRAVELLING FELLOWSHIP
AUGIS Symposium
EUROCRATS, EUROPHILES AND THE ISLAND RACE: MAKING SENSE OF THE EWTD
Chairs: Professor Michael Griffin (President, AUGIS) Mr Rowan Parks (Edinburgh)
Professor Brian Rowlands (Vice President-Elect, ASGBI)
4.00 DEBATE: NICE GUIDELINES ON DYSPEPSIA
Chair: Mr Robert Lane (President, ASGBI)
For: Mr Robert Walt (Birmingham) Against: Professor Michael Bramble (Middlesbrough) 4.50 GUIDELINES FOR MANAGING (COLORECTAL) LIVER METASTASES
4.30 4.30
Best Practice: VII
1: THE ROLE OF CHEMOTHERAPY IN IMPROVING OUR OPTIONS Professor John Primrose (Southampton)
EUROPEAN WORKING TIME DIRECTIVE (EWTD)
2: HOW FAR CAN WE GO WITH SURGERY? Mr Myrddin Rees (Basingstoke)
T6L
Chairs: Mr Robert Lane (President, ASGBI) Professor Brian Rowlands (Vice President-Elect, ASGBI)
4.30 2: EWTD AND THE SAC IN GENERAL SURGERY Mr William Allum (London) 4.40 3: UK TRAINING ISSUES Mr Dominic Slade (Manchester) 4.50 4: IRISH TRAINING ISSUES Mr Graham Roche-Nagle (Cork) 5.00 DISCUSSION
5.30
T7L
T4A
C O R P O R AT E PAT R O N S R E C E P T I O N 32
&
ON
57799 final prog timetable
29/3/05
11:42 am
Page 33
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
Colorectal Papers (x 9) 8 mins + 2 mins
General Papers (x 9) 8 mins + 2 mins
Six of the Best Breast Papers 10 mins + 5 mins
Chairs:
Chairs:
Chairs:
Mr Jim Hill (Manchester) Mr Graeme Duthie (Cottingham)
Mr Michael Crumplin (Wrexham) Mr Nicholas Wilson (Winchester)
Mr Graham Layer (Guilford) Mr Marcus Galea (Swindon)
4.00 7499: IS THERE A VALID NEED FOR THE ESTABLISHMENT OF A DEDICATED EMERGENCY COLORECTAL SERVICE IN A DISTRICT GENERAL HOSPITAL? W Hawkins*, K Moorthy, R T Patel and K Yoong (Dudley)
4.00 6936: THE ACCURACY OF SELF-ASSESSMENT BY SURGICAL TRAINEES C G Burt* and D C Wilkins (Plymouth)
Adjudicator:
4.10 7473: THE ROLE OF COLONOSCOPIC SURVEILLANCE FOLLOWING POTENTIALLY CURATIVE RESECTION FOR COLORECTAL CANCER C G Davies, M R Stephens*, A Feroz, B L McNabb and K D Vellacott (Newport) 4.20 7548: T1 COLORECTAL CANCERS: ARE WE DOING IT RIGHT? S Bhattacharya* and C Wilson (Ayr) 4.30 7533: EFFECT OF CHANGES IN THE THRESHOLD OF INVESTIGATION OF ANAEMIA ON STAGE OF PROXIMAL COLON CANCER H Gray*, M Ballal, D Smith, R Hodder, S N Selvachandran and D Cade (Crewe) 4.40 7270: IS SLEEP DISRUPTED IN PATIENTS UNDERGOING ELECTIVE RESECTION FOR COLORECTAL CANCER? P M King*, J M Blazeby, P Ewings, A H Kendrick, R Kipling and R H Kennedy (Taunton and Bristol) 4.50 7266: COMPLICATIONS ASSOCIATED WITH ILEOSTOMY CLOSURE: A REVIEW N B Oozeer*, M R Kalbassi, M Mercer-Jones, D A Browell and W J Cunliffe (Gateshead) 5.00 7183: SAFETY OF SELF EXPANDING METAL STENTS FOR LEFT-SIDED LARGE BOWEL OBSTRUCTION: OUR EXPERIENCE V Rao*, S Dalmia, S I Haider, R Orme, T M Hunt and M Smith (Shrewsbury) 5.10 7179: MICROMETASTATIC CELLS IN BONE MARROW OF PATIENTS WITH COLORECTAL CANCER: AN INDEPENDENT PROGNOSTIC VARIABLE FOLLOWING SURGICAL RESECTION R Macadam*, J Wilson, I A Hunter, K MacLennan and P Guillou (Leeds) 5.20 7051: DOES PRE-OPERATIVE MAGNETIC RESONANCE IMAGING REDUCE POSITIVE CIRCUMFERENTIAL RESECTION MARGIN IN RECTAL CANCER? R Sabbagh*, P R Shah, M E Foster, A Woodward, E Hicks, R Rhys, J L Shannon, C Champ and D Stock (Pontypridd)
T4B
Mr Robert Carpenter (London) 4.00 6674: LONG-TERM FOLLOW-UP AFTER EXCISION OF RADIAL SCARS AND COMPLEX SCLEROSING LESIONS OF THE BREAST K B Muhammad, M Worrall, J R Steel, P A Jones and R M Watkins (Plymouth)
4.10 6863: WHOLE GUT PERMEABILITY IN ACUTE PANCREATITIS K Grover*, M Gatt, B S Reddy, A D G Anderson, S C Fleming, C J Mitchell and J MacFie (Scarborough and Cornwall) 4.20 6837: BASIC SURGICAL TRAINING IN THE ERA OF THE NEW EUROPEAN WORKING TIME DIRECTIVE: WHAT ARE THE PROBLEMS AND HOW CAN IT BE IMPROVED? R J E Skipworth*, L A Fulton, J D Terrace and D N Anderson (Livingston)
4.15 7556: PREOPERATIVE STAPHYLOCOCCUS AUREUS CARRIAGE AND ITS INFLUENCE ON POSTOPERATIVE WOUND INFECTIONS IN BREAST SURGERY: A PROSPECTIVE, MULTICENTRE, OBSERVATIONAL STUDY A Krishna*, S Stallard, D C Smith, A McConnachie and W D George (Glasgow)
4.30 6683: ADHESIONS: INERT SCARS OR DYNAMIC VASCULAR STRUCTURES? J Epstein*, S Wilkowz, S T O'Dwyer, G Ireland, S E Herrick and M S Wilson (Manchester)
4.30 6510: BREAST CANCER TRENDS IN DIVERGENT SOCIAL CLASSES: DEVIL IN THE DETAIL S D Roy*, P Srivastava, S N Selvachandran and D Kupp (South Cheshire and Stoke on Trent)
4.40 7279: ROUTINE USE OF AN ILEOSTOMY ROD: IS IT A BRIDGE TOO FAR? P Glen*, M Speirs, D Hughes, I Robertson, L Donnelly, R N Scott and A Macdonald (Airdrie) 4.50 6644: CRITICAL EVALUATION OF THE HIGHER SURGICAL TRAINEE LOGBOOK REGIONAL ANALYSIS DATABASE FOR YORKSHIRE K Grover *, R Achuthan and J Macfie (Scarborough) 5.00 5771: SURGEONS SHOULD WARM-UP BEFORE OPERATING: THE EFFECT OF VIRTUAL REALITY ON SURGICAL PERFORMANCE H Gracie* and R McCloy (Manchester)
4.45 7372: BREAST CANCER TARGETS: MISSING THE POINT? T E Irvine* and E F Shah (Hastings) 5.00 6911: PROPHYLACTIC MASTECTOMY: INDICATIONS AND OUTCOME G Safdar, S Peart, S Chatterjee, J Cook, N Alam and L Wyld (Sheffield) 5.15 7206: IS BREAST CANCER SURVIVAL IMPROVING? A Imkampe*, C Chianakwalam, S Bendall, J Padgham and T Bates (Ashford, Kent)
5.10 6532: CONTRAST ENHANCED INTRA-OPERATIVE ULTRASOUND (CE-IOUS) IS AN ESSENTIAL TOOL DURING PARTIAL HEPATECTOMY FOR METASTASES S J Moug*, E Leen, P Ceccotti, P Glen, T Albrecht, J Hohmann, A Oldenburg, J P Ritz and P G Horgan (Glasgow and Berlin) 5.20 6677: ANAESTHETICS TAKE LONGER THAN 10 YEARS AGO: 2002 COMPARED WITH 1992 J Shabbir*, K Krishna and A L Widdison (Truro)
T4C
T5D
& A S G B I A N N UA L D I N N E R : G L A S G OW H I LT O N H OT E L 33
57799 final prog timetable
29/3/05
11:42 am
Page 34
FRIDAY 15th APRIL 2005 – Morning Session (pre-Coffe) Time
09.00
Lomond
Alsh
625 seats
220 seats ALS Symposium
Royal College of Physicians and Surgeons of Glasgow Macewen Lecture
LAPAROSCOPIC MANAGEMENT OF THE ACUTE ABDOMEN
TISSUE REGENERATION
Chair: Professor Michael Bailey (President, ALS)
Professor Angus McGrouther (Manchester)
1: LARGE BOWEL EMERGENCIES Mr Michael Li (Hong Kong)
Chair: Professor Graham Teasdale (President, RCPSG)
2: GYNAECOLOGICAL EMERGENCIES Professor Christopher Sutton (Guildford) 3: SMALL BOWEL OBSTRUCTION AND OTHER EMERGENCIES Mr Benoit Navez (Gilly, Belgium) 4: THE POST OPERATIVE ACUTE ABDOMEN Professor Michael McMahon (Leeds)
09.30 09.30
F1L Best Practice: VIII ASSESSMENT AND EXAMINATIONS FOR THE FUTURE TRAINEE Chairs: Mr Graham Layer (Guildford) Professor John Primrose (Southampton)
1: JCIE Mr David Galloway (Chairman, JCIE) 2: WORKPLACE-BASED ASSESSMENT: LESSONS LEARNED FROM FOUNDATION AND THE IMPLICATIONS FOR SURGICAL TRAINING Mr Jonathan Beard (Sheffield) 3: POSTGRADUATE DEAN Dr Sarah Thomas (Postgraduate Dean, South Yorkshire and South Humber)
10.30 10.30 11.00 34
F2L
COFFEE
F1A
BREAK
57799 final prog timetable
29/3/05
11:42 am
Page 35
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
ACPGBI Symposium
Best Practice: IX
Best Practice: X
Chair:
MELANOMA AND SARCOMA
Mr Paul Finan (Leeds)
UPDATE ON THE MANAGMENT OF HEAD INJURIES
Chairs: Mr Meirion Thomas (London)
9.00 1: EVALUATION OF THE PELVIC FLOOR IN FUNCTIONAL DISORDERS Mr Graeme Duthie (Hull)
Chairs: Mr James Steers (President, Society of British Neurological Surgeons)
Professor Paul Redmond (Cork)
Professor Philip Barker (Birmingham)
1: TRENDS IN INCIDENCE AND MORTALITY IN MELANOMA Ms Victoria Giblin (London)
9.20 2: FISTULATING CROHN’S DISEASE Mr Iain Anderson (Manchester) 9.40 3: STAGING AND SURGERY FOR RECTAL CANCER Mr Nigel Hall (Cambridge) 10.00 4: THERAPEUTIC OPTIONS FOR ANAL FISSURE Mr Ian Lindsey (Oxford) 10.20 DISCUSSION
2: SURGICAL CONTROVERSIES IN MELANOMA Mr Meirion Thomas (London) 3: SURGICAL MANAGEMENT OF SOFT TISSUE SARCOMA Mr Andrew Hayes (London)
1: WHAT NEUROSURGEONS NEED TO KNOW: EFFECTIVE COMMUNICATION AND SAFE TRANSFER Mr Jake Timothy (Leeds) 2: IMAGING FOR NEUROTRAUMA: THE PLACE OF PLAIN X-RAY, CT, MRI IN HEAD AND NECK Mr Donald Hadley (Glasgow) 3: SURGERY FOR HEAD INJURY: WHO NEEDS WHAT SURGERY AND WHEN? Professor David Mendelow (Newcastle)
4: MANAGEMENT OF GIST Dr Mark Verrill (Newcastle)
4: INTENSIVE CARE ASPECTS OF HEAD INJURY: WHAT PARAMETERS TO MONITOR AND WHY Mr Peter Hutchison (Cambridge) 5: REHABILITATION AND LONG TERM CARE: WHAT IS THE REAL OUTCOME AFTER HEAD INJURY AND CAN IT BE IMPROVED BY REHABILITATION? Dr Brian Pentland (Edinburgh)
F1B
AND
F1C
TRADE
F1D
EXHIBITION 35
57799 final prog timetable
29/3/05
11:42 am
Page 36
FRIDAY 15th APRIL 2005 – Morning Session, continued (post-coffee/pre-lunch) Time
11.00
Lomond
Alsh
625 seats
220 seats
Best Practice: XI
ALS Symposium
MULTI-DISCIPLINARY CANCER MANAGEMENT
BEST PRACTICE IN LAPAROSCOPIC SURGERY
Chairs:
Chair:
Professor Niall O’Higgins (President, RCSI)
Mr Christopher Royston (Hull)
Mr Michael Thompson (Portsmouth)
1: RECTAL CANCER Mr Michael Li (Hong Kong)
1: QUALITY IMPROVEMENT IN SURGICAL ONCOLOGY: A CANADIAN PROVINCIAL APPROACH Professor Hartley Stern (Ottawa, Canada)
2: RADICAL PROSTATECTOMY Mr Christopher Eden (Basingstoke)
2: ROLE OF CANCER NETWORKS AND MULTIDISCIPLINARY TEAMS Mr Michael Kelly (Leicester) 3: MULTI-DISCIPLINARY APPROACH TO PELVIC MALIGNANCY Mr Peter Sagar (Leeds)
3: OESOPHAGO-GASTRIC CANCER Professor Raffaele Pugliese (Milan, Italy) 4: ALS GUIDELINES FOR BEST PRACTICE Mr Chitrakanti Raja Kapadia (Airedale)
4: GI NON-SURGICAL ONCOLOGY: WHAT’S NEW? Dr David Sebag-Montefiore (Leeds)
SPONSORED BY
12.30 12.30
F3L
F2A
Royal College of Surgeons of Edinburgh Lecture BEST PRACTICE NEEDS AUDIT WITH BITE Mr Steve Nixon (Edinburgh)
Chair: Mr John Smith (President, RCSEdin)
1.00 1.00 2.00 36
F4L
LUNCH
BREAK
57799 final prog timetable
29/3/05
11:42 am
Page 37
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
ABS @ BASO Symposium
Overseas Surgical Fellowship Session
SARS Research Symposium
MANAGING HIGH RISK FAMILIAL BREAST CANCER
Chair:
PREOPERATIVE OPTIMISATION OF THE SURGICAL PATIENT: SCIENTIFIC BASIS FOR BEST PRACTICE
Mr John Rennie (Chairman, Overseas Surgical Fellowship Group)
Chair: 11.00 Overseas Guest Lecturer 1: GEOGRAPHY, CULTURE AND SURGERY Dr Imre Loefler (Nairobi, Kenya)
Professor Paul Sauven (Chelmsford)
11.00 1: GUIDELINES: NICE OR NOT NICE? Professor Paul Sauven (Chelmsford)
Chair: Mr Gordon Carlson (Manchester)
11.00 1: IDENTIFYING THE PATIENT AT RISK: THE SCIENCE OF TRIAGE Mr Iain Anderson (Manchester)
11.30 DISCUSSION
11.10 2: ASSESSMENT OF RISK Professor John Robertson (Nottingham)
11.35 2: TEACHING VVF SURGERY IN AFRICA Mr Brian Hancock (Manchester)
11.30 3: COMMUNICATION OF RISK Dr Penny Hopwood (Manchester)
11.25 2: PREOPTIMISATION OF ORGAN FUNCTION IN THE HIGH-RISK SURGICAL PATIENT: AN EVIDENCE-BASED APPROACH Professor David Bennett (London)
11.55 DISCUSSION
11.45 4: MANAGEMENT OF THE HIGH RISK WOMAN Professor Gareth Evans (Manchester) 12.05 5: OUTCOMES OF RISK REDUCING SURGERY Professor Emile Rutgers (Amsterdam, Holland) DISCUSSION
12.00 3: EXPERIENCES IN MALAWI Dr Kandise Jackson (London) 12.10 4: SITTILINGI RURAL HOSPITAL – AN INNOVATIVE HEALTH CARE MODEL BY THE ASSOCIATION OF RUAL SURGEONS OF INDIA Dr Srinivasamurthy Devaraj (Warwick)
11.50 3: PREOPERATIVE OPTIMISATION OF NUTRITIONAL AND METABOLIC STAUS AND MANIPULATION OF THE STRESS RESPONSE Professor Olle Ljungqvist (Stockholm, Sweden) 12.15 PANEL, DISCUSSION AND QUESTIONS
12.20 5: WORKING IN TIBET Miss Anya Adair (Edinburgh) 12.30 DISCUSSION
F2B
F2D
12.35 DEBATE: THE VALUE OF AN OVERSEAS SURGICAL EXPERIENCE AS PART OF THE UK TRAINING SCHEME – PROS & CONS SHO/SpR versus Mr Simon Fraser (Edinburgh) and Mr Graham Wilson (Edinburgh) 12.55 DISCUSSION
F2C
AND
TRADE
EXHIBITION 37
57799 final prog timetable
29/3/05
11:42 am
Page 38
FRIDAY 15th APRIL 2005 – Morning Session, continued (post-lunch/pre-close of conference) Time
2.00
Lomond
Alsh
625 seats
220 seats
Best Practice: XII
ALS Travelling Scholarship Presentations
PENSIONS AND INDEPENDENT PRACTICE
Chair: Professor Michael Bailey (President, ALS)
Chairs:
1: A LAPAROSCOPIC COLORECTAL FELLOWSHIP YEAR DOWN UNDER Mr Etienne Moore (North Hampshire)
Mr Ian Finlay (Glasgow) Mr Graham Layer (Guildford)
1: YOUR NHS AND PRIVATE PENSION: HOW MUCH AND WHEN? Mr Ronald Bowie (Chair, Pensions Board of the Institute of Actuaries) 2: NHS CONTRACTING IN THE PRIVATE SECTOR: WHO’S RESPONSIBLE FOR WHAT? Mrs Ursula Ward (Chief Executive, Portsmouth Hospitals) Mr David Tennett (Chief Executive, Ross Hall Hospital BMI Healthcare)
2: STUDY VISIT TO BRISBANE AND MELBOURNE Mr Auden Sigurdsson (Shropshire) 3: VISIT TO DANIEL CHERQUI’S LIVER UNIT AT HOSPITAL HENRI MONDOR Ms Meg Finch-Jones (Bristol) 4: LAPAROSCOPIC COLORECTAL EXPERIENCE IN A SOUTH AUSTRALIAN TRAINING POST Mr Kevin Sargen (Norwich)
Dr Riaz Mohammed (Medical Defence Union, Scotland)
F3A
2.30 2.30
Six of the Best Laparoscopic Papers 10 mins + 5 mins Chairs: Mr Mark Vipond (Gloucester) Mr Michael Thompson (Bristol)
Adjudicator: Mr Robert Foley (Bedford) 2.30 6678: GALLBLADDER CARCINOMA: A SINGLE CENTRE 15-YEAR EXPERIENCE S S Ching * and M J McMahon (Leeds) 2.45 7467: CONSERVATIVE LAPAROSCOPIC TREATMENT OF SPLENIC INJURIES WITH AN ABSORBABLE MESH C G S Huscher, C Ponzano, M Di Paola, A Mingoli, A Recher and T Arulampalam (Rome and Colchester) 3.00 7431: DOES IRRITABLE BOWEL SYNDROME AFFECT QUALITY OF LIFE IN PATIENTS FOLLOWING LAPAROSCOPIC CHOLECYSTECTOMY? G R Kirk*, J Clarke, M Regan, W D B Clements and T Diamond (Belfast) 3.15 7475: LAPAROSCOPIC PANCREATICODUODENECTOMY C G S Huscher*, C Ponzano, M Di Paola, A Recher and T Arulampalam (Rome and Colchester) 3.30 6964: SPLENECTOMY: IS THE LAPAROSCOPIC APPROACH JUSTIFIED FOR ALL? C J Pattenden*, C D Sutton and D M Lloyd (Leicester)
3.30
3.45 7472: LAPAROSCOPIC VERSUS OPEN SUBTOTAL GASTRECTOMY FOR DISTAL GASTRIC CANCER: 5-YEAR RESULTS OF A RANDOMIZED PROSPECTIVE TRIAL C G S Huscher*, M Di Paola, C Ponzano, G Sgarzini, A Sansonetti, and T Arulampalam (Rome and Colchester)
F5L
4.00 C 38
L
O
S
E
F4A
O
F
C
O
N
F
E
R
E
57799 final prog timetable
29/3/05
11:42 am
Page 39
Boisdale
Carron
Dochart
220 seats
200 seats
200 seats
Military Surgery Symposium Chairs: Surgeon Vice-Admiral Ian Jenkins (Surgeon General, Defence Medical Services) Surgeon Captain Philip Barker (Professor of Military Surgery)
Colorectal Papers (x 12) 8 mins + 2 mins
General Papers (x 9) 8 mins + 2 mins
Chairs:
Chairs:
Mr Paul Finan (Leeds) Mr Michael Kelly (Leicester)
Professor Arthur Tanner (Dublin) Mr John Rennie (London)
2.00 7532: VALIDATION OF A PATIENT CONSULTATION QUESTIONNAIRE AND DERIVED WEIGHTED NUMERICAL SCORE FOR THE PRIORITISATION OF COLORECTAL REFERRALS IN WALES M Ballal*, S Naughton, D J Hay and A Maw (Rhyl and Crewe)
2.00 1: OVERVIEW OF SURGICAL TRAINING WITHIN DMS Surgeon Commander Chris Parry
2.10 6998: EVALUATION OF COLONOSCOPY FOR COLORECTAL CANCER: A PROSPECTIVE MULTI-CENTRE STUDY S Purkayastha*, P P Tekkis, A W Darzi, A R Radford, J J Smith, M R Thompson and J D Stamatakis (London)
2.15 2: OPPORTUNITIES, EXPERIENCE AND SUPPORT Lieutenant Colonel Doug Bowley Surgeon Commander Chris Streets
2.20 7361: THE MANCHESTER HEALTH QUESTIONNAIRE AND ITS RELATIONSHIP TO ANAL SPHINCTER FUNCTION C L Nockolds*, G L Hosker and E S Kiff (Manchester)
2.45 3: DEPLOYMENTS: THE GOOD AND THE BAD Lieutenant Colonel David Vassalo
2.30 7347: EXPLORING THE PROTEOME AS A RESPONSE PREDICTOR FOR RECTAL CANCER UNDERGOING NEOADJUVANT RADIOCHEMOTHERAPY F M Smith*, R B Stephens, E F Petricoin, L A Liotta, M J Kennedy and J V Reynolds (Dublin and Bethesda, USA)
3.00 4: WAR SURGERY: WHAT’S DIFFERENT ABOUT IT? Colonel Keith Galbraith
2.00 6749: SPECIALISATION OF EMERGENCY SURGERY IN THE MANAGEMENT OF PERFORATED PEPTIC ULCER DISEASE A J Robson*, J M J Richards, S J Nixon and S Paterson-Brown (Edinburgh) 2.10 5781: DEVELOPING ASSESSMENTS OF SURGICAL SKILLS FOR THE GMC PERFORMANCE PROCEDURES J D Beard*, W E G Thomas, J Rochester, B C Jolly, D I Newble and L J Southgate (Sheffield and GMC) 2.20 5780: ASSESSING THE TECHNICAL SKILLS OF SURGICAL TRAINEES J D Beard*, W E G Thomas, J Rochester, B C Jolly, D I Newble and L J Southgate (Sheffield)
2.40 7170: PATIENT-BASED OUTCOMES AFTER DYNAMIC GRACILOPLASTY: AN INDEPENDENT EVALUATION T Tillin*, R A Feldman and N S Williams (London)
2.30 7077: GIVE PATIENTS THE CHOICE: ‘WALK IN WALK OUT’ (WIWO) HERNIA CLINIC D R Leff *, S Renton and R P Bhutiani (London)
3.30 6: HOW IT WORKS IN THE RESERVES Major Ben Banerjee
2.50 6977: MAGNETIC RESONANCE COLONOGRAPHY - A NEW IMAGING MODALITY FOR DIAGNOSING COLORECTAL CANCER: A META-ANALYSIS S Purkayastha*, P P Tekkis, T Athanasiou, O Aziz, R Negus, W Gedroyc and A W Darzi (London)
2.40 7580: SURGICAL TRAINING AND THE NEW DEAL A George*, M Burke and D Defriend (Torquay)
3.45 7: THE DIPLOMA IN MILITARY SURGERY Surgeon Captain Philip Barker
3.00 6954: NINETY AND STILL BATTLING: COLORECTAL CARCINOMA IN THE NONAGENARIANS T Tang*, J Lealand and B V Praveen (Essex)
3.15 5: THE INTERFACE WITH THE NHS: IMPLICATIONS FOR SURGICAL TRAINING Colonel Simon Mellor
3.10 6901: THE EFFECT OF COLONIC RESECTION ON RECOVERY OF GASTROINTESTINAL FUNCTION FOLLOWING MAJOR ABDOMINAL SURGERY G MacKay*, R G Molloy and P J O'Dwyer (Glasgow) 3.20 6841: COLORECTAL CARCINOMA IS ASSOCIATED WITH A FIELD CHANGE OF INCREASED APOPTOTIC INHIBITION IN ADJACENT COLORECTAL MUCOSA S Badvie*, A Hanna-Morris, S Saini , H J N Andreyev , P Cohen and T G Allen-Mersh (London)
2.50 7448: CLEAN PRACTICE PROTOCOL: INTERVENTIONAL AUDIT OF HAND WASHING AND CLEAN PRACTICE ACROSS SURGICAL SPECIALITIES AT AN ACUTE MULTIDISCIPLINARY HOSPITAL S Sen, A Shah, J Daurka, R Bird, A Loh and A Howard* (London) 3.00 7445: PROCESSES OF CARE IN ACUTE SURGICAL ADMISSIONS: ROOM FOR IMPROVEMENT? K S Stevenson*, S C Gibson, D MacDonald, D Hole, P N Rogers, D S Byrne and D B Kingsmore (Glasgow) 3.10 7236: IS SENTINEL LYMPH NODE BIOPSY (SLNB) FOR MALIGNANT MELANOMA JUSTIFIED? F Sagias*, P Ryan, M Boss, R Lindley and O Khan (Kent)
3.30 6806: THE LONG TERM EFFICACY OF INTRA ANAL COLLAGEN INJECTIONS IN PATIENTS WITH PASSIVE FAECAL LEAKAGE OF VARYING SEVERITY M Lim*, S Stojkovic, P Sagar, P Finan and D Burke (Leeds) 3.40 6919: COMPARISON OF HOSPITAL EPISODE STATISTICS (HES) WITH THE ASSOCIATION OF COLOPROCTOLOGY OF GREAT BRITAIN AND IRELAND (ACPGBI) COLORECTAL CANCER DATABASE MGarout*, P Tekkis, A W Darzi, J Stamatakis and P Aylin (London and ACPGBI)
3.20 6986: VALIDATION OF THE MODIFIED EARLY WARNING SYSTEM FOR BEDSIDE MONITORING OF THE SURGICAL PATIENT T Ramkumar*, I Rechner, M Odell, J Fielden, A Kapila and R Farouk (Reading)
3.50 6264: UNREASONABLE EXPECTATIONS IN EMERGENCY COLORECTAL CANCER SURGERY? M G A Norwood*, M S Metcalfe, A S Miller and D Hemingway (Leicester)
F3B
R
E
N
C
E
&
D
F3D
F3C
E
L
E
G
A
T
E
S
D
E
P
A
R
T 39
57799 final prog timetable
29/3/05
11:42 am
Page 40
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
POSTERS W1M1: GENERAL SURGERY
W1M2: LAPAROSCOPIC
9.00 6118: STAT SIGNALLING DIRECTS RESOLUTION OF INFLAMMATION THROUGH NFKAPPA-B INHIBITION D A Harris*, C A Fielding, R M McLoughlin, M E Foster, S A Jones and N Topley (Cardiff and Llantrisant)
9.00 6603: ON TABLE CHOLANGIOGRAPHY FOR LAPAROSCOPIC CHOLECYSTECTOMY: “NEVER SAY DIE TO THE DYE.” A J Shah*, J Gilmour, J Barry, R J Delicata, R L Blackett, C Bransom and D R B Jones (Abergavenny)
9.05 6217: RECOGNITION AND TREATMENT OF ABDOMINAL COMPARTMENT SYNDROME (ACS): A QUESTIONNAIRE STUDY OF INTENSIVE CARE UNITS IN THE UNITED KINGDOM A Tiwari*, S Louth, F Myint and G Hamilton (London)
9.05 6261: THE LEARNING CURVE OF LAPAROSCOPIC NISSEN FUNDOPLICATION I Hadjiloucas*, E Mulgrew, R Horsley, C Lewis and S E A Attwood (Salford)
9.10 6617: THE EFFECTIVENESS, RELIABILITY AND ACCEPTABILITY OF PEER MARKING IN FIRST YEAR MEDICAL STUDENTS R English*, Y Ben-Shlomo, S T Brookes, U Fallon and J M Blazeby (Bristol) 9.15 6616: SURGERY BY NUMBERS A Kingsnorth (Plymouth) 9.20 6645: GASTROINTESTINAL STROMAL TUMOURS (GIST): CLINICO-PATHOLOGICAL STUDY OF 185 CASES I Ahmed*, S L Parsons, I A Soomro, T A McCulloch and N T Welch (Nottingham) 9.25 5851: A COMPARISON OF DIFFERENT METHODS OF RISK STRATIFICATION IN URGENT AND EMERGENCY SURGERY W D Neary*, D Prytherch, C Foy, B Heather and J J Earnshaw (Portsmouth) 9.30 6491: A PROSPECTIVE STUDY OF TELEPHONE FOLLOW-UP AFTER TREATMENT FOR MINOR ANORECTAL CONDITIONS R C Fallaize*, C Tinline-Purvis, A R Dixon and A M PullyBlank (Bristol) 9.35 6756: PROSPECTIVE STUDY OF CLINICAL DATA COLLECTION USING PALM PILOT AND TRADITIONAL PAPER FORM T Kurzawinski*, C Matejowsky, A Kendle and R Skillen (London)
9.15 6632: A RETROSPECTIVE STUDY OF OPEN AND LAPAROSCOPIC INCISIONAL HERNIA REPAIRS M A Scott*, K Grant and V Jain (Luton) 9.20 6665: PAEDIATRIC LAPAROSCOPIC NEPHRECTOMY: THE LEARNING CURVE W M El-Saify, M Kulkarni and A B Mathur (Norwich) 9.25 7139: LAPAROSCOPIC LARGE VOLUME MICROWAVE TISSUE ABLATION OF LIVER TUMOURS USING A NOVEL APPLICATOR A D Strickland*, F Ahmad, P J Clegg, N J Cronin and D M Lloyd (Leicester and Bath) 9.30 6900: AN AUDIT OF LAPAROSCOPIC COLORECTAL RESECTIONS PERFORMED IN ONE YEAR BY TWO NEWLY APPOINTED CONSULTANTS T Arulampalam*, R Austin and R Motson (Colchester) 9.35 7069: ASSESSMENT OF TECHNICAL SURGICAL ERRORS COMMITTED DURING TRAINING COURSES BY OBSERVATIONAL CLINICAL HUMAN RELIABILITY ASSESSMENT M R Hussain*, B Tang, J P Martindale and A Cuschieri (Dundee)
9.40 6773: EARLY ULTRASOUND CAN REDUCE THE LENGTH OF HOSPITAL STAY G Bazoua*, L Krishnamoorthy and C A Gateley (Newport)
9.40 7199: DOES HEPATIC MICROWAVE TISSUE ABLATION INDUCE A SYSTEMIC INFLAMMATORY RESPONSE? AN INVESTIGATION WITH A NOVEL MICROWAVE SYSTEM F Ahmad*, A D Strickland, R Basit, G S M Robertson and D M Lloyd (Leicester)
9.45 6774: POSSUM AND P-POSSUM SCORING SYSTEMS OVERESTIMATE MORTALITY IN PATIENTS WITH SEVERE PERITONITIS TREATED WITH LAPAROSTOMY PLUS IMMEDIATE VACUUM ASSISTED ABDOMINAL CLOSURE (VAC) R A S Cacciola *, N Charaklias, D J Hay and A Maw (Cardiff and Rhyl)
9.45 7197: CLINICAL COMPARISON OF DEFECTS WITH THAT FOUND DURING LAPAROSCOPIC REPAIR OF VENTRAL HERNIAS; A CASE FOR HIGH RECURRENCE RATE IN OPEN REPAIR OF VENTRAL HERNIA M Z Ullah* and A Bhargava (Essex)
9.50 6782: DEGREES IN TRAINING. HOW ADVANTAGEOUS ARE THEY WHEN APPLYING FOR JUNIOR SURGICAL POSITIONS? S K Richards*, A K Y Pentlow and B D Pentlow (Bristol and Newcastle-upon-Tyne)
9.50 7269: DEXTERITY ANALYSIS FOR THE ASSESSMENT OF LAPAROSCOPIC PROCEDURES IN THE OPERATING THEATRE R Aggarwal*, K Moorthy, T Grantcharov, P Papasavas, T Milland, A Dosis, F Bello and A Darzi (London, Denmark and Pittburgh, USA)
9.55 6854: PRE VS POSTPYLORIC FEEDING: A RANDOMISED CLINICAL TRIAL M Gatt *, A Coppack, L McNaughton, C Ramsey, L Wallace, C J Mitchell and J MacFie (Scarborough) 10.00 6947: EPIDEMIOLOGY AND TRENDS IN MAJOR TRAUMA IN NORTHERN IRELAND C Baird and B McNicholl (Belfast) 10.05 7000: IS THE HEPATOCYTE GROWTH FACTOR REGULATORY SYSTEM THE REASON FOR WOUNDS BECOMING CHRONIC? K Conway*, P Price, K G Harding and W G Jiang (Cardiff) 10.10 7212: HOW ACCURATELY CAN DIRECT AND INDIRECT INGUINAL HERNIAS BE DISTINGUISHED? P Sanjay* and A Woodward (Llantrisant) 10.15 7406: SURGICAL EMERGENCY REVIEW CLINIC: A NEW CONCEPT B Piramanayagam*,G Barsoum, D Burkitt, M Budhoo and C Hendrickse 10.20 7565: ADVERSE EVENTS AND ADVERSE PROCESSES: HOW CAN QUALITY OF CARE BE BEST IMPROVED? K S Stevenson, S C Gibson, D MacDonald, D Hole, P N Rogers, D S Byrne and D B Kingsmore (Glasgow) 10.25 7616: HOUSE OFFICERS IN SURGICAL TRAINING A George*, M Burke and D Defriend (Torquay)
40
9.10 6615: APPLICATION OF LAPAROSCOPY IN REVERSAL OF HARTMANN'S PROCEDURE G Bouras *, H Inoue, M Arenas, J Leroy, D Mutter and J Marescaux (Strasbourg)
9.55 7614: ROLE OF STAGING LAPAROSCOPY IN UPPER GI MALIGNANCY V R Patcha*, J P Gilmour, S Kumar, M Nutt and B O’Riordan (Carmarthen) 10.00 7454: ROUTINE LAPAROSCOPIC REPAIR OF PRIMARY UNILATERAL INGUINAL HERNIAS – A VIABLE ALTERNATIVE IN THE DAY SURGERY UNIT? M Duff*, R Mofidi and S J Nixon (Edinburgh) 10.05 7466: LAPAROSCOPIC RESECTION OF GASTRIC LEIOMYOMA: A SHORT SERIES K Krishna*, P Peyser and A Widdison (Truro) 10.10 7507: MINIMALLY INVASIVE SURGERY: A CHOICE FOR "ALL COMERS" WITH BILIARY AND GASTRIC OUTLET OBSTRUCTION A M Owera*, M Al-Rashedy, A M Hamade and B J Ammori (Manchester) 10.15 7537: THE IMPACT OF PATIENT CONTROLLED ANALGESIA ON DAY CASE LAPAROSCOPIC CHOLECYSTECTOMY IN AN INPATIENT MODEL S Sinha*, V Munikrishnan, J Montgomery and S Mitchell (Torquay) 10.20 7542: THE RELATIVE SAFETY OF VERES NEEDLE COMPARED TO THE OPEN TECHNIQUE WHEN USED TO ESTABLISH A PNEUMOPERIONEUM D Lawes*. M Ahmad. J Smith and B Lovett (Basildon) 10.25 WITHDRAWN
57799 final prog timetable
29/3/05
11:42 am
Page 41
POSTERS W2M1: UPPER GASTROINTESTINAL
W2M2: BREAST
11.30 7131: THE INFLUENCE OF A POSITIVE CIRCUMFERENTIAL RESECTION MARGIN ON THE PROGNOSIS IN RESECTED OESOPHAGEAL CANCER: UNIVARIATE AND MULTIVARIATE SURVIVAL ANALYSIS E A Griffiths*, Z Brummell, S Pritchard and I M Welch (Manchester)
11.30 5874: SKIN SPARING MASTECTOMY AND IMMEDIATE BREAST RECONSTRUCTION: DOES IT INCREASE RISK OF LOCAL RECURRENCE OF BREAST CANCER? M Hussien, A Patel, T Leslie, I Daltrey, J Cook, Z E Winters and Z Rayter (Bristol)
11.40 7045: A DAMPENED C-REACTIVE PROTEIN RESPONSE FOLLOWING LIVER RESECTION AS AN INDICATOR OF POOR HEPATIC RESERVE S H Rahman*, J Evans, G J Toogood, J P A Lodge and R Prasad (Leeds) 11.45 5836: VALIDATING PROPHYLACTIC TOTAL GASTRECTOMY FOR CDH1 GERMLINE GENE MUTATION C J Moran*, M Joyce, M Maher, G E Connolly and O J McAnena (Galway) 11.50 6527: DOES SURGERY HAVE A ROLE IN LOCALLY ADVANCED OESOPHAGEAL CANCER? S A Suttie*, A G K Li, E Fernandes, J Wong, M Nicolson and K G M Park (Aberdeen) 11.55 6682: HYPOXIA AND ANGIOGENESIS IN COLORECTAL LIVER METASTASES C D Sutton*, L J Marshall, J C Goddard, K O’Byrne, G Garcia, J L Jones, A R Dennison, G Poston, D M Lloyd and D P Berry (Liverpool) 12.00 6688: THE RELATIONSHIP BETWEEN SOCIOECONOMIC DEPRIVATION AND OESOPHAGEAL AND STOMACH CANCER INCIDENCE AND SURVIVAL J A Rink*, S Godward and K Hosie (Plymouth) 12.05 6810: OUTCOME FOLLOWING RE-RESECTION FOR COLORECTAL LIVER METASTASES – ANALYSIS OF PROGNOSTIC FACTORS AND INFLUENCE OF THE TYPE OF FIRST HEPATECTOMY Z Z R Hamady*, H Nishio, S W Fenwick, R Prasad, G J Toogood and J P A Lodge (Leeds) 12.10 6960: NF-KAPPAB ACTIVITY AND CYTOKINES PATTERN PRE AND POST CHEMORADIOTHERPY IN OESOPHAGEAL CANCER PATIENTS M M M Abdel-Latif, J M O’ Riordan, R Narayanasamy, D Kelleher and J V Reynolds (Dublin) 12.15 7059: THE EXTENT OF GASTRECTOMY FOR OGJ TUMOURS AND TYPE OF RECONSTRUCTION AFFECT THE DUODENO-OESOPHAGEAL REFLUX I E Katsoulis *, I Robotis and P Yannopoulos (Athens) 12.20 7057: VALUE OF HISTOLOGY IN A HIGH-VOLUME CHOLECYSTECTOMY UNIT D Roy*, S A Pilkington, S K C Toh, S S Somers, A M Walters and S A Sadek (Portsmouth) 12.25 7102: HEPATIC RESECTION: TOWARDS MINIMAL BLOOD LOSS AND MORTALITY N Karanjia*, N Quiney, W Fawcett and J Remington (Guildford) 12.30 7106: MESENTERIC LYMPH DUCT LIGATION REDUCES RED BLOOD CELL DAMAGE CAUSED BY ACUTE PANCREATITIS D J Mole*, T Berezina, S Zaets, Z Spolarics, N V McFerran, G Machiedo, T Diamond and E A Deitch (Newark and Belfast) 12.35 7119: ACUTE PANCREATITIS: AN UNDER-ESTIMATED RISK OF PERCUTANEOUS TRANSHEPATIC DISTAL BILIARY INTERVENTION A Z Al-Bahrani*, A Holt, G H Abid, S O’Shea, S Lee and B J Ammori (Manchester) 12.40 7154: RAPID LARGE VOLUME MICROWAVE TISSUE ABLATION OF UNRESECTABLE LIVER TUMOURS USING A NOVEL APPLICATOR: RESULTS OF A PILOT CLINICAL TRIAL F Ahmad, A D Strickland, P J Clegg, N J Cronin, M Elabassy, G S M Robertson and D M Lloyd (Leicester and Bath)
11.35 5878: CLEAR SURGICAL EXCISION MARGINS ARE A KEY FACTOR IN REDUCING DCIS RECURRENCE RISK FOLLOWING BREAST CONSERVING SURGERY N L P Barnes, S Rimouche*, W F Knox and N J Bundred (Manchester) 11.40 6485: METASTATIC PATHWAYS IN EARLY BREAST CANCER M B Klevesath*, K Pantel, S W Duffy, P Gough, L Bobrow and A D Purushotham (Cambridge, Hamburg, London and King’s Lynn) 11.45 6508: THE VALUE OF POST OPERATIVE HAEMOGLOBIN ASSESSMENT FOLLOWING ROUTINE THERAPEUTIC BREAST CANCER SURGERY A Narayanan*, D Clarke, A O B Johnston and S Harries (Warwick) 11.50 6578: BREAST CANCER PATIENTS OVER THE AGE OF 80 - SURGERY VERSUS PRIMARY ENDOCRINE TREATMENT V S R Rao*, J K A Jameel, T K Mahapatra, P J Drew and J N Fox (Cottingham) 11.55 6968: CORRELATION OF MRNA FOR OESTROGEN RECEPTOR BETA VARIANTS WITH OUTCOME IN TAMOXIFEN TREATED BREAST CANCER R Vinayagam*, M P A Davies, D R Sibson and C Holcombe (Liverpool and Wirral) 12.00 7021: COMPLICATION RATES OF SKIN-SPARING MASTECTOMY WITH IMMEDIATE TRAM FLAP RECONSTRUCTION D J Thomson *, E Wu, P S Tibbitts, C L E Osborne and E H Drabble (Plymouth) 12.05 7141: PREDICTORS OF POSITIVE MARGINS IN LOBULAR CARCINOMA TREATED WITH BREAST CONSERVATION M F Dillon *, A D K Hill, F J Fleming, A O’Doherty, C M Quinn, E W McDermott and N O’Higgins (Dublin) 12.10 7143: WOUND INFECTION PROPHYLAXIS IN BREAST SURGERY: A RANDOMISED CONTROLLED TRIAL COMPARING THE EFFICACY OF ANTIBIOTICS AND PERIOPERATIVE WOUND WARMING S Kumar*, A Melling, P F Wong, D Whetter and D J Leaper (Stockton-on-Tees) 12.15 7147: A PATHOLOGICAL ASSESSMENT OF ADEQUATE MARGIN STATUS AND PREDICTORS OF RESIDUAL DISEASE IN BREAST CONSERVATION SURGERY M F Dillon*, A D K Hill, C M Quinn, E W McDermott and N O’Higgins (Dublin) 12.20 7155: THE EFFICACY OF ULTRASOUND, STEREOTACTIC AND CLINICAL CORE BIOPSIES IN THE DIAGNOSIS OF BREAST CANCER, WITH AN ANALYSIS OF FALSE NEGATIVE CASES M F Dillon, A D K Hill, C M Quinn, A O’Doherty, E W McDermott and N O’Higgins (Dublin) 12.25 7178: SIMPLE TECHNIQUE TO PREVENT DOGEAR AFTER MASTECTOMY S Govindarajulu*, S R Narreddy, S J Cawthorn and A K Sahu (Bristol) 12.30 7193: PROSPECTIVE EVALUATION OF ARM SWELLING FOLLOWING LEVEL III AXILLARY CLEARANCE: 5 YEAR RESULTS S M Kieran, A D K Hill, M F Dillon, M Duff, E W McDermott and N O’Higgins (Dublin) 12.35 7380: THE PROGNOSTIC SIGNIFICANCE OF MUC1 EXPRESSION IN PRIMARY BREAST CANCER AND THE EFFECT OF NEOADJUVANT TAMOXIFEN TREATMENT ON ITS EXPRESSION N Kachroo*, D A Browell, W J Cunliffe and B K Shenton (Gateshead) 12.40 7385: BREAST IMPLANT SALVAGE AND LAVAGE FOR THE TREATMENT OF INFECTED BREAST IMPLANTS FOLLOWING IMMEDIATE BREAST RECONSTRUCTION P S Tibbitts*, E Wu, C L E Osborne, D Thomson and E H Drabble (Plymouth)
12.45 7241: GASTRO-OESOPHAGEAL REFLUX DISEASE AFFECTS VOICE QUALITY J Pearson*, E Abberton, A Fourcin and M Hashemi (London)
12.45 7411: RAMAN SPECTROSCOPY IS A SENSITIVE, SPECIFIC AND RAPID TECHNIQUE FOR THE ASSESSMENT OF LYMPH NODE METASTASES IN BREAST CARCINOMA J Smith*, C Kendall, J Christie-Brown, C Chan, A Sammon, H Barr and N Stone (Gloucester)
12.50 7438: MODIFIED D2 GASTRECTOMY FOR CANCER: THE LEARNING CURVE UNMASKED A N Hopper*, M R Stephens, G Blackshaw, J Barry, P Edwards, I Hodzovic, K Harries and W G Lewis (Newport)
12.50 7449: SYSTEMATIC CAVITY SHAVES REDUCES POSITIVE MARGINS AND REEXCISION RATES IN BREAST CONSERVING SURGERY S Janes*, M Stahnke, S Singh and B Isgar (Wolverhampton)
12.55 7463: OUTCOME OF MODIFIED D2 GASTRECTOMY FOR JUNCTIONAL CANCER OF THE PROXIMAL STOMACH R Stratford, A N Hopper*, M R Stephens and W G Lewis (Newport)
PROGRAMME
11.35 6687: THE IMPACT OF SOCIOECONOMIC DEPRIVATION ON THE TREATMENT OF OESOPHAGEAL AND STOMACH CANCER IN EAST ANGLIA 1993-2001 J A Rink*, S Godward and K Hosie (Plymouth)
12.55 7626: TRAINEES’ EVALUATION OF A SIMULATOR FOR SENTINEL NODE BIOPSY IN BREAST CANCER: A NEW STANDARD M R S Keshtgar, D W Chicken, W Waddington and P Ell (London)
41
57799 final prog timetable
29/3/05
11:42 am
Page 42
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
POSTERS W3M1: TRANSPLANT AND VASCULAR 1.30 5848: CREATION OF TOLEROGENIC ANTIGEN PRESENTING CELLS VIA INTRACELLULAR CTLA4: A NOVEL STRATEGY WITH POTENTIAL CLINICAL UTILITY IN TRANSPLANTATION P H Tan*, O B Herrera, J Yates, J E Harper, M P Watson, C Chan, S A Xue, W J Jordan, R Dong, H J Stauss, M A Ritter, R I Lechler, G Lombardi and A J T George (London) 1.35 6328: WARM HYPOXIA-REOXYGENATION TRIGGERS APOPTOSIS OF HUMAN SINUSOIDAL ENDOTHELIAL CELLS N R Banga*, A Graham, L Burn, G J Toogood, S Homer-Vanniasinkam and K R Prasad (Leeds, Bradford and Sheffield) 1.40 7041: THE ADDITION OF MYCOPHENOLATE AND/OR BASILIXIMAB TO CALCINEURIN-INHIBITOR IMMUNOSUPPRESSION REDUCES THE HIGH RISK OF ACUTE REJECTION IN LIVE DONOR TRANSPLANTS N R Brook*, I Au-Yong and M L Nicholson (Leicester) 1.45 WITHDRAWN 1.50 WITHDRAWN
3.05 7287: GROWTH FACTOR AND GROWTH FACTOR RECEPTOR EXPRESSION IN HEALING ISCHAEMIC ULCERS M O Murphy *, J Ghosh, N Khwaja, A T Halka, S Herrick, P Fulford and M G Walker (Manchester) 3.10 7369: INCREASED HIF-1ALPHA EXPRESSION AND ANGIOGENESIS IN CRITICAL LIMB ISCHAEMIA (CLI) IN HUMAN T K Ho*, D J Abraham, C M Black, V Rajkumar, C DiSalvo, R K Walesby, C Hart and D M Baker (London) 3.15 7371: SHORT-TERM RESULTS OF A PROSPECTIVE STUDY OF CAROTID ARTERY STENTING (CAST) UNDER NEURO-PROTECTION AND CAROTID ENDARTERECTOMY (CEA) IN HIGH RISK PATIENTS N Hynes *, B Mahendran, J Asad, E Andrews, D Courtney, S Tawfik, G O Sullivan and S Sultan (Galway)
1.55 7586: LIVER RESECTION FOR NON-COLORECTAL NON-NEUROENDOCRINE HEPATIC METASTASES P S Jambulingam *, M A Silva, C V Kantharia, C Coldham, A D Mayer, J A C Buckels, S R Bramhall and D F Mirza (Birmingham)
3.20 7401: CAN PRE-OPERATIVE DUPLEX MARKING OF THE SAPHENO-POPLITEAL JUNCTION (SPJ) BE AVOIDED? A Kambal*, M Najem, D Jacobs, K Modaresi, P Smart, S Renton and T Hussain (London)
2.00 6642: IMPROVING OPERATIVE CODING ACCURACY: THE ROLE OF THE SURGEON D J Williams*, T Beckitt, J Day, P M Lamont, F C Smith and R N Baird (Bristol)
3.25 7622: PEAK WALL STRESS; VALUE AND LOCATION IN RUPTURED AND NONRUPTURED ABDOMINAL AORTIC ANEURYSMS M S T Heng, A K Venkatasubramaniam, M J Fagan, J W Collier, G M Desai, B Ray, D Lee, I Chetter and P T McCollum (Hull)
2.05 6194: SCREENING FOR ABDOMINAL AORTIC ANEURYSMS IN PATIENTS WITH CARDIOVASCULAR SYMPTOMS A Hanly, S Javed, D Moisey, J Horgan and C Kelly (Dublin) 2.10 7396: INFLUENCE OF ANEURYSM MORPHOLOGY ON PROCEDURE COST AND HOSPITAL STAY K Krishna *, N Sinclair, J Hancock, S J Travis and K R Woodburn (Truro) 2.15 5975: MOST PATIENTS WITH VARICOSE VEINS HAVE FEARS OR CONCERNS ABOUT THE FUTURE, IN ADDITION TO THEIR PRESENTING SYMPTOMS H Decaluwe*, J MacIntyre, J F Thompson, A R Cowan and W B Campbell (Exeter) 2.20 6786: DOES ENDOVENOUS LASER TREATMENT (EVLT) IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH VARICOSE VEINS? R J Beale*, A I D Mavor and M J Gough (Leeds) 2.25 6903: MRSA SCREENING IN VASCULAR SURGERY: THE WAY FORWARD? D Malde*, A Abidia, A Nasim, M Welch and C N McCollum (Manchester) 2.30 WITHDRAWN 2.35 6949: RELATIONSHIP OF ISCHAEMIA MODIFIED ALBUMIN (IMA) AND CARDIAC TROPONIN I (CTNI) DURING ABDOMINAL AORTIC ANEURYSM REPAIR S D Hobbs*, P C Haggart, R Gallacher, A B M Wilmink, D J Adam, A Jones and A W Bradbury (Birmingham) 2.40 7068: INTERMITTENT CHRONIC ELECTRICAL STIMULATION PROVIDES SUSTAINABLE FUNCTIONAL AND HAEMODYNAMIC IMPROVEMENTS IN STABLE CLAUDICANTS: A COST EFFECTIVE ALTERNATIVE? M A Oldfield*, M D Brown* and M Simms (Birmingham) 2.45 7121: DILEMMA IN THE MANAGEMENT OF YOUNG ISCHEMIC PATIENTS WITH THROMBOANGITIS OBLITERANS (TAO) R P S Gambhir* (Pune, India) 2.50 7130: ABDOMINAL COMPARTMENT SYNDROME AFTER REPAIR OF RUPTURED AORTIC ANEURYSM – DOES MESH CLOSURE ALTER MORTALITY? O Shannack*, K Bofkin, D C Berridge, D J A Scott, J I Spark and P J Kent (Leeds) 2.55 7160: VARICOSE VEIN SURGERY: PATIENT’S MISCONCEPTIONS PROVE DIFFICULT TO DISLODGE. M F Dillon, C T J Carr, K K Austin, T M F Feeley and S Tierney (Dublin)
42
3.00 7176: SINGLE CENTER EXPERIENCE OF 400 VASCULAR ACCESS PROCEDURES USING AN ‘INTENT TO TREAT’ RULE FOR REPORTING RESULTS S Narayanan*, A Sanu, A De, R Griffiths and A da Silva (Wrexham)
57799 final prog timetable
29/3/05
11:42 am
Page 43
POSTERS W3M2: COLORECTAL 1.30 6309: EFFECT OF PYRROLIDINE DITHIOCARBAMATE ON INTESTINAL BLOOD FLOW IN ISCHAEMIA REPERFUSION INJURY OF THE INTESTINE I H Mallick*, W Yang, A Seifalian and M Winslet (London)
3.00 7450: MAST CELL DEGRANULATION ENHANCES INTESTINAL HEALING UNDER ISCHAEMIC CONDITIONS J B Conneely*, D C Winter and D J Bouchier-Hayes (Dublin)
1.35 6606: COLONOSCOPY FOR SCREENING OF PATIENTS WITH A FAMILY HISTORY OF COLORECTAL CANCER M G Tytherleigh, V V Ng*, L O Mathew, T Banerjee, K V Menon and R Farouk (Reading)
3.05 WITHDRAWN
1.45 6509: COLORECTAL CANCER TRENDS IN VARIOUS SOCIOECONOMIC CLASSES: ARE WE TARGETING THE RIGHT POPULATION? S D Roy*, D Cade, M Deakin* and D J Corless (South Cheshire and Stoke on Trent) 1.50 6668: DO WE PRODUCE SALICYLATES IN VIVO? J S Dreyer*, G Smith, S C Whitelaw, G J Baxter, S Lutfy and J R Paterson (Dumfries) 1.55 6685: A PROSPECTIVE STUDY TO ASSESS PERFORMANCE OF THE SPECIALIST COLORECTAL UNIT S M Alishahi, J Brennan and R J C Steele (Dundee) 2.00 6702: INTESTINAL STOMAS: AN ANALYSIS OF 216 CASES S Dalmia*, K Marimuthu, K Nagpal and G Matthew (Nuneaton) 2.05 6814: ANAL CANAL SENSATION IS AN IMPORTANT FACTOR IN THE OUTCOME OF TREATMENT WITH INTRA ANAL COLLAGEN INJECTIONS FOR PATIENTS WITH PASSIVE FAECAL LEAKAGE M Lim*, S Stojkovic, P Sagar, P Finan and D Burke (Leeds) 2.10 7137: IDENTIFICATION OF UP-REGULATED GENES BY ARRAY ANALYSIS IN THE PATHOGENESIS OF ULCERATIVE COLITIS J C Singh*, S R Carding and J P A Lodge (Abergavenny and Leeds) 2.15 6899: THE OUTCOME OF PATIENTS WITH LOCALLY ADVANCED PRIMARY AND RECURRENT COLON CANCER G MacKay*, R G Molloy and P J O'Dwyer (Glasgow) 2.20 6930: DAY CASE STAPLED HAEMORRHOIDOPEXY G C Beattie, T K McAdam, S A McIntosh and M A Loudon (Aberdeen) 2.25 7003: AN ASSESSMENT OF CELLULAR RESPONSE TO 5FU WITH FLT PET F Pakzad*, M Loizidou, P J Ell and I Taylor (London) 2.30 7054: IMPLICATION OF SUB-SPECIALISATION ON THE PROVISION OF GENERAL SURGICAL SERVICE P R Shah*, R Barker and P N Haray (Pontypridd, Cardiff and Merthyr Tydfil)
3.15 7536: ROLE OF VECTOR VOLUME MANOMETRY IN THE MANAGEMENT OF FAECAL INCONTINENCE M Hanief*, K Natarajan and M Aslam (London) 3.20 7610: THE ROLE OF PREOPERATIVE COUNSELLING IN DETERMING QOL IN PATIENTS WITH PERMANENT STOMA A Lala * and Jethwa (Birmingham) 3.25 7611: IS DIET THE CAUSE OF VITAMIN B12 DEFICIENCY AFTER RESTORATIVE POCTOCOLECTOMY? M S Muhtaseb, R F Mckee, J H Anderson and I G Finlay (Glasgow)
PROGRAMME
1.40 7087: ATTENUATION OF COLONIC SECRETION BY THE CALCIUM SENSING RECEPTOR IS MEDIATED BY BASOLATERAL NKCC. A POTENTIAL TARGET IN DIARRHOEAL ILLNESSES N O'Brien*, L Magner, G C O'Sullivan, J P Geibel and B J Harvey (Cork and New Haven, USA)
3.10 7503: OUTCOMES OF PATIENTS UNDERGOING EMERGENCY COLORECTAL SURGERY BY HIGHER SURGICAL TRAINEES ARE COMPARABLE TO THOSE OPERATED BY CONSULTANTS W Hawkins *, K Moorthy, R T Patel and K Yoong (Dudley)
2.35 7172:WITHDRAWN 2.40 7202: NURSE-LED COLORECTAL CLINICS: AN INNOVATIVE APPROACH! M Lewis*, P Shah, A Joseph and P N Haray (Merthyr Tydfil and Pontypridd) 2.45 7260: DELORME’S PROCEDURE FOR RECTAL PROLAPSE: LOW RISK, LOW RECURRENCE – LOW UTILISATION? V R Patcha*, J P Gilmour and W G Sheridan (Carmarthen) 2.50 7298: DELAY IN THE DIAGNOSIS OF PROXIMAL COLON CANCER S Rai* and J S Jameson (Leicester) 2.55 7366: DO SPONTANEOUS APOPTOSIS AND COX 2 EXPRESSION PREDICT RESPONSE OF RECTAL CANCER TO NEOADJUVANT RADIOCHEMOTHERAPY? F M Smith*, C Adida, E Kay, P Crotty, R B Stephens, M J Kennedy and J V Reynolds (Dublin)
43
57799 final prog timetable
29/3/05
11:42 am
Page 44
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
The world’s favourite suture1 is now better than ever
NEW Coated VICRYL* Plus Antibacterial Suture Now with protection against bacterial colonisation • Coated VICRYL* Plus Antibacterial (Polyglactin 910) Suture has a zone of inhibition that is effective against the pathogens that most frequently cause Surgical Site Infection (SSI)2 • Same handling and performance you’ve come to expect from Coated VICRYL* (Polyglactin 910) Suture
For more information visit www.ethiconproducts.co.uk
Innovation with every stitch. Exclusively ETHICON 44
References: 1. Data on file at ETHICON US. 2. Rothenburger S, Spangler D, Bhende S, Burkley D. In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (Coated Polyglactin 910 with Triclosan) using zone of inhibition assays. Surg Infect. 2002;3(suppl 1):S79-S87.
A division of JOHNSON & JOHNSON MEDICAL LIMITED P.O. Box 408, Bankhead Avenue, Edinburgh EH11 4HE. Telephone: 0131 453 5555 Fax: 0131 453 6011 www.ethiconproducts.co.uk Registered Office: Simpson Parkway, Livingston, EH54 7AT, Reg No. SC132162. Capitalised names are Trademarks of ETHICON.
29/3/05
11:42 am
Page 45
PROGRAMME
57799 final prog timetable
Vessel Sealing Technology for advanced laparoscopic procedures Laparoscopic Obesity Surgery
Laparoscopic Colorectal Surgery
154 Fareham Road GOSPORT Hampshire PO13 0AS Tel: 01329 224411 Fax: 01329 224390
www.tycohealthcare.co.uk
45
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
46
29/3/05 11:42 am Page 46
Floor Plan
57799 final prog timetable
29/3/05
11:42 am
Page 47
LIST OF EXHIBITORS Stand
Company
Stand
Actamed Ltd
68
medi UK Ltd
59
Action On General Surgery
31
Medlogic Global Ltd
81
Amdel Medical Ltd
94
Medtronic Xomed
11
Astra Tech Ltd
64
Nikomed Ltd
12
Atrium Medical
88
Novartis Pharmaceuticals UK Ltd
39
B Braun Medical Ltd
35
Nutricia Clinical Care
29
B-K Medical
14
Nuview Ltd
17
Bard
46
Nycomed UK Ltd
84
Bolton Surgical Ltd
25
Perimed UK Ltd
26
Boston Scientific Ltd
20
Pfizer Ltd
Cook
42
Pharmabotics Ltd
49
CryoLife Europa Ltd.
58
Pierson Surgical Ltd
88
Deltex Medical
62
PPM Software Ltd
18
Dendrite Clinical Systems Ltd
24
PROACT Medical Ltd
1
DGL Information Technologies (UK) Ltd
80
Richard Wolf UK Ltd
40
Doctors.net.uk
69
Roche Products Ltd
38
Endoscopic Solutions
63
Sandison Easson & Co
89
ERBE Medical UK Ltd
86
sanofi-aventis Group
Ethicon
43
Schebo Biotech UK Ltd
Ethicon Endo-Surgery
43
Sigmacon/Laprosurge
Eurosurgical Ltd
71
SonoSite Ltd
Finishing Touches
41
SRA Developments Ltd
67
Genzyme Biosurgery
16
St James's Place Partnership
28
GlaxoSmithKline UK
66
Strakan Pharmaceuticals Ltd
92
Gyrus International Ltd
73
Stryker UK Ltd
65
Haemoband Surgical Ltd
6
Huntleigh Healthcare Ltd
76
TSL plc
22
Internet Café (sponsored by Stryker)
65
Tyco Healthcare (UK) Commercial Ltd
51
IntuMed
36
UK Medical Ltd - Surgical Division
Karl Storz Endoscopy (UK) Ltd
49
Vascutek Ltd
57
KeyMed
34
W L Gore & Associates (UK) Ltd
82
Limbs & Things
37
Wisepress Online Bookshop Ltd
10
Mantis Surgical Ltd
72
York Medical Technologies Ltd
27
T M Lewin
7
79 and 90 2 60 8
5
PROGRAMME
Company
9
47
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
48
29/3/05
11:42 am
Page 48
EXHIBITORS
Stand 64 ASTRA TECH LTD
Stand 68 ACTAMED LTD
Stroudwater Business Park, Brunel Way, Stonehouse, Gloustershire, GL10 3SX
Calder Island Way, Wakefield, West Yorkshire, WF2 7AW
Tel: 01453 791763
Tel: 01924 200550
Fax: 01924 200518
Email:
[email protected] The Specialist Products team will be exhibiting the Scanlan range of surgical instrumentation, and single use products designed to meet the specific needs of the cardiac, thoracic, vascular, transplant and neuro surgical specialties. Actamed will also be exhibiting Surgical Acuity loupes which are outstanding where it really counts - in Resolution, Field Width, and Field Depth - giving surgeons superior visualisation. Made of Titanium, with a choice of frames, the loupes are lighter than conventional loupes. Also on display is the BFW Thru-The-Lens Headlight/Video System that provides a surgeon's eye view of any procedure, offering the first fully integrated zeroparallax system with zoom option. Stand 31 ACTION ON GENERAL SURGERY South West Peninsula Health Authority, Peninsula House, Kingsmill Road, Tamar View Industrial Estate, Saltash, Cornwall, PL12 6LE Fax: 01752 841670 Email:
[email protected] [email protected] Action on General Surgery is a Department of Health funded Programme testing out new and innovative ways of delivering general surgical services. 19 national pilot sites in England have recently concluded their pilot developments. The outcomes and learning experiences from this work will be shared with delegates at the session on Thursday 14th April from 11.00am to 12.30pm, when the Good Practice Guidance will be formally launched. Please join us at that session and also visit us on Stand 31 for further information and the chance of winning a Bottle of Champagne!
Fax: 01453 791001
Stand 88 ATRIUM MEDICAL INTERNATIONAL, LLC Peter House, Oxford Street, Manchester, M1 5AN Tel: +44 (161) 209 3675 Fax: +44 (161) 209 3676 Email:
[email protected] www.atriummed.com Atrium Medical has 24 years of experience and true innovations in Cardiothoracic, Vascular, Hernia Repair and Endovascular Surgery, and is now directly represented in Great-Britain. See for yourself the variety in our Chest Drainage range, from the redesigned Ocean™ water-seal system to the most innovative, wearable and waterless operation Express Mini™. Feel the lightweight Prolite™ Ultra Mesh and the 3D Proloop™ Plug for Hernia Repair, along with the unique pulsatile Advanta™ SST Vascular Graft. It is truly a good time to (re)discover Atrium! Stand 35 B.BRAUN MEDICAL LTD Thorncliffe Park, Sheffield, South Yorkshire, S35 2PW Tel: 0114 225 9176
Fax: 0114 225 9119
B. Braun Medical Ltd are proud to exhibit at this years ASGBI meeting here in Glasgow. We are presenting many new and exciting products for both open and laparoscopic General Surgery, reinforcing our commitment to continuous product development and innovation. New products for this year include Digital Camera Systems combined with EDDY, an advanced DVD based recorder, plus the light yet highly stable Variglide port system. We look forward to welcoming you to Stand 35 to discuss your requirements and to give you the opportunity to experience our award winning AdTec Needle Holder, winner of 'Innovations of the Year 2004' by the Society of Laparoendoscopic Surgeons-USA.
Stand 94 AMDEL MEDICAL LTD 7 Progress Business Centre, Whittle Parkway, Slough, SL1 6DQ Tel: 01628 669400
Fax: 01628 664355
Amdel Medical is a new UK Medical device company. In partnership with Omnitract USA we will be providing the UK healthcare sector with a market leading range of surgical retractors. On display will be retractors for Cardio Thoracic, Urology, Gynaecology, Abdominal and Colon surgical procedures. Amdel Medical will also be demonstrating a new and exciting range of sterile and reusable surgical clothing for both patient and clinical personnel. As a new company we look forward to meeting you sometime during the Exhibition on stand 94.
Stand 14 B-K MEDICAL UK 11 Grove Park, Waltham Road, White Waltham, Berkshire, SL6 3LW Tel: 01628 825770
Fax: 01628 826970
Stand 46 BARD Forest House, Tilgate Forest Business Park, Brighton Road, Crawley, West Sussex, RH11 9BP Tel: 01293 527888 Fax: 01293 552428 Email:
[email protected] Bard Davol – Total Hernia Solutions. A philosophy of innovation; reduced incision size, reduced dissection, reduced fixation and improved patient
29/3/05
11:42 am
Page 49
outcomes. This year, four major new products complement an already comprehensive range. To find out more and experience “Total Hernia Solutions” visit the Bard Davol stand. Whilst there, test your skill and win FA cup tickets. Put the fun back into Hernias! From the Vascular Division, Bard is delighted to be exhibiting Dynaflo™; a new exciting above the knee graft. Finally Vacora™ – a vacuum assisted breast biopsy device, disposable or reusable biopsy systems and feeding products. ™ Trademarks of C.R. Bard, Inc. or an affiliate. Stand 25 BOLTON SURGICAL LTD Unit 3 Nutwood Trading Estate, Limestone Cottage Lane, Sheffield, South Yorkshire, S6 1NJ Tel: 0114 234 1252 Fax: 0114 285 3106 Email:
[email protected] Bolton Surgical are manufacturers and repairers of theatre quality surgical instruments with over 80 years in the healthcare sector. We manufacture bespoke instruments to match your requirements and our Colorectal range is the most unique and varied available. We do not compromise on quality. To discuss your requirements for all principles of surgery, please visit Stand 25. Stand 20 BOSTON SCIENTIFIC LTD New England House, Sandridge Park, Porters Wood, St Albans, Hertfordshire, AL3 6PH Tel: 01727 831666 Fax: 01727 797699 www.bostonscientific.co.uk Boston Scientific is one of the world's largest medical device company's dedicated to less-invasive therapies. The company's products and technologies are designed to reduce risk, trauma, cost procedure time and the need for aftercare. The products and technologies are generally used for enlarging narrowed blood vessels to prevent heart attack and stroke, clearing passages blocked by plaque to alleviate pain, opening obstructions and bringing relief to patients suffering from various forms of cancer, performing biopsies and ultrasounds mapping electrical problems, in the heart, placing filters to prevent blood clots from reaching the lungs, heart or brain, and treating urological renal pulmonary, cerebrovascular and gastrointestinal diseases. Stand 42 COOK National Technology Park, O'Halloran Road, Limerick, Ireland Tel: + 353 61 334440
Fax: + 353 61 334441
SURGISIS is a biomaterial used instead of mesh. While SURGISIS reinforces and supports, the body’s healing process repairs weakened tissue. Eventually replaced with organized host tissue, SURGISIS becomes even stronger over time. It reduces pain after inguinal hernia repair and can be used in infected or potentially contaminated ventral hernias. Focus. Integrity. Ingenuity. Dedication. Vision. The list goes on. And at the end of it is a name that stands for the highest quality available in endoscopic technology- yesterday, today and tomorrow.
Stand 58 CRYOLIFE EUROPA LTD Europa House, Fareham Heights, Standard Way, Fareham, Hampshire, P016 8XT Tel: 01329 229800
Fax: 01329 229801
CryoLife Europa Ltd announces the arrival of the BioGlue Syringe System. The easiest just got easier. Clinically proven in over 150,000 procedures worldwide. BioGlue Surgical Adhesive is now available in a fully disposable syringe system in 2ml and 5ml volumes. This in addition to the existing delivery device based system and offers the following benefits. A smaller profile improves site access and visualization. All-inclusive packaging saves time and storage space. BioGlue Surgical Adhesive is CE marked for cardiothoracic, pulmonary, vascular and general surgical applications including dura mater repair. Stand 62 DELTEX MEDICAL Terminus Road, Chichester, West Sussex, PO19 8TX Tel: 01243 774837
Fax: 01243 532534
Helping patients get better, quicker. Deltex Medical, the world leader in Oesophageal Doppler Monitoring, invites you to discuss significantly improving surgical outcomes through simple changes to intra-operative patient management. The CardioQ™ enables active management and optimisation of haemodynamic status. Level 1A clinical data across a wide-range of moderate and major surgical procedures consistently shows reduced complications leading to 30% to 40% reductions in length of stay. The benefits shown by the RCTs have recently been replicated and audited at a typical DGH, helping to make implementation and funding a priority for management as well as clinicians. Stand 24 DENDRITE CLINICAL SYSTEMS LTD 59A Bell Street, Henley-on-Thames, Oxfordshire, RG9 2BA Tel: 01491 411288 Fax: 01491 411377 E-mail:
[email protected] www.e-dendrite.com
PROGRAMME
57799 final prog timetable
Dendrite Clinical Systems is working with an increasing number of surgical specialties to give individual surgeons, surgical departments and professional societies with analytical methods that enable a deep understanding of their own results. Dendrite supplies flexible clinical database software and comprehensive data analysis systems for tracking surgical outcomes that are highly pertinent to the requirements of clinical audit and governance. With inbuilt risk stratification algorithms including Bayes and logistic regression models (e.g. for POSSUM, Parsonnet scoring), surgeons, in any speciality, can benchmark their results against national standards with suitable adjustment for severity of illness using well-proven techniques such as CUSUM curves, VLAD analysis & Funnel Plots. Dendrite's customer base includes over 100 hospitals in the UK and 35 National & International databases, including registries for The Association of Upper Gastrointestinal Surgeons, The British Association of Endocrine Surgeons, The Society of
49
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
50
29/3/05
11:42 am
Page 50
Cardiothoracic Surgeons, The Vascular Society. Whether you want to set up a local database to support clinical governance and audit or establish a new national database, we have a solution for you.
Stand 43 ETHICON PO Box 408, Bankhead Avenue, Edinburgh, EH11 4HE Tel: 0800 864 060
Stand 80 DGL INFORMATION TECHNOLOGIES (UK) LTD 42 Celtic Court, Ball Moor, Buckingham Industrial Park, Buckingham, Buckinghamshire, MK18 1RQ Tel: 01280 824600
Fax: 01344 864 122
ETHICON ENDO-SURGERY The Braccans, London Road, Bracknell, Berkshire, RG12 2AT Tel: 0800 864060 Fax: 01344 864122 www.jnjgateway.com www.ethiconproducts.co.uk
Fax: 01280 824700
Stand 69 DOCTORS.NET.UK 69 Milton Park Estate, Abingdon, Oxfordshire, OX14 4RX Helpdesk: 01235 828400 www.Doctors.net.uk Doctors.net.uk Limited was founded in 1998 by Dr Neil Bacon, an Oxford Specialist, to build an electronic network for doctors that would help improve healthcare. www.Doctors.net.uk provides a secure spam and virus-protected e-mail service, advanced accredited interactive education and a wide range of online services. Membership is free and over 110,000 UK doctors are now members, including 33,000 GPs and 77,000 Hospital Specialists. Come and meet the Doctors.net.uk team at Stand 69 to find out more - members and nonmembers are welcome!
JOHNSON & JOHNSON, ETHICON, ETHICON ENDO-SURGERY and JOHNSON & JOHNSON WOUND MANAGEMENT will be presenting their latest product innovations. ETHICON will be presenting Coated VICRYL Plus Antibacterial (Polyglactin 910) Suture, the first and only antibacterial suture which offers protection against bacterial colonisation of the suture line and PROCEED Surgical Mesh, a multilayer tissue separating mesh for incisional hernia repair. ETHICON ENDO-SURGERY will be launching: Harmonic ACE™ - Twice as fast as existing LCSC5, seals up to 5mm vessels. CONTOUR™ Curved Cutter Stapler – making low anterior resections easier. Endopath® XCEL™ - the only trocar that offers unencumbered laparoscopic access. Stand 71 EUROSURGICAL LTD
Stand 63 ENDOSCOPIC SOLUTIONS
Merrow Business Centre, Guildford, Surrey, GU4 7WA
Houldsworth Mill Business and Arts Centre, Houldsworth Street, Reddish, Stockport, SK5 6DA
Tel: +44 (0)1483 456007 Fax: +44 (0)1483 456008 Email:
[email protected]
Tel: 0870 241 2785
Laparoscopic instrumentation including bi-polar, suction / irrigation & new Trinox(tm) trocar systems are displayed. Our range of documentation Photo/TV & Video equipment together with Light Sources & Insufflation stack systems complement the latest disposable verres needles & camera drapes. The new Epitome Diathermy Scalpel is a must to see. The excellent Polytech-Silimed range of breast prosthesis & tissue expanders for breast reconstructive surgery, including the re-approved micro-polyurethane coated implants, with the lowest capsular contraction rate & none rotation will be displayed. Snowden-Pencer instruments including Tebbetts breast retractors will be exhibited. For post surgical requirements Veronique garments fulfill your needs.
Fax: 0161 975 6229
Endoscopic Solutions will be exhibiting a range of cutting edge products. These include the new automatic opening tissue retrieval sacs from Espiner Medical. These include the largest “sac on a stick” currently available, for spleens. We will show MGB’s state of the art camera system which could make the traditional laparoscope extinct! We will exhibit Sofradim’s vast array of hernia meshes for open and laparoscopic, inguinal and incisional hernia repairs. We will show for the first time a new innovative mesh for Lichtenstein repairs and the new 20 clip resorbable clip applicator. Stand 86 ERBE MEDICAL UK
Stand 41 FINISHING TOUCHES (SPMU) LTD
The Antler Complex, 2 Bruntcliffe Way, Morley, Leeds, LS27 0JG Tel: 0113 253 0333 Fax: 0113 253 2733 Mail:
[email protected]
E-
ERBE UK will be showing the latest developments in the field of electrosurgery - the ERBE VIO system incorporating the BiClamp vessel fussion option, and the latest ERBE APC 2 ARGON PLASMA COAGULATOR. The ERBE IES 2 smoke evacuation system with its intelligent approach to safe and effective removal of surgical smoke will be on demonstration. ERBE UK look forward to welcoming you to discuss your Electrosurgical requirements.
Offington House, 29 Offington Lane, Worthing, West Sussex, BN14 9RG Tel: 08452 301210 / 301310 Fax: 08703 501410 Email:
[email protected] www.wakeupwithmakeup.co.uk We are the leading company for all aspects of micropigmentation, medical tattooing. Micropigmentation is used in post breast care to create areolas after reconstruction, in maxillo facial
29/3/05
11:42 am
Page 51
departments to camouflage scars and in radiography as a non-permanent way 'to mark the spot'. Our digital machine, the PRECISION PLUS is the ultimate micropigmentation system, EEC approved to standard Class 2a medical and designed to the highest safety standards - no needle stick and less trauma for your clients. We offer fantastic pigments and consumables and guarantee unrivalled and efficient customer support. Micropigmentation enables you to make the Finishing Touches to your work. Contact Dawn Forshaw or Samantha Jones Stand 16 GENZYME BIOSURGERY 4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, OX4 2SU Tel: 01865 405200 Fax: 01865 774172 Email:
[email protected] Genzyme Biosurgery welcomes you to stand 16 to discuss our Sepra™ family of biomaterial products, designed to reduce post-surgical adhesions. Seprafilm®, a translucent, bioresorbable membrane, is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic surgery. Clinically proven to reduce the incidence, extent and severity of adhesions, Seprafilm is ideally suited for use in procedures such as small bowel resection and colon resection. Sepramesh® is a polypropylene mesh for hernia repair, with a Seprafilm anti-adhesion coating on one side. This unique mesh encourages tissue in-growth to the anterior side for a secure hernia repair, but minimises the risk of visceral adhesions and tissue attachment to the posterior side. We look forward to discussing the benefits that Sepra products can offer your surgical practice. Stand 66 GLAXOSMITHKLINE UK LTD Stockley Park West, Uxbridge, Middlesex, UB11 1BT Tel: 020 8990 2747 Fax: 020 8990 4333 Email:
[email protected] GlaxoSmithKline (GSK) is a leading research-based pharmaceutical company with a mission to improve the quality of human life by enabling people to do more, feel better and live longer. Headquartered in the UK, GSK is one of the biggest companies in the UK and the country's biggest pharmaceutical company. GSK makes prescription medicines, vaccines, over-thecounter medicines and oral care and nutritional healthcare products. GSK has particularly strong positions in several therapeutic areas including respiratory, anti-viral, central nervous system, diabetes and vaccines. Last year GSK invested £2.8 billion researching and developing innovative new medicines to treat diseases such as cancer, diabetes, asthma, psychiatric illness and HIV/AIDS. GSK UK has a dedicated Hospital Specialist Medicines Team, working specifically in the areas of anaesthesia and thrombosis. You can meet the Hospital Specialist Medicines Team at the GSK stand in the exhibition area.
Stand 73 GYRUS INTERNATIONAL LTD 410 Wharfedale Road, Winnersh Triangle, Wokingham, Berkshire, RG41 5RA Tel: 0845 601 6610 Fax: 01189 219 800 Email:
[email protected] Gyrus is a British company founded in1989 in Cardiff, Wales. Now employing over 650 people worldwide, Gyrus is the leader in bipolar electrosurgery. Gyrus offers specific products which address open and laparoscopic procedures such as Colectomy, Bariatrics and Nissen fundoplication. Advantages include superior technology performance in both hemostasis and transaction of tissue, vessel sealing and convenience of use over conventional instruments. Come and visit us on Stand 73 to see our range of products and to arrange an evaluation. Stand 6 HAEMOBAND SURGICAL LTD 8 Cromac Quay, Belfast, Northern Ireland, BT7 2JD Tel: + 44 (0)28 9033 1200 Fax: + 44 (0)28 9023 9922 Email:
[email protected] www.haemoband.com The Haemoband Multi-Ligator is a unique, selfloading, rubber band ligation device for haemorrhoids. Pre-loaded with four rubber bands, the unit has been designed to optimise, simplify and substantially cost-reduce the ligation process. It provides greater precision and reliability in the treatment of haemorrhoids, whilst reducing the treatment time for surgeons and can be used singlehandedly without the need for nursing assistance. Disposable and low cost, the Haemoband offers a vastly superior alternative to current devices: Low cost, Solo-operation, Multi-banded application, Rapid, Accurate, Reduced patient discomfort, Fully disposable unit, Clinically efficient. Stand 76 HUNTLEIGH HEALTHCARE LTD
PROGRAMME
57799 final prog timetable
310 – 312 Dallow Road, Luton, Bedfordshire, LU1 1TD Tel: 01582 745700 Fax: 01582 745745 Email:
[email protected] www.huntleigh-healthcare.com As pioneers of Intermittent Pneumatic Compression (IPC) therapy, Huntleigh Healthcare is well placed to offer a comprehensive range of products and services for the prophylaxis of Deep Vein Thrombosis (DVT) during orthopaedic, trauma, urological and general surgery. We present the market leading Flowtron® Excel System and the innovative Flowtron® Universal System offering the choice of foot, calf or thigh-length compression from a single pump. Proven to be clinically effective, IPC therapy has the advantage of being simple to use, non-invasive and has the additional benefits of helping to reduce oedema and post-operative pain. Also showing will be Huntleigh Healthcare’s new Intraoperative Probe and a new range of vital signs monitors.
51
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
52
29/3/05
11:42 am
Page 52
Stand 36 INTUMED
Dissector anatomical CD-ROMs, and the Karl Storz Medi Pack portable camera & light source system.
IFSC House, Custom House Quay, International Financial Services Centre, Dublin 1
Stand 72 MANTIS SURGICAL
Tel: 00 353 1 605 4329
Fax: 00 353 1 605 4301
IntuMed specialises in Medical training for Healthcare professionals, pharmaceutical and medical equipment companies, worldwide. IntuMed’s flagship product called BeST Online (basic electronic surgical training). BeST is the world's first online general surgical training program. This interactive training resource is the product of an international joint venture between IntuMed, Harvard Medical International and the Royal College of Surgeons in Ireland. BeST provides online surgical training for trainee surgeons who are preparing and studying for the MRCS exam (Membership of the Royal College of Surgeons). IntuMed offers custom developed medical training, based on our library of content and imagery, or creating content to our clients’ specifications. Stand 49 KARL STORZ ENDOSCOPY (UK) LTD 392 Edinburgh Avenue, Slough, Berkshire, SL1 4UF Tel: 01753-503500 Fax: 01753-578124 Email:
[email protected] Karl Storz Endoscopy are pleased to present:- * IMAGE1 – The world’s first truly digital surgical endoscopic camera system. * OR1 – The Karl Storz Integrated Operating Theatre – Operational Safety, Practical Efficiency and Total Surgical Control. The Operating Theatre of the future – Now! * AIDA DVD – integrated digital image capture directly to CD/DVD. * ClickLine ‰ - the most extensive range of laparoscopic instrumentation. Please come and visit the Karl Storz stand for the latest in endoscopic equipment and instrumentation. Stand 34 KEYMED Keymed House, Stock Road, Southend-on-Sea, Essex, SS2 5QH Tel: 01702 616333
Fax: 01702 465677
Stand 37 LIMBS & THINGS Sussex Street, St Philips, Bristol, BS2 0RA Tel: + 44 (0)117 311 0513 Fax: + 44 (0)117 311 0501 Email:
[email protected] www.limbsandthings.com Limbs & Things supplies training and demonstration materials for healthcare professionals, incorporating synthetic soft tissue models, multimedia training systems and a design & build service. We are pleased to announce that in England, Scotland & Wales all of our products, from both the Clinical and Surgical ranges, can now be purchased directly from us. In addition, we are authorised distributors for the Reality Surgery DVD library of operative surgery, Mentice virtual reality surgical training systems, METI Pelvic ExamSIM, Primal Pictures and VH
Unitech House, Bond Close, Kingsland Business Park, Basingstoke, Hampshire, RG24 8PZ Tel: 01256 365450 Fax: 01256 365486 www.mantissurgical.co.uk Mantis Surgical is proud to display its comprehensive range of products for laparoscopic upper gastro-intestinal and colorectal surgery. With our main aim of offering product innovation in a cost-effective manner, we are able to offer high quality products for a wide range of surgical procedures. Products range from simple specimen retrieval bags to a complete range of laparoscopic ports, to products for obesity surgery and tissue reinforcement. Please come and visit us during the conference to find out more about our exciting range of products. Stand 59 MEDI UK LTD Plough Lane, Hereford, Herefordshire, HR4 0EL Tel: 01432 373500 Fax: 01432 373510 Email:
[email protected] www.mediuk.co.uk Medical compression hosiery for the treatment of venous disease, when matched with a patient's needs, is an indispensable element of a treatment programme and a recognised method for improving the patient's quality of life. Compression garments are widely accepted as an important component in the patient's overall care plan. Since the early 1920s medi has focused exclusively on the design and manufacture of medical compression products for use in Vascular, Lymphology, Anti-Coagulation and DVT prevention treatment, which includes the mediven*Travel sock for long haul air travel. Medi are committed to identifying and satisfying the compression needs of your patients. To achieve this goal we believe that an active and ongoing partnership is essential with Vascular specialists and their teams. We welcome your interest and comments. Stand 81 MEDLOGIC GLOBAL LTD Western Wood Way, Langage Science Park, Plympton, Plymouth, Devon, PL7 5BG Tel: 01752 209955
Fax: 01752 209956
Stand 11 MEDTRONIC XOMED Suite 1, Sherbourne House, Croxley Business Centre, Watford, WD18 8WW Tel: 01923 212213 www.xomed.com
Fax: 01923 241004
Medtronic Xomed, pioneers of innovative solutions
29/3/05
11:42 am
Page 53
in surgical care for over 30 years, have strived to continuously develop our technology, offering up-todate medical solutions to aid and assist the surgeon. Growing demand for intraoperative nerve monitoring during thyroidectomies and parathyroidectomies presents an ideal opportunity to offer you our latest Nerve Monitor. As an established market leader within nerve monitoring, we have been developing our technology for over a decade, and are delighted to be able to introduce the NIMTM2.0 Nerve Integrity Monitor along with our range of EMG Reinforced Endotracheal Tubes. Stand 12 NIKOMED LTD Stuart Court, Spursholt Place, Salisbury Road, Romsey, Hampshire, S051 6DJ Tel: 01794 525100
Stand 17 NUVIEW LTD Fax: 01794 525101
Nikomed will be exhibiting a full range of laparoscopic instrumentation and laparoscopic kits for the use in both upper GI and colorectal surgery. The technologies demonstrated are of the highest quality and are priced competitively. The HAGA Band, a weight loss treatment through a gastroplasty operation performed laparoscopically, will also be on display along with the BAG Gastric Balloon for the staging and management of obese patients. Please visit Nikomed at Stand 12 to see our extensive range of cost effective solutions. Stand 39 NOVARTIS PHARMACEUTICALS UK LTD Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR Tel: 01276 698544
major surgery is significantly delayed by the development of temporary insulin resistance, and is associated with muscle weakness and wasting. Clinical evidence suggests that postoperative insulin resistance and the stress response to major abdominal surgery can be significantly attenuated by preoperative carbohydrate loading. Preoperative carbohydrate loading up to 2 hours before surgery has become an integral part of enhanced recovery programs in several European countries. Nutricia Clinical Care, a major player in enteral nutrition, would like to invite you to discover Nutricia preOp, a clear carbohydrate drink designed to aid the optimal preparation of your patients before surgery. To find out more visit us on Stand 29 and take part in our competition.
Fax: 01276 698605
A commitment to improve the outcome and quality of life of patients with cancer has been the driving force for Novartis Oncology in developing new and novel compounds. Using rational drug design, molecular abnormalities can be targeted, preserving normal cells and minimising the negative impact of cancer therapy on patients. Exploiting these novel forms of research, Novartis Oncology has become the leading company in signal transduction inhibition worldwide. Targeted therapies for extended adjuvant and advanced breast cancer, tumour-induced hypercalcaemia, skeletal-related events from malignancies involving bone, chronic myeloid leukaemia, gastrointestinal stromal tumours and other cancers are changing disease management. Please see us on Stand 39 for more information. Stand 29 NUTRICIA CLINICAL CARE White Horse Business Park, Trowbridge, Wiltshire, BA14 0XQ Tel: 01225 711688 Fax: 01225 711798 Email:
[email protected] www.nutricia-clinical-care.co.uk Are your patients fit for surgery? Recovery after
Unit 21, Daniels Industrial Estate, Bath Road, Stroud, Gloucestershire, GL5 3TJ Tel: +44 (0) 1453 759659 Fax: +44 (0) 1453 759950 Email:
[email protected] www.voroscopes.co.uk Nuview, a British company, specialising in magnification and illumination products for surgery will be exhibiting a wide range of products for surgeons and trainees at this years ASGBI meeting. Carl Zeiss surgical loupes, ranging from x2 to x8 magnification in a range of working distances, will be on show so that surgeons may try loupes to ensure the perfect visual result. The latest LED and Carl Zeiss fibre optic illumination equipment will also being demonstrated which can be added to most types of Loupes to enhance visualisation. A visit to Stand 17 could change your view forever. Stand 84 NYCOMED UK LTD The Magdalen Centre, Oxford Science Park, Oxford, OX4 4GA Tel: 01865 784500 www.nycomed.com
Fax: 01865 784501
Nycomed UK Ltd is delighted to be exhibiting for the first time at the ASGBI meeting in Glasgow. Nycomed is a pharmaceutical company differentiated by its European focused marketing strategy. There are about 3,000 people working in 19 European countries bringing hospital products to the marketplace. Nycomed is pleased to introduce TachoSil® (surgical haemostat) to UK surgeons, and we look forward to meeting you at Stand 84.
PROGRAMME
57799 final prog timetable
Stand 26 PERIMED UK LTD Tel: 07860 362379 Email:
[email protected] We specialise in the supply of instruments for assessment of the local tissue status at the microcirculatory level in both the research and clinical fields. Periflux SYSTEM 5000 provides a unique combination of non-invasive techniques for assessment of the local tissue perfusion, oxygenation and metabolic function. PeriScan PIM II Laser
53
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
29/3/05
11:42 am
Page 54
Doppler Perfusion Imager is for mapping the microcirculation distribution over the surface of tissues up to 18x18 cm with applications in Dermatology, Diabetes & Wounds assessment. A range of Ultrasound Doppler instruments, manufactured by PARKS Medical Electronics are available exclusively in the UK from Perimed. Stand 7 PFIZER LTD Walton Oaks, Dorking Road, Walton-on -the-Hill, Surrey, KT20 7NS Tel: 01304 616161
Fax: 01737 332511
Pfizer, with its UK business headquarters in Surrey and global headquarters in New York, is a researchbased global pharmaceutical company. Pfizer discovers, develops, manufactures and markets leading prescription medicines for humans and animals, and many of the world's best-known consumer treatments. In 2003, Pfizer's net contribution to UK Government was over £190 million; with a research and development spend of over £600 million. Every month, over two million patients in the UK are prescribed a Pfizer medicine. It is estimated that, on any given day, 40 million people around the world are treated with a Pfizer medicine. Stand 49 PHARMABOTICS LTD 20 Woodmancott, Winchester, Hampshire, S021 3BN Tel/Fax: + 44 (0) 1256 398003 Email:
[email protected] www.pharmabiotics.com In recent years soft-tissue training simulators have made a major contribution to medical education. Thus enabling trainees to practise their skills and gain confidence before working on humans. In collaboration with University College London, Pharmabotics have developed a Sentinel Node Biopsy simulator. This innovative product has similarities to that of human tissue, necessary for gamma probe guided sentinel node mapping. Now to become a primary tool for surgical skills training in the fight against Breast Cancer, the Royal College of Surgeons are now setting up five major centres around the UK using this simulator in specified focused training courses. Pharmabotics products can be seen on the Karl Stortz Stand 49. Stand 88 PIERSON SURGICAL LTD North Bradley House, North Bradley, Trowbridge, Wiltshire, BA14 0TA Tel: + 44 (0)7785 295594 Fax: + 44 (0)7092 315510Email:
[email protected] Pierson Surgical Ltd was formed by Annie Pierson in 2002 as a specialist surgical products distributor with a primary focus on Cardiac and Vascular products. Current products include: Sutures – a wide spectrum of high quality sutures for all aspects of surgery. Stainless Steel Sternal closing Wires. Polyester Patches, Vascular and Thoracic Grafts. Sensipull Aortic Punch, a unique, innovative design that gives
54
you excellent tactile feedback to ensure that every punch is effortless and perfect. Murray Specialist Chairs – a wide range of special operators’ chairs and stools for all clinical practitioners. Innovative designs coupled with remarkable build quality and a unique five-year guarantee. Keeler Magnification Loupes. Surgical Instruments – customised to individual requirements, Instrument repairs. Diamond Knives. Annie looks forward to meeting you on the stand. Stand 18 PPM SOFTWARE LTD Bretby Business Park, Ashby Road, Stanhope Bretby, Derbyshire, DE15 0YZ Tel: 01283 553430 / 07860 525831 Fax: 01283 553431 Email:
[email protected] 'PPM' - PRIVATE PRACTICE MANAGER. Please visit Stand 18 to find out why so many of your colleagues have implemented 'PPM'- Private Practice Manager. 'PPM' will provide all the facilities for the complete Administration and Financial Control of your Private Practice. The service includes on site installation and personal training. In addition, the flexibility of the software means it can be customised, in many area's, to your particular requirements. Alternatively, if you would like to arrange a demonstration, after the exhibition, contact Tom Hunt, details above. Stand 1 PROACT MEDICAL LTD 9-13 Oakley Hay Lodge, Great Folds Road, Oakley Hay Business Park, Great Oakley, Northamptonshire, NN18 9AS Tel: 0870 909 7400 Fax: 0870 909 7500 Email:
[email protected] PROACT Medical Ltd are pleased to introduce the Bladion Molecular Resonance Generator, a remarkable evolution in electro-surgical practice which promises considerable benefits for both patient and surgeon. Rather than using thermal vaporisation to cut and coagulate tissue, the Bladion operates at the resonant frequency of the fluid bond between cells to produce a non-traumatic cold cut of the tissue and a soft coagulation. The result is a cut that heals easily, providing excellent aesthetic results with a significant reduction in post-operative pain and swelling. For the number one product at the show, please visit Stand 1 or call us on 0870 909 7400. Stand 40 RICHARD WOLF UK LTD Waterside Way, Wimbledon, London, SW17 0HB Tel: 020 8944 7447
Fax: 020 8944 1311
Stand 38 ROCHE PRODUCTS LTD 40 Broadwater Road, Welwyn Garden City, Hertfordshire, AL7 3AY Tel: 0800 3281 629 Roche has been a world leader in Oncology for over 40 years, researching and developing innovative
29/3/05
11:42 am
Page 55
treatments for cancer. The Roche oncology portfolio includes innovative targeted treatments for breast, colorectal and haematological cancers along with supportive care treatments for patients undergoing chemotherapy. Roche was the first company to introduce monoclonal antibodies in the treatment of cancer – novel drugs which, unlike chemotherapy target the cancer cells directly. Stand 89 SANDISON EASSON & CO Specialist Medical Accountants, Rex Buildings, Alderley Road, Wilmslow, Cheshire, SK9 1HY Tel: 01625 527351 Fax: 01625 539315 Email:
[email protected] www.sandisoneasson.co.uk Established 25 years ago by the sons of two former Hospital Consultants, Sandison Easson & Co is an independent, highly regarded, firm of Chartered Accountants specialising in acting exclusively for Doctors of Medicine in all areas of the United Kingdom. The firm provides advice on a pro-active basis to clients, in addition to the preparation of their accounts, tax returns and associated matters. The four partners travel extensively throughout the country meeting clients on a regular basis at their home, surgery, consulting rooms or the firm’s offices, whichever is more convenient for the client. Stands 79 and 90 SANOFI-AVENTIS One Onslow Street, Guildford, Surrey, GU1 4YS Tel: 01732 584398 The sanofi-aventis Group is the world’s 3rd largest pharmaceutical company, ranking number 1 in Europe. Backed by a world-class R&D organization, sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular disease, thrombosis, oncology, diabetes, central nervous system, internal medicine, vaccines. The sanofi-aventis Group is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Stand 60 SIGMACON/LAPROSURGE Heriots Wood, The Common, Stanmore, Middlesex, HA7 3HT Tel: 020 8950 9501 www.laprosurge.net
Fax: 020 8950 9199
LaproSurge continually strive to manufacture cost effective Laparoscopic disposable devices. This year at ASGBI we are launching our NEW range of Trocar and Cannula. Other new products include disposable hook and spatula electrodes and CLEARFLOW ULTRA a smoke filter designed specifically for use with Ultrasonic devices. Sigmacon will be exhibiting LUXTEC headlights, Light sources and Headlight Video Cameras. Stand 8 SONOSITE LTD Alexander House, 40A Wilbury Way, Hitchin, Hertfordshire, SG4 OAP Tel: 01462 444800 www.sonosite.com SonoSite is the world leader in hand-carried ultrasound with over 20,000 systems installed worldwide. Since shipping our first product in 1999, our hand carried systems have been changing the way medicine is practiced by changing the how, when and where of ultrasound. SonoSite is transforming the way surgeons think about patient care. Our technology is state of the art, but it is also extremely straightforward. Our systems boot up within twelve seconds, and are pre-configured by exam type so you turn it on and it's ready to scan, enabling you to focus on the patient, not the technology. Visit our stand to see the very latest in hand carried ultrasound technology or contact Bernard Vincent, General Manager. Stand 67 SRA DEVELOPMENTS LTD Bremridge House, Ashburton, South Devon, TQ13 7JX Email:
[email protected]
Stand 2 SCHEBO
• BIOTECH UK LIMITED
PO Box 6359, Basingstoke, RG22 4WE Tel: 01256 477259 Fax: 01256 477259 Email:
[email protected] www.schebo.co.uk
•
The results of ScheBo Biotech’s tests are particularly relevant in gastroenterology and managing cancer patients. The ScheBo® Tumor M2-PK Test detects a tumour metabolic marker that is over-expressed in many different cancers, including gastrointestinal, lung, breast and urological tumours. An independent study of the Tumor M2-PK EDTA-plasma Test in the diagnosis of periampullary cancer is presented at this meeting. New results for the stool test in colorectal cancer and clinical study results with the EDTA-plasma Test in various cancers are available. The ScheBo® Pancreatic Elastase 1 Stool Test is fast becoming the most frequently-used test for measuring pancreatic exocrine function. Please visit our stand for further clinical and technical information. ®
•
PROGRAMME
57799 final prog timetable
Lotus Ultrasonic Scalpel Torsional ultrasound is making waves As surgeon switch from old to new, Answering what the surgeon craves. Fast cutting and its bloodless too! We’ve avoided sitting on the fence, Torsional mode is here to stay; Great surgical performance In a cost-effective way. Visit us on Lotus stand, Our name is SRA Come join the ever-growing band Of surgeons doing it the LOTUS way!
•
55
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
56
29/3/05
11:42 am
Page 56
Stand 28 ST. JAMES'S PLACE PARTNERSHIP
Stand 5 T M LEWIN
St James's House, Castle Quay, Castle Boulevard, Nottingham, NG7 1FW
106 Jermyn Street, Piccadilly, London, SW1Y 6EQ
Tel: 01623 799002
Fax: 01623 799005
Stand 92 STRAKAN PHARMACEUTICALS LTD Buckholm Mill, Galashiels, TD1 2HB, Scotland Tel: + 44 (0)1896 668060 (Contact: Andrew Morris) Strakan Pharmaceuticals is the commercial arm of UK-based ProStrakan Group Ltd, a rapidly expanding specialty pharma company engaged in the research, development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. Rectogesic® 0.4% glyceryl trinitrate (GTN) ointment was approved for marketing in the UK in September 2004. Indicated for the relief of chronic anal fissure pain, it is applied twice daily, delivering a standardised daily dose (3mg) of GTN. It is stable for at least 2 years. Due for launch in 2005, Rectogesic® is the first licensed product for the management of this painful and debilitating condition. Stand 65 STRYKER UK LTD Stryker House, Hambridge Road, Newbury, Berkshire, RG14 5EG Tel: 01635 262400 Fax: 01635 580300 Email:
[email protected] www.stryker.co.uk www.strykerendo.com At Stryker, we believe results speak louder than words. Since the Company’s founding in 1941, that philosophy has made us a leader in the worldwide medical device market and placed us at the forefront of medicine’s most promising solutions. Today, we are one of the preeminent medical products and services companies in the world. Stryker is the technology leader in the operating room. Our innovative products help give surgeons more control and patients better outcomes - while making surgery easier and more efficient for medical professionals and hospital administrators. We were the first to combine voice activation, infrared technology and high definition capture and display devices to fully integrate the operation room. In fact, we offer a broad range of products that have made us the leader in minimally invasive surgery in today's advanced, and rapidly changing, operation room environments. At Stryker, we do more than make promises; we deliver exceptional results. Visit us on Stand 65 – where you can see the latest in High Definition technology.
Tel: 020 7389 3570 Fax: 020 7389 3577 Email:
[email protected] www.tmlewin.co.uk T M Lewin is a privately-owned family business with over one hundred years' of experience in making and selling fine Jermyn Street shirts. Our shirts are still made to the same exacting standards as they were over a century ago. The passion for the quality is at the heart of everything we do. Please do not hesitate to contact us on 0207 389 3570 or email us at
[email protected] Alternatively please view our web site which is updated on a regular basis www.tmlewin.co.uk Stand 22 TSL PLC Victoria House, Victoria Road, Aldershot, Hampshire, GU11 1EJ Tel: 01252 369604
Fax: 01252 333010
Over 100,000 patients worldwide have benefited from Permacol‚ technology. Products include Permacol‚ Surgical Implant, Permacol‚ Injection, Pelvicol‚, ZIMMER‚ Collagen Repair Patch and ENDURAGen™. With its excellent safety record, longevity, low adhesion profile and biocompatibility, Permacol‚ technology has been successfully used in general, urogynaecology, maxillofacial, ENT, plastic and orthopaedic surgery. The clinical benefits of Permacol‚ in general surgery are demonstrated in our 'Book of Abstracts', including adhesion studies, case studies, and long term clinical outcomes. Pick up a copy from Stand 22 and discover why many surgeons are using Permacol‚ as the implant of choice for soft tissue repair. Stand 51 TYCO HEALTHCARE (UK) COMMERCIAL LTD 154 Fareham Road, Gosport, Hampshire, P013 0AS Tel: 01329 224411 Fax: 01329 224390 Email:
[email protected] www.tycohealthcare.co.uk World Class Products; World Class Care. Tyco Healthcare, incorporating Auto Suture, Valleylab and Syneture, is very proud to again be a Corporate Sponsor of the Association of Surgeons of Great Britain and Ireland. In line with our commitment to innovation and quality of care and building on a foundation of excellence, we have, in the last year, launched the Ligasure V 5mm vessel sealing instrument, the New Generation GIA and a number of educational programs offering courses in Laparoscopic Colorectal surgery and Bariatric Surgery. We look forward to meeting you on Stand 51 and showing you how our product range can assist you in providing the highest standards of patient care.
29/3/05
11:43 am
Page 57
Stand 9 UK MEDICAL LTD - SURGICAL DIVISION Albreda House, Lydgate Lane, Sheffield, South Yorkshire, S10 5FH Tel: 0114 268 8880
Fax: 0114 268 8881
Stand 57 VASCUTEK, A TERUMO COMPANY Newmains Avenue, Inchinnan, Renfrewshire, PA4 9RR Tel: (+44) 141 812 5555 Fax: (+44) 141 812 7170 www.vascutek.com VASCUTEK, a TERUMO Company, combines state of the art PTFE, textile and gelatin sealant technologies with a commitment to focused research. The company offers an extensive range of sealed and unsealed ePTFE and polyester prostheses to meet the global needs of vascular and cardiovascular surgeons. SEALPTFE™ & Taperflo™ offer ePTFE grafts with minimal suture hole bleeding, minimal graft "sweating" and the option to bond antibiotic. This has the potential to offer a reduction in theatre and in post-operative complications. A SEALPTFE™ is also available with Unity™ Construction – the world’s only ePTFE grafts with ePTFE support. The Fluoropassiv™ range of grafts and carotid patches are made from a unique fluoropolymer coated polyester biomaterial. The Fluoropassiv™ biomaterial exhibits significantly reduced thrombogenicity compared to polyester and ePTFE. Gelsoft™ Plus is the first of a new generation of zero porosity polyester grafts, featuring a unique, Köper warp knitted structure that minimizes graft dilatation whilst maintaining the handling characteristics associated with knitted grafts. The Gelsoft Plus Equi-flo™ graft, designed specifically for axillo-bifemoral procedures, exhibits significantly improved primary patency compared with 90 degree angled designs. At Vascutek, our ethos of total commitment to all our customers is delivered through technical excellence, stringent quality control and a constant dialogue with the surgical community worldwide.
Stand 10 WISEPRESS ONLINE BOOKSHOP The Old Lamp Works, 25 High Path, Merton Abbey, London, SW19 2JL Tel: 020 8715 1812 Fax: 020 8715 1722 Email:
[email protected] www.wisepress.co.uk Wisepress Online Bookshop is pleased to present a display of titles selected especially for the Association of Surgeons of Great Britain and Ireland conference from the world's leading publishing houses. All titles can be bought or ordered at the congress or via our website: www.wisepress.co.uk . Whatever your book requirements, Wisepress will be happy to help - whether you are an author seeking a publisher, or are having difficulty obtaining a title, our professional staff will be happy to assist you. Stand 27 YORK MEDICAL TECHNOLOGIES LTD Unit 1, The Vivars Centre, Vivars Way, Selby, Yorkshire, Y08 8BE Tel: 01757 702444 Fax: 01757 702744 www.yorkmedicaltechnologies.com York Medical Technologies Ltd (YMT) is a distributor of high quality surgical instruments and disposable products, based in Selby, North Yorkshire. YMT offers a comprehensive range of surgical instruments covering all surgical disciplines. We are the exclusive distributor for Stille Instruments from Sweden, renowned for their range of Super Cut Scissors, and other precision instruments. YMT is also the exclusive distributor for the Thompson retractor, the original table mount system. We also offer a good competitive range of German instruments for general, laparoscopic, plastic and orthopaedic surgery from Zepf and Tontarra.
PROGRAMME
57799 final prog timetable
Stand 82 W L GORE & ASSOCIATES (UK) LTD Kirkton South Road, Kirkton Campus, Livingston, EH54 7BT Tel: 00800 633 44673 Fax: 01506 460492 Email:
[email protected] Gore presents two new bioabsorable products to this meeting. Gore Seamguard, a bioabsorbable Staple Line Reinforcement material for use with surgical staplers. Gore Seamguard material has evolved to meet the challenges of open and minimally invasive surgery. Gore bioabsorbable hernia plug has been developed as an alternative to the permanent hernia plug. It is bioabsorbed in approximately 6 months, thus reducing the potential chronic complications associated with permanent plugs. The device is highly adaptable and easily tailored to create an optimal fit for the defect. The Gore bioabsorbable hernia plug is the solution to problems with permanent hernia plugs.
57
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
58
29/3/05 11:43 am Page 58
Braun ad to come
57799 final prog timetable
29/3/05
11:43 am
Page 59
MOYNIHAN TRAVELLING FELLOWSHIP 2005 The Association’s prestigious Moynihan Travelling Fellowship, up to the value of £5,000 is available annually, by open competition, to Specialist Registrars, towards the end of higher surgical training, or Consultants within five years of appointment at the closing date for this application. The Fellowship is intended to enable the successful candidate to broaden their education and to present and discuss their contribution to British and Irish surgery overseas. It is not appropriate, however, that the award be used as part-funding for an off-service year of training. Candidates must be residents of the United Kingdom or the Republic of Ireland but need not be either Fellows or Affiliate Fellows of the Association; however they should be engaged in general surgery or in one of its specialties. A full Curriculum Vitae should be submitted giving details of past and present appointments and publications, together with a detailed account of the proposed programme of travel, costs involved and objectives to be achieved. Shortlisted candidates will be interviewed by the Scientific Committee of the Association, at 2.00pm on Thursday 3rd November 2005. The Committee will pay particular attention to originality, scope and feasibility of the proposed itinerary. The successful candidate will be expected to act as an ambassador for British and Irish Surgery and should be fully acquainted with the aims and objectives of the Association of Surgeons and its role in surgery. After the Fellowship the successful candidate will be required to provide a written report of their Fellowship for inclusion in the Association’s Executive Newsletter, and to address the ASGBI Annual Scientific Meeting, 18th to 20th April 2007, in Manchester. Requests for information and Applications (15 copies) should be submitted to: Moynihan Travelling Fellowship 2005, Honorary Secretary, Association of Surgeons of Great Britain and Ireland, Royal College of Surgeons of England, 35/43 Lincoln’s Inn Fields, London, WC2A 3PE. Deadline for applications: Monday 3rd October 2005
PROGRAMME
Association of Surgeons of Great Britain and Ireland
2005 OVERSEAS SURGICAL FELLOWSHIP The Association of Surgeons of Great Britain and Ireland, together with the British Journal of Surgery Society, are offering to sponsor surgeons wishing to work on a short term basis, primarily in the Third World. This Scheme is run in conjunction with the Tropical Health and Education Trust to provide support for overseas medical schools in the development of their undergraduate and postgraduate training programmes and also for research, thereby, establishing links with these centres. Only Fellows including Full, Senior, Associate and Affiliates of the Association of Surgeons may apply and, if successful, a grant of up to £2,000 will be made available to individual applicants. Further details are available from Miss Bhavnita Borkhatria, Association of Surgeons of Great Britain and Ireland, Royal College of Surgeons, 35/43 Lincoln’s Inn Fields, London,WC2A 3PE. Deadline for applications: Monday 3rd October 2005
59
ANNUAL SCIENTIFIC MEETING: THE COMPLEAT SURGEON Edinburgh, 3rd to 5th May 2006
57799 final prog timetable
60
29/3/05
11:43 am
Page 60
Association of Surgeons of Great Britain and Ireland
ANNUAL SCIENTIFIC MEETING 2006 The Association’s 2006 Annual Scientific Meeting will be held from Wednesday 3rd to Friday 5th May 2006 at the Edinburgh International Conference Centre The theme of the Meeting will be
“THE COMPLEAT SURGEON” The closing date for the submission of abstracts will be midnight on Friday 4th November 2005
For further information, please contact: Association of Surgeons of Great Britain and Ireland 35-43 Lincoln’s Inn Fields London WC2A 3PE Tel: 020 7973 0300 Fax: 020 7430 9235 Email:
[email protected] or visit
www.asgbi.org.uk
FLOOR PLAN OF THE SECC
First Floor
11:43 am
Ground Floor
29/3/05
Trade Exhibition
57799 final prog timetable Page 61
ANNUAL SCIENTIFIC MEETING: BEST PRACTICE Glasgow, 13th to 15th April 2005
57799 final prog timetable
29/3/05
11:40 am
Page 1
Association of Surgeons of Great Britain and Ireland at The Royal College of Surgeons of England 35/43 Lincoln’s Inn Fields London WC2A 3PE Telephone: 020 7973 0300 Fax: 020 7430 9235 Email:
[email protected]
www.asgbi.org.uk
